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Summary  
Summary   
The protozoan parasite Plasmodium falciparum causes the most severe form of human 
malaria, an infectious tropical disease of global public health importance. Despite efforts and 
means to prevent or treat this disease, there are still over 200 million cases and almost half a 
million deaths annually attributed to P. falciparum. Transmitted to the human host by female 
Anopheles mosquitos serving as vector, the parasite eventually invades erythrocytes and starts 
asexual replication. This stage causes the clinical symptoms of malaria.  
The red blood cell is an interesting choice of a host cell for the intracellular parasite P. 
falciparum as it lacks a nucleus, protein transport machinery, and its nutrient channels are inactive. 
To survive within this host environment, the parasite therefore has to remodel its host cell. The 
extensive host cell remodelling of human erythrocytes during the course of P. falciparum infection 
is facilitated by a large number of proteins which the parasite exports into its host cell cytoplasm. 
The function of the majority of these proteins remains elusive. Existing data suggests that some of 
these exported parasite proteins target the host cytoskeleton and modulate its properties, as 
apparent in changed mechanical properties of the host cell.  
The aim of this project was to identify interactions between host cytoskeleton and exported 
parasite proteins and to create a protein interaction network of the remodeled cytoskeleton. 
Identifying the key players and essential interactions in the process of host cell remodelling will 
lead to the identification of new targets in the fight against the malaria parasite. To this end, a 
number of exported proteins belonging to the PHIST family were selected. All selected PHIST 
proteins were exported into the host cell with most of them localizing in proximity to the 
erythrocyte cytoskeleton or membrane. The promiscuous biotin ligase BirA* (BioID) was fused to 
these proteins and upon addition of biotin proteins in the proximity were labelled with biotin. This 
allowed the pull-down using streptavidin-beads and identification of potential interaction partners 
of these transgenic, exported proteins by mass spectrometry. Based on the results from this study 
and additional data from previous projects, I generated a network of potential protein-protein 
interactions at the erythrocyte cytoskeleton. 
A standard approach to verify potential protein interactions is to perform reverse protein pull-
downs. Because erythrocytes lack a nucleus, the classical transgenic approach to add molecular 
tags to erythrocyte proteins or to modify them in any way is not possible. To circumvent this 
holdback and to facilitate immunoprecipitations with erythrocyte proteins as bait, I generated 
parasite lines which expressed and exported different tagged human cytoskeleton proteins. These 
transgenic human proteins were designed to be exported and to be soluble within the cytosol of 
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the infected erythrocyte. It was expected that these proteins would bind to their putative 
endogenous parasite binding partners while these are transported to their final destination within 
the host cell. These transgenic human proteins can then be used for immunoprecipitations to 
identify these binding partners. I tested several export sequences and showed that each of them 
resulted in efficient export of the intracellular loop of band 3 (residues 1-379) and the full-length 
band 4.1. In both of these cell lines, the majority of the protein was soluble in the host cytosol. 
Due to time constraints, these cell lines could not be further analyzed in detail. 
While little is known about the function and role of exported proteins in host cell remodeling 
during asexual developmental stages, even less is known about these proteins and their functions 
during gametocyte development of P. falciparum. Until recently, it was difficult to obtain high 
numbers of gametocytes, making it difficult to study host cell remodeling in these stages. The 
availability of a transgenic cell line from the Voss lab at Swiss TPH, in which high sexual conversion 
rates can be induced, provides a great opportunity to study these interactions in gametocytes. 
Taking advantage of this cell line we characterized GEXP02, a member of the PHIST protein family 
which is expressed and exported in gametocytes. We confirmed the expression pattern and 
localized GEXP02 at the periphery of the gametocyte-infected erythrocyte. By immuno-
precipitation and mass spectrometry we could identify cytoskeleton proteins as well as other 
exported proteins as potential interaction partners. Based on co-labelling of GEXP02 with 
PFI1780w and PF3D7_0424600, two other PHIST proteins, we could confirm these as likely 
interaction partners. In GEXP02 knock-out parasites, no obvious detrimental effect or phenotype 
could be observed in asexual parasites or during gametocyte development nor throughout the 
mosquito stages or in liver hepatocyte infectivity. Although no function could be assigned to this 
protein, our study is one of the first to characterize in great detail an exported protein in 
gametocytes and shows that the erythrocyte cytoskeleton is targeted by exported parasite 
proteins also during gametocyte development.  
Furthermore, within the context of this present study, I conducted two extensive literature 
reviews. In one review I collected information on the functionally elusive PHIST family in the genus 
Plasmodium. The review on the PHIST protein family presents an in-depth overview on this 
protein family. It acts as a reference work for quick, but detailed information on these proteins that 
are thought to be involved in cytoskeleton remodelling. The other review concerned protein-
protein interactions involved in host cytoskeleton remodeling of P. falciparum. By combining 
pieces of existing information, new insights were gained in this review. I could show that each 
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stage of the intraerythrocytic life cycle presents different challenges to the intracellular survival of 
the parasite. Consequently, P. falciparum remodels its host cell differently in the various stages to 
meet the specific needs.  
In summary, this thesis provides new insight into host cell remodeling by the malaria parasite, 
shows the importance of exported proteins in this process, and offers a new tool in the study of 
interactions between erythrocyte cytoskeleton and exported parasite proteins. 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Malaria Epidemiology 
Malaria is a tropical disease caused by the unicellular Apicomplexan parasite Plasmodium. 
Five Plasmodium species cause human malaria: P. falciparum, P. vivax, P. malariae, P. ovale, and P. 
knowlesi. While P. vivax is the most wide-spread species, P. falciparum causes the most severe 
form of malaria, called malaria tropica (1-3).  
The 2017 WHO World Malaria Report shows progress made in the fight against malaria. 
Between 2010 and 2016, an increase was reported for the distribution of insecticide-treated nets, 
the number of febrile children seeking health care and being tested for malaria, as well as the 
number of pregnant women receiving preventive treatment. In the same time interval, the 
incidence rate decreased by 18% and a number of countries has reported zero cases for the last 
years or has been certified as malaria free (4).  
Despite this progress and despite being a preventable and treatable disease, malaria still has 
a major global impact on health and economy. It has caused an estimated 216 million cases and 
445’000 deaths in 2016, with half of the human population at risk of infection (4). Malaria remains 
endemic in 76 countries, most of which are located in subsaharan Africa, and the tropical regions 
of Southeast Asia and South America (Figure 1). 80% of all malaria cases were reported from 15 
countries, all but one in subsaharan Africa, indicating that this region suffers the greatest malaria 
burden (4). 
Figure 1. Malaria endemic countries. World map showing the 2016 status of countries with 
indigenous malaria cases in 2000. Figure adapted from WHO World Malaria Report 2017 (4). 
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Malaria Life Cycle 
P. falciparum has a complex life cycle alternating between two different hosts, the human host 
and the arthropod vector. Upon the bite of an infected female Anopheles mosquito, a few 
sporozoites are injected into dermal tissue (Figure 2A). These sporozoites then migrate through 
the tissue by gliding motility until they reach the blood stream. From there, sporozoites eventually 
reach the liver, traverse through Kupffer cells hepatocytes, and finally invade liver hepatocytes (3). 
Once inside the hepatocyte, sporozoites start replication, at the end of which thousands of 
merozoites are formed (3, 5). Upon rupture of the hepatocyte, merosomes are released into the 
blood stream and subsequently release the merozoites which then invade erythrocytes (6). This 
starts the 48 hour asexual replication cycle (Figure 2B).  
Figure 2. Life cycle of P. falciparum. The life cycle starts with the transmission event during a 
mosquito blood meal (A), followed by the liver stage (B) and the intra-erythrocytic stages 
consisting of asexual replication (C) and sexual development (D). After transmission to the 
mosquito, sexual replication occurs in the mosquito midgut (E) and then final developmental 
stages occur in the basal lamina (F). Figure adapted from Cowman et al. (3). 
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For the first half of the intra-erythrocytic cycle, the parasite is in the ring stage. This is 
followed by the trophozoite and schizont stages. Mature schizonts release merozoites into the 
blood stream in an event known as egress. These released merozoites start a new asexual 
replication cycle (Figure 2C) (3). During each asexual cycle, a few parasites commit to sexual 
development. Once these committed parasites reinvade a new host cell, they become 
gametocytes. Gametocytes sequester in the bone marrow. Sexual development can be divided 
into five distinct morphological stages, with stage V being mature gametocytes which re-enter the 
blood stream (7). Stage V gametocytes can be transmitted to the mosquito vector during a blood 
meal (Figure 2D). In the mosquito midgut, male and female gametocytes become gametes, fuse 
into a zygote, and undergo meiosis (Figure 2E). Following meiosis, ookinetes migrate into the 
midgut endothelium. There, they develop into oocysts inside which sporozoites are formed. 
Mature sporozoites migrate to the salivary gland and are ready for transmission to a new human 
host (Figure 2F) (3).  
Clinical Symptoms, Treatment, and Prevention 
Clinical symptoms are only caused during the asexual blood stages. The most common and 
also non-specific clinical symptoms are fever, nausea, vomiting, and muscle pain. In severe cases 
life-threatening complications such as cerebral malaria (coma), anaemia, and organ failure can 
occur (3, 8).  
A number or antimalarial drugs are available. However, in recent years, resistance to some of 
these antimalarial drugs has been reported (9). For example, resistance against artemisinin has 
surfaced in Southeast Asia, conferred by the C580Y point mutation in Kelch 13, a proposed E3 
adaptor protein (10). Emerging resistances threaten malaria control programs and elimination 
efforts and underline the need for further research in drug and vaccine development. To minimize 
the risk of resistance formation, WHO recommends Artemisinin-based combination therapies. 
The most effective way to fight malaria and work towards its elimination would be vaccines. 
Albeit research for malaria vaccines is ongoing and various candidates are at different stages of 
clinical trials, none has yet been licensed for commercial use (11). 
Early malaria diagnosis is essential for successful treatment and interrupting the transmission 
cycle. Different types of diagnostic tools are available, each of them bearing intrinsic advantages 
and disadvantages with regard to sensitivity, availability, and given infrastructures. The most 
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sensitive means of malaria diagnosis is PCR. Antigen-based rapid diagnostic tests and parasite 
detection by microscopy of Giemsa-stained blood smears are standard diagnostic tools in low 
resource or field settings (12).  
Protein Export 
Since the erythrocyte is a terminally differentiated cell that lacks both a nucleus and a 
secretory system/protein trafficking machinery, P. falciparum has to extensively remodel the red 
blood cell in order to turn it into a suitable host and ensure its survival. Exported parasite proteins 
and their interactions with host proteins are responsible for this remodeling. To reach their 
interaction partners and to fulfill their role, these parasite proteins have to cross two membranes: 
the parasite plasma membrane (PPM) and the parasitophorous vacuole membrane (PVM). 
Exported proteins are classified into two different groups, those with a known export signal, and 
those lacking such a signal. 
A group of exported parasite proteins possesses a pentameric amino acid motif RxLxE/Q/D, 
with x representing any amino acid. The discovery of this Plasmodium Export Element (PEXEL) 
allowed for the prediction of about 460 exported proteins (13-16), accounting for approximately 
10% of the parasite’s proteome (17).  
A number of exported proteins lack a known export signal and are thus called PEXEL-
negative exported proteins (PNEP). Some PNEPs are associated with Maurer’s clefts and PfEMP1 
trafficking such as MAHRP1/2, SBP1, and REX1/2, indicating their significance in host cell 
remodeling (18). However, the lack of an export signal makes it impossible to predict their 
number, making PNEPs somewhat of a black box in these processes.  
Proteins are translated in the parasite cytosol. Normally, co-translational entry into the ER and 
thus entry into the secretory pathway is mediated by a signal peptide, a hydrophobic region at 
the N-terminus of the nascent protein. Once inside the ER, the PEXEL motif is cleaved after the 
leucine residue by Plasmepsin V, the N-terminus is acetylated (19, 20), and proteins are folded by 
chaperones. Proteins destined for export are then transported by vesicles to the PPM and are 
secreted into the PV (21). 
The next barrier to be crossed is the PVM. A multi-protein complex, the Plasmodium 
translocon of exported proteins (PTEX), translocates proteins across the PVM. The PTEX consists 
of three essential proteins EXP2, PTEX150, HSP101, as well as two non-essential proteins PTEX88 
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and TRX2. Multiple copies of EXP2 proteins form a pore that spans the PVM while multiple copies 
of PTEX150 and HSP101 extend the pore on the luminal side of the PV. Once unfolded, proteins 
are translocated by the PTEX from the PV lumen into the erythrocyte cytosol in an ATP-dependent 
process (22-25). The newly discovered Exported Protein-Interacting Complex (EPIC) is thought to 
shuttle proteins targeted for export to the PTEX and thus aid in translocation across the PVM (26). 
Chaperones assist in refolding and/or further trafficking of these proteins. Now in the host cell, 
exported proteins have to reach their final destination such as the iRBC cytoskeleton and 
membrane, Maurer’s clefts, J-dots, vesicles, or the host cytosol (reviewed in (27)).  
Figure 3. Protein export in P. falciparum. During their export from the parasite into the host, 
parasite proteins have to cross several membranes, including the parasite membrane (PM), the 
parasitophorous vacuole membrane (PVM), and in the case of secreted proteins also the 
erythrocyte plasma membrane (EPM). Vesicular transport, translocation through pore complexes, 
and chaperone-assisted protein refolding are some means involved in protein export. Figure 
adapted from De Koning-Ward et al. (27). 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Functions of Exported Proteins 
Exported proteins are central to the intracellular survival of P. falciparum and thus fulfil a 
variety of functions within the host cell. One of these functions is nutrient uptake. While the 
malaria parasite feeds on hemoglobin, this does not provide all amino acids as hemoglobin lacks 
for example isoleucine. To access required solutes and amino acids not (sufficiently) found within 
the host cytoplasm, the permeability of the iRBC membrane has to be increased, allowing uptake 
of nutrients from the extracellular environment and ion homeostasis. This new permeability 
pathway (NPP) consists of parasite-derived membrane channels called Plasmodial surface anion 
channel (PSAC). These channels are inserted into the PPM and facilitate solute uptake (28-30). 
Many exported proteins assist in trafficking of others. On the way to their final destination, 
many exported proteins pass through Maurer’s clefts, or are transported in vesicle-like structures 
or in protein complexes containing chaperones. Thus, some proteins are simply exported to 
establish the trafficking machinery for those exported proteins that interact with and modify the 
host (reviewed in (31, 32)). Gametocyte sequestration in the bone marrow requires parasite-
induced alterations to host cytoskeleton deformability and rigidity. Apart from STEVOR (33), such 
a role for most exported proteins in gametocytes has yet to be confirmed (7). 
PfEMP1, Immune Evasion, and Cytoskeleton Remodeling 
The growing parasite has to avoid clearance by the spleen in order to ensure its survival and 
to continue in its life cycle. The evolutionary answer to this is cytoadhesion mediated by P. 
falciparum exported membrane protein 1 (PfEMP1), an exported transmembrane protein which is 
inserted into the iRBC membrane in surface protrusions referred to as knobs (34). The PfEMP1 
ecto-domain mediates binding to cell receptors such as CD36, ICAM, CSA, and EPCR (35, 36). 
This binding between PfEMP1 and cell receptors is associated with severe malaria and thus plays 
a central role in the pathogenicity of P. falciparum (36-38). A number of exported parasite proteins 
are involved in local remodeling of the cytoskeleton to connect it to knobs and PfEMP1. Thus, 
exported proteins are central to the successful completion of the intra-erythrocytic development 
and to the continuation in the life cycle of P. falciparum. The processes and key players in the 
remodeling of the iRBC cytoskeleton are reviewed in detail in Chapter 2. 
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PHIST Proteins 
Bioinformatics analyses identified eighty-nine P. falciparum proteins that share common 
features. They contain four consecutive alpha helices and conserved tryptophan residues. These 
proteins were grouped into the Plasmodium helical interspersed subtelomeric (PHIST) family. 
Based on the number and position of the conserved tryptophan residues, PHIST proteins are 
further divided into sub-categories: PHISTa, PHISTb, and PHISTc, with seven of the PHISTb 
proteins containing a DnaJ domain (39). Previous studies have shown that at least some of the 
PHIST proteins localize at the iRBC cytoskeleton. One PHIST protein was shown to interact with 
PfEMP1 and cytoskeletal proteins and was thus suggested to be involved in PfEMP1 anchoring 
(40-42). When investigating the sub-cellular localization of PHIST proteins, a number of them were 
found to localize to the iRBC periphery (43). Again another study detected a binding motif which 
in one protein is known to bind to cytoskeleton protein band 4.1, suggesting some of the PHISTs 
to possess a cytoskeleton binding capacity (44). An in-depth review on the PHIST protein family is 
found in Chapter 3.  
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Aims and Objectives 
The overall aim of this thesis was to investigate the function and role of selected exported 
parasite proteins. Many exported proteins are directly or indirectly involved in the process of host 
cell remodeling, which leads to knob formation and PfEMP1 anchoring, and thus to morbidity and 
mortality. While a number of studies have focused on exported proteins, the majority of them still 
remain enigmatic. To close this knowledge gap, a set of ten PHIST proteins was selected to be 
investigated in more detail with special focus on their interaction partners. Understanding the 
function of exported proteins can help to identify new targets in the fight against malaria. 
In the effort to identify potential interaction partners for proteins of interest, immuno-
precipitations play a central role. As exported parasite proteins also target the iRBC cytoskeleton, 
reverse immunoprecipitations would need to be performed to verify proposed protein-protein 
interactions. Due to the interconnectivity of the cytoskeleton, these have proven difficult. 
Furthermore, with the erythrocyte being a terminally differentiated cell that lacks a nucleus, the 
genetic manipulation of erythrocyte proteins remains a challenge. Thus, a system needs to be 
designed that allows for genetic manipulation of erythrocyte proteins which are then exported 
into the host cell and that can then be used in assays such as immunoprecipitations. 
There is an even greater knowledge gap on the function of exported proteins in host 
cytoskeleton remodeling during gametocyte development. Uncovering their potential role in the 
processes of altering cell deformability and sequestration could identify new ways to interfere with 
gametocyte development and thus interfere with transmission to the mosquito.  
OBJECTIVE 1 
Characterization of selected PHIST proteins as well as the identification and confirmation of 
potential interaction partners to generate a network of protein-protein interactions at the 
remodeled iRBC cytoskeleton (see Chapter 4). 
OBJECTIVE 2 
Generation of transgenic parasite lines that express and export (truncated versions of) human 
cytoskeleton proteins to be used in immunoprecipitations and the confirmation of potential 
interactions with exported parasite proteins as detected in Objective 1 (see Chapter 5). 
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OBJECTIVE 3 
Characterization of a PHIST protein (GEXP02) that is expressed and exported during the 
gametocyte stages with regard to its possible role in host cytoskeleton remodeling during this 
developmental phase (see Chapter 6).  
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Abstract 
The asexual intraerythrocytic development of Plasmodium falciparum, causing the most 
severe form of human malaria, is marked by extensive host cell remodeling. Throughout the 
processes of invasion, intracellular development, and egress, the erythrocyte membrane skeleton 
is remodeled by the parasite as required for each specific developmental stage. The remodeling is 
facilitated by a plethora of exported parasite proteins and the erythrocyte membrane skeleton is 
the interface of most of the observed interactions between parasite and host cell proteins. 
Host cell remodeling mostly has been described in the context of protein export or for the 
description of parasite induced structures such as Maurer’s clefts or knobs on the host cell surface. 
Here we attempt to go beyond this and review the molecular level of each host cell remodeling 
step at each stage of the intraerythrocytic development of P. falciparum. We describe key events 
such as invasion, knob formation, and egress, and identify the interactions between exported 
parasite proteins and the host cell cytoskeleton. We discuss each remodeling step with respect to 
time and specific requirement of the developing parasite to explain host cell remodeling in a 
stage-specific manner. Thus, we highlight the interaction with the host membrane skeleton as key 
event in parasite survival.  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Introduction 
Plasmodium 
Malaria is caused by the intracellular apicomplexan parasite of the genus Plasmodium. This 
infectious disease is transmitted by the bite of an infected female Anopheles mosquito. Despite 
many efforts towards its elimination, malaria remains a major global health burden, causing 
roughly 430’000 deaths and 210 million infections per year, while 3.5 billion people live at risk of 
infection (1, 2). 
Six Plasmodium species cause human malaria: P. falciparum, P. vivax, P. ovale curtisi, P. ovale 
wallikeri, P. malariae, and P. knowlesi (1, 3). Of these, Plasmodium vivax is the most widespread 
species, while the most severe form of malaria is caused by P. falciparum (4). 
The Life Cycle of P. falciparum 
Throughout its life cycle, P. falciparum alternates between two hosts, the arthropod vector 
and the human host. During a blood meal of an infected female Anopheles mosquito, 
extracellular sporozoites are transmitted into dermal tissue subsequently reaching blood vessels 
from where they are transported to the liver. Sporozoites transverse and invade hepatocytes 
where they replicate and develop into merozoites that are released into the peripheral blood. 
Once in the blood merozoites invade erythrocytes and the asexual replication cycle starts which is 
responsible for all clinical symptoms of malaria. During each intra-erythrocytic developmental 
cycle few parasites commit to sexual development and become gametocytes. Mature 
gametocytes are transmitted to mosquitoes during a blood meal. In the mosquito midgut, male 
and female gametocytes become gametes which then fuse into a zygote. After development in 
the mosquito sporozoites are formed, migrate to the salivary glands, and can be transmitted to 
the next human host (1, 5).  
Why to remodel the host cell? 
P. falciparum invades its host cell to replicate and to be transmitted and all changes during 
the 48 hours intraerythrocytic cycle are logical consequence for this. Host cell invasion requires 
the parasite to cross the erythrocyte membrane and cytoskeleton. Replication and formation of 
daughter cells leads to substantial increase of size and the once discoid red blood cell changes 
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into a more spherical infected red blood cell (iRBC) with the consequence that it can no longer 
pass through the spleen. To avoid splenic clearance the parasite sequesters at the endothelial 
lining of the capillaries in deep tissue. This cytoadhesion requires the parasite to insert antigens 
into the host cell membrane and to anchor them in knob complexes to the iRBC cytoskeleton in 
order to mediate adhesion. At the end of the intraerythrocytic cycle, the merozoites exit from their 
host cell and must cross the iRBC cytoskeleton and membrane again. Each stage therefore has its 
own requirements and through remodeling of the host cell the parasite fulfills those requirements 
and the exported parasite proteins play a key role in these processes.  
A number of reviews mention how extensively P. falciparum remodels the host cell but focus 
on exported parasite proteins, the machinery required for export, and the establishment of exo-
membrane structures which aid in protein trafficking (5-8). Despite such large body of information, 
the interaction of these exported proteins and the alteration of host proteins through these 
interactions are often neglected. Here we focus on the iRBC cytoskeleton because it is the target 
or interface of many known host-parasite interactions and it is continually remodeled throughout 
the intraerythrocytic asexual and sexual development (Figure 1). The erythrocyte cytoskeleton is 
remodeled during invasion, knob formation, egress, or during gametocyte maturation. Each step 
has been shown to require specific modifications of the cytoskeleton and here we review the 
different modifications and the key players involved in each stage or specific event. We highlight 
and discuss the specific steps involving host-parasite interactions at the iRBC cytoskeleton. 
Protein Export 
To initiate host cell changes the parasite must export a large number of proteins to refurbish 
the iRBC. In this process all exported proteins need to pass through the parasite and 
parasitophorous vacuole membranes. The identification of the Plasmodium export element 
(PEXEL), a pentameric amino acid motif, was a major breakthrough and allowed to predict a large 
number of exported proteins (9, 10). Currently, proteins carrying a PEXEL, a more relaxed PEXEL 
(11), or a non-canonical PEXEL (12), allowed the prediction of over 460 exported proteins. In 
addition there is another group of exported proteins lacking a known export motif and these are 
referred to as PEXEL negative exported proteins (PNEPs) (13). Exported proteins have been 
implicated in the genesis of new organelles or functional complexes/structures such as the PTEX 
(14), Maurer’s clefts (MCs) (15), J-dots (16, 17), knobs (18), and the new permeability pathway (19, 
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20) as previously reviewed (8, 21, 22). Many of these proteins also are involved in remodeling of 
the cytoskeleton and export of these proteins leads to the pathology of falciparum malaria. 
The human red blood cell cytoskeleton 
The erythrocyte membrane skeleton is a two dimensional hexagonal lattice formed by 
(α1β1)2-spectrin tetramers (about 180 nm in length) which are connected at their ends by short 
actin filaments (35 nm). These junctions are stabilized by band 4.1, forming a ternary complex 
(23-26). Multiple other proteins either stabilize this meshwork or support its attachment to the red 
cell membrane. Proteins involved in actin binding and turn-over are adducin, tropomodulin, 
tropomyosin, and others as reviewed in (25). The spectrin-tetramer is bridged in its middle to 
band 3, an integral membrane protein via ankyrin, keeping the skeleton close to the cell 
membrane (23, 24, 27, 28). Another link between the skeleton and the membrane is formed by 
the interaction between the cytoplasmic face of Glycophorin A and band 4.1, which in turn 
associates with actin (23). An alternative vertical connection between membrane and skeleton is 
facilitated by p55 linking Glycophorin C and band 4.1 (29). The highly elastic properties and 
unique biconcave shape of the erythrocyte membrane skeleton allow for passive deformation 
which occurs during the passage through the spleen (23, 30). 
Life cycle stage and event specific remodeling of the host cell cytoskeleton 
In a simplified model the mature human erythrocyte can be divided into three major 
components: membrane, membrane skeleton, and cytosol, of which all are important sites for the 
intracellular development of the parasite. During invasion and egress, the cytoskeleton and 
erythrocyte membrane have to be crossed, and during other stages, the cytoskeleton and 
membrane need to be modified to accommodate the needs of a growing parasite that tries to 
evade the host immune system. 
Invasion 
Erythrocyte invasion is a fast and well-orchestrated process that is completed within less than 
two minutes (Figure 2). The initial contact is yet not well understood but the merozoite surface 
protein 1 (MSP1) seems to mediate the initial binding between merozoite and erythrocyte (31). 
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This causes a weak deformation of the erythrocyte at the site of merozoite attachment (31-34) and 
could be the result of cytoskeleton phosphorylation induced by increased Ca2+ (32, 35). Ca2+ 
concentration determines the shape of the erythrocyte through modulating protein 
phosphorylation which in turn regulates protein-protein interactions at the erythrocyte 
cytoskeleton. 
The initial contact is followed by stronger binding mediated by members of two Plasmodium 
protein families, the erythrocyte binding-like proteins (EBL) or the P. falciparum reticulocyte-
binding protein homologs (PfRh) to glycophorin A, B, C, or to the complement receptor 1 on the 
erythrocyte surface (31). This interaction between the Rh5-complex and Basigin leads to an influx 
of Ca2+ into the erythrocytes which triggers phosphorylation of membrane skeleton proteins (34) 
such as spectrin (36) or band 3 (37, 38). Once phosphorylated, band 3 dissociates from ankyrin 
and spectrin thereby weakening the cytoskeleton and detaching it from the membrane at the site 
of entry (37, 39). Binding of recombinant Rh5 to RBCs not only causes also increased 
phosphorylation of ankyrin and adducing leading to dissociation from the skeleton and its 
weakening but also increases the overall size of the spectrin meshwork (34). The importance of 
band 3 in invasion is evident in the higher resistance to P. falciparum invasion of ovalocytic 
erythrocytes which carry a 27 bp deletion in the band 3 gene (40, 41).  
Another mechanism emerged for protein depletion and detachment of the cytoskeleton at 
the site of entry. Band 3 as well as ankyrin, adducin, or band 4.1 are proteolytically cleaved (42, 
43) and proteases potentially involved are chymotrypsin-like protease (42), the parasite serine 
protease gp76 (44, 45), falcipain 1 (46), or plasmepsin II (47, 48). Some of these proteases are also 
found in schizonts and it is not clear whether they are involved in egress or if they are stored in 
apical organelles of newly formed merozoites to be used later. Some of these proteases have only 
been tested on substrates in vitro and their true function has not been clearly elucidated.  
It is intriguing to note that band 4.1 can be proteolytically cleaved during the invasion 
process (43). However, when band 4.1 is already absent due to its gene deletion in hereditary 
elliptocytosis invasion of merozoites is less efficient. Band 4.1 links the spectrin-actin cytoskeleton 
to glycophorin C and thus to the membrane and gives it an important function in maintaining the 
structural integrity of the cytoskeleton (49). Elliptocytes also have been reported to display 
decreased membrane deformability and rigidity and in both, ovalocytosis and elliptocytosis, the 
altered structural integrity of the cytoskeleton impairs the invasion process. 
!21
Chapter 2: Cytoskeleton Remodeling Review   
Binding of EBA-175 to Glycophorin A induces phosphorylation of cytoskeletal proteins 
tropomodulin, adducin, ankyrin and band 4.1, leading to increased deformability of the 
erythrocyte, which is important for merozoite invasion. Blocking this phosphorylation prevents 
increase of deformability and thus prevents parasite invasion (31, 50). In contrast, Koch et al. 
reported that binding of EBA-175 to Glycophorin A increased the erythrocyte stiffness which 
seemed to enhance invasion probably as result of cross-linking of Glycophorin A to the membrane 
skeleton (39, 51).  
It was also reported that elevated Ca2+ concentrations cause membrane budding or intake of 
vesicles into erythrocytes that normally do not phagocytose (52-54). This and the depletion of 
cytoskeletal proteins from the site of invasion resulting in loosening of the membrane from the 
cytoskeleton, could promote membrane wrapping which had been described to occur during 
invasion and could contribute to the energy needed for this process (36, 55). Membrane wrapping 
or budding presumably are the same processes in merozoite invasion and membrane wrapping 
around the merozoite leads to budding and subsequent intake of the parasite. At the same time 
the parasite becomes enclosed within the parasitophorous vacuole membrane (PVM). 
Most of the cytoskeleton remodeling occurs at the very initial phase of contact between the 
merozoite and the erythrocyte with the purpose to facilitate entry and PVM formation. After 
successful invasion the membrane is resealed and the cytoskeleton is most likely restored (55). 
RBC membrane and cytoskeleton pose an obstacle to merozoite invasion but in the best interest 
of the merozoite these barriers are crossed without causing permanent damage to the host cell.  
Ring Stage 
The first half of the intraerythrocytic developmental cycle is referred to as the ring stage, a 
name inspired by its typical shape or morphology as seen by Giemsa staining (56). Within minutes 
after invasion, the parasite starts exporting proteins into the host cell (5), a continuous process 
until the end of the 48 h developmental cycle. One of the earliest exported proteins is the PHIST 
(Plasmodium helical interspersed subtelomeric) protein RESA, which is discharged from dense 
granules into the parasitophorous vacuole and then exported into the host cell (57). Malaria 
induces fever episodes episode (58) and stability of the spectrin network decreases as 
temperature increases (59). Hence, binding of phosphorylated RESA to repeat 16 of β-spectrin 
conveys protection against thermally induced denaturation by increasing the rigidity of the iRBC 
to have a protective effect, while still remaining sufficiently deformable to allow for splenic 
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passage (57, 59-63). This stabilizing effect might be mediated by the DnaJ chaperone domain of 
RESA which could prevent unfolding of spectrin (64).  
Several high molecular weight proteins (RhopH) are discharged from the rhoptries during 
invasion and are found throughout the entire intraerythrocytic cycle at the iRBC periphery. 
Multiple host cytoskeleton and exported parasite proteins have been identified as potential 
interaction partners suggesting that RhopH proteins might be involved in host cell remodeling. 
While no functional analyses supporting this conclusion have been provided (65, 66) this clearly 
indicates that parasite proteins are present in the host cell from the moment of invasion. However, 
it is possible that these proteins are involved in invasion and simply remain in the host cell not 
having any known function anymore. 
While almost no phosphorylation is found during the ring stage, band 3 was shown to be 
phosphorylated at tyrosine residues (67) coinciding with a reduced lateral mobility (68). At the 
same time, this indicates that proteins phosphorylated during invasion are actively 
dephosphorylated during the ring stage otherwise they still would be detected. This also supports 
the notion that cytoskeleton modifications observed during invasion are reversible and non-
destructive. Little is known about further modifications of the iRBC cytoskeleton during the next 
hours until the transition from ring to trophozoite stage which is accompanied by major 
remodeling processes. There is little further information on the first half of the intraerythrocytic life 
cycle. It is unclear whether there are slowly progressing modifications but the rest of this part of 
the cycle seems to be quite uneventful. As the host’s fever episode lasts throughout almost the 
entire ring stage, cytoskeletal modifications other than protection against thermally induced stress 
would be detrimental and probably are not possible. Any modifications which would further 
increase the deformability of the host cell would put the iRBC cytoskeleton at risk of collapsing. 
Similarly, increasing rigidity too much would cause the circulating iRBC to be cleared out by the 
spleen. Therefore, this stage seems to prepare for major changes occurring when the parasite 
develops into the trophozoite stage. Transcriptome analysis of the early stage shows genes up-
regulated that are involved in transcription translation and in metabolic processes (69). Structures 
such as the PTEX (14), MCs (15), J-dots (16, 17) and other components of the protein export and 
trafficking machinery are generated at this stage. Many proteins are synthesized and exported to 
MCs, where they are stored until trafficked to their final destination. MCs seem to be larger in size 
during ring stage than in trophozoites (70), suggesting a possible function as storage organelles. 
Many exported proteins accumulate in MCs, but do not yet interact with the host cell 
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cytoskeleton, but they are present in large quantities and in close proximity to their destination 
from where they may be discharged when needed. The reduced size of MCs in trophozoites (70) 
could imply that transiently stored cargo has been discharged and could explain the rapid 
changes occurring during the transition to trophozoites.  
Transition from Ring to Trophozoite Stage 
During the first hours of infection P. falciparum establishes a fully functional protein trafficking 
machinery enabling transport of proteins to various subcellular localizations. The transition from 
ring to trophozoite stage around 16-24 hours post invasion the parasite is marked by multiple 
changes in the iRBC. The parasite exports proteins that target the cytoskeleton changing its 
properties and structure, knobs appear on the surface of the host cell, and the mobile MCs are 
tethered to the cytoskeleton. All these changes described in detail below occur to facilitate 
cytoadherence to avoid splenic clearance and to prepare for future growth, replication, and 
formation of daughter cells. 
Reorganization of the iRBC cytoskeleton 
During this transition phase, RESA disappears from the cytoskeleton and seems to be 
replaced by MESA, although they do not share the same binding partner or site (59, 71). As 
described earlier, RESA seems to protect the host cell cytoskeleton against thermal damage which 
is no longer needed since at this stage of infection body temperature decreases to normal (58). 
Whilst RESA stabilizes the cytoskeleton, binding of MESA alters its stability by competing with the 
host protein p55 for binding to band 4.1, a protein involved in stabilizing the spectrin-actin 
network. A 19 amino acid motif of phosphorylated MESA interacts with a 51 aa motif encoded by 
exon 10 of band 4.1 (72-75). The interaction at the ternary complex between band 4.1, actin, and 
spectrin seems to be regulated through the level of phosphorylation. In iRBCs band 4.1 shows an 
increased level of phosphorylation, which weakens its interaction with the cytoskeleton (76). MESA 
and band 4.1 are phosphorylated independently but this modification is important for their 
interaction (72, 77, 78). The removal of p55 weakens the spectrin-actin interaction and free 
spectrin ends are generated and used to anchor knobs to the cytoskeleton. At the same time free 
actin becomes available and is used to grow filaments to connect MCs with the cytoskeleton. It is 
unclear whether MESA competes with every single p55 molecule or if this competition takes place 
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only in focal spots where knobs are being formed. Actin is absent from knobs but is still found in 
close proximity (79-81) suggesting that the site of actin mining and knob formation are identical. 
The presence of a band 4.1-binding motif in 13 other exported parasite proteins (75) suggests 
that MESA is most likely not the only protein involved in restructuring the iRBC cytoskeleton.  
Knob formation and Cytoadhesion 
Knobs are protrusions on the iRBC surface formed by an electron-dense layer underneath the 
iRBC membrane consisting of a protein complex dominated by KAHRP (18, 82) and an underlying 
spiral scaffold (81). Knobs were reported in association with cytoskeletal junctions, although not all 
junctions showed presence of knobs (18, 83, 84). KAHRP self-assembles underneath the iRBC 
membrane, is essential for knob formation (82, 85), and binds spectrin, actin, and band 4.1 
(86-88). A 72 amino-acid stretch of KAHRP binds α-spectrin at repeat 4 (88) while the 5’ repeat 
region of KAHRP binds β-spectrin at repeats 10-14. This binding is strengthened through 
complementary isoelectric charges and takes place adjacent to the spectrin-ankyrin interaction 
site at repeats 14-15 of β-spectrin (82, 89, 90). This interaction takes place close to ankyrin and 
KAHRP also interacts with ankyrin. As a result, each knob is connected to four to eight spectrin 
tetramers leading to a higher spectrin density in knob areas than anywhere else in the skeleton 
(84). Presumably, the spectrin ends connected to the knobs were generated during actin mining. 
Neither the composition of the knob spiral scaffold (spectrin was excluded as a component) nor 
the exact interactions to link this spiral to the erythrocyte cytoskeleton are known, but it was 
proposed that the spiral would give knobs their shape and provide mechanical stability (81). A 
detailed model of knobs has been described by Cutts et al. (90). 
Probably the most important function of knobs is to anchor PfEMP1 which accumulates at the 
iRBC surface around 16-20 hpi (91). PfEMP1 mediates cytoadhesion to the endothelial lining of 
the capillaries (92-96) and iRBC sequestration is linked to severe malaria (97, 98) making PfEMP1 
the major virulence factor of P. falciparum. A large number of proteins seem to be exported only 
to build knobs and remodel the host cytoskeleton conferring these adherent properties which 
allows the parasite to massively grow and replicate.  
A number of other exported proteins localize close to the knobs and might cross-link or 
anchor them to the cytoskeleton and play a role in structural integrity and shape of knobs. PHIST 
proteins have been implicated as linkers between cytoskeletal and exported parasite proteins (63, 
99). PFE1605w (LyMP), a member of the PHIST family interaction has been shown with band 3 
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(100) and a number of ATS domains of PfEMP1 (100-102). PFI1780w, another PHIST protein, also 
has been shown to bind the ATS domain of some PfEMP1 molecules (99). The same ATS domain 
of PfEMP1 was shown to interact also with α-spectrin via its repeat 17 (90). There is controversial 
evidence that KAHRP anchors PfEMP1 to the knobs (87, 103), while an interaction with actin 
potentially provides another link to the cytoskeleton (104). Some of these interactions have only 
been observed in vitro and have not been confirmed otherwise.  
Anchoring of Maurer’s clefts 
In ring stage parasites MCs are mobile and become arrested during the transition to 
trophozoites around 20-24 hpi (105, 106). The tethering to the cytoskeleton was proposed already 
a decade ago but no mechanism could be shown (91, 107). Recently, two links of MCs to the 
cytoskeleton have been described, one being mediated by actin filaments. In the erythrocyte 
cytoskeleton actin filaments are quite short with only 35-37 nm in length, connecting multiple 
ends of spectrin tetramers in the junctional complexes (25). At the transition to trophozoites actin 
mining causes these filaments to shorten and the free actin is used to generate 40-950 nm long 
filaments which extend inwards into the iRBC making the skeleton three dimensional (79, 107, 
108). These new actin filaments show branching points normally not seen in uninfected 
erythrocytes (25, 79) and cryo-electron tomography showed that these remodeled actin filaments 
often start close to knobs and connect to MCs (79, 80, 108). The capacity of PfEMP1 and KAHRP 
to bind actin could indicate their involvement in anchoring the remodeled actin filaments to the 
iRBC cytoskeleton (82, 86, 104). At the MCs two proteins, PfPTP1 and Pf332 have been found to 
be essential for the attachment of the remodeled actin filament (80, 109-112). Both proteins show 
peak expression during the transition phase and have been detected in MCs at transition until 
egress (80, 112, 113). PfPTP1 not only links MCs to actin filaments but seem to play a role in 
remodeling and organizing these filaments (80). Pf332 has been shown to bind actin in a non-
competing way with PfEMP3 which additionally also binds spectrin (111, 114). The MC resident 
protein SBP1 shares its expression pattern and localization with PfPTP1 and Pf332 (110, 115) and it 
was proposed that these three proteins form a complex (80). Phosphorylated SBP1 further 
interacts with LANCL1, a human protein that is recruited to MCs (116, 117). Another MCs protein 
PFE60, also known as PIESP2, interacts with MAHRP1, SBP1, and Pf332, but was shown not co-
localize to PfEMP3 in immunofluorescence assays, indicating that PfEMP3 localizes to another sub-
cellular location (118) most probably to the iRBC cytoskeleton. The role of PfEMP3 remains elusive 
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but it possibly could bind native actin filaments or it could provide the anchoring point of 
remodeled actin filaments to the cytoskeleton. Figure 3 presents a possible scenario how the actin 
filaments are anchored to the MCs and the cytoskeleton (Figure 3). The question remains how 
newly growing actin filaments are directed towards MCs and how they are stabilized? One 
potential candidate is PfHRP2 which has the capacity to stabilize and bind to actin filaments at 
acidic pH and also localizes to the iRBC periphery (119). 
The importance of actin remodeling and the link to MCs is supported by observations with 
hemoglobinopathic erythrocytes. Oxidative stress on hemoglobinopathic iRBCs impaired the 
growth of actin filaments, caused MCs to be distorted, and to retain their mobility during mature 
stages. This coincides with decreased replication rate, reduced levels of protein export to the 
iRBC skeleton and membrane, and no PfEMP1 was found on the iRBC surface. It has been 
proposed that cargo vesicles would be moved along actin filaments towards the iRBC membrane 
by actin treadmilling (70, 79, 80, 108, 120, 121).  
Another connection of MCs to the cytoskeleton is mediated by tethers consisting mainly of 
the exported small MAHRP2 protein (7, 122, 123) but neither anchor point at MCs or at the 
cytoskeleton is known and no further function has been assigned to these structures. 
Both events, linking the MCs to the cytoskeleton and knob formation, seem to occur at the 
same time and we propose that knob formation and MCs arrest require free spectrin ends for 
stabilization and anchoring which in turn locally frees up actin which is repurposed into filaments 
responsible for vesicular cargo transport to the cytoskeleton. Because this would weaken the 
skeletal stability, exported parasite proteins must interact with cytoskeletal proteins to enhanced 
stability. The number of exported proteins targeting the iRBC skeleton at this life cycle stage is 
coherent with the model. In this refurbishing process of the iRBC a number of questions remains 
such as what triggers these, how is it orchestrated, and could potentially a drug target interfere 
with this process? 
Further changes during ring to trophozoite transition 
Once MCs are arrested, knobs are formed, and the iRBC cytoadheres, the parasite starts its 
rapid growth. The completion of these modifications of the host cell is seen as the end of the 
transition phase (70, 105). 
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Trophozoite 
As a result of the cytoskeletal modifications, the spectrin network size increases in 
trophozoites (68). Computer modeling suggested that additional linkages between the 
cytoskeleton and the membrane which are caused by knob structures can account for the 
observed increased rigidity (Figure 4) (124). 
Similar to the ring stage, during the trophozoite stage little major changes to the host cell 
seem to occur. It is rather the parasite’s most metabolically active phase during the 
intraerythrocytic cycle (125) and prepares the parasite for replication and formation of daughter 
cells. Although most cytoskeleton remodeling occurs during the transition between ring to 
trophozoite, some of these changes gradually continue throughout the trophozoite stage and 
probably even until egress. First knobs appear around 20 hpi and their numbers increase linearly 
while their size decreases until 36 hpi (126, 127), which marks the end of the trophozoite stage 
(56). This constant remodeling indicates that protein export still occurs and that those proteins 
accumulate within the iRBC or at its cytoskeleton. 
Schizont 
During the schizont stage, daughter cells are being produced which subsequently will 
reinvade new host cells. A series of genome replications and nuclear divisions occur and individual 
merozoites are formed by segmentation (128). Proteins synthesis during this phase is focused on 
merozoite proteins and proteins that are required for invasion (69). At this time the number of 
knobs decreases (126, 127) and there is some evidence that the erythrocyte cytoskeleton is 
dismantled starting up to 15 hours prior to egress which corresponds to onset of the schizont 
stage. Proteins associated with junctional complexes such as adducin and tropomyosin are lost 
from the cytoskeleton, indicating that some remodeling or dismantling occurs. This is 
accompanied by an increased spectrin mesh size and the temporal appearance of holes in the 
cytoskeleton (129, 130). It is unclear why this happens so early since the structural integrity must 
still be maintained until egress. However, recent literature suggests that cytoskeleton degradation 
only occurs immediately before egress (131). 
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Egress 
Parasite egress has been described by different models but irrespective of the model the 
actual processes all require degradation of the PVM and the iRBC cytoskeleton and membrane to 
release the newly formed merozoites. In contrast to invasion, egress is a rather destructive event 
and the iRBC cytoskeleton and membrane are now degraded by proteases to release the 
merozoites. At the end erythrocytic life cycle SERA6, a PV resident protein, is cleaved and 
activated by SUB1 (128, 132, 133) and subsequently crosses the now partially degraded PVM and 
localizes to the iRBC cytoskeleton. There it cleaves β-spectrin at its actin-binding site, leading to 
disrupting of the connection between the spectrin tetramers and the junctional complex. This is 
essential for the breakdown of the iRBC cytoskeleton and the final release of merozoites (131, 
134). Interestingly, SERA8, another member of the SERA family, was found to be essential in 
egress of sporozoites from oocysts, indicating that SERA proteases might play a general role 
during egress of infective P. falciparum stages (135). A number of other proteins are proteolytically 
cleaved during egress of which most are associated with or are part of the iRBC cytoskeleton 
(129). Besides SERA6, SUB1 was also reported to cleave spectrin and probably band 3 (31, 131). 
MESA, ankyrin, and band 4.1 were also found to be degraded during egress (136, 137). Other 
proteases implicated in egress are calpain-1, falcipain, and plasmepsins (48, 129, 137-139). 
Falcipain and some plasmepsins which usually localize in the food vacuole (140) are also found to 
degrade the cytoskeleton during egress. The same processes that perforate the PVM might also 
perforate the food vacuole and thus releasing these proteases into the iRBC cytosol where they 
might assist in cytoskeleton breakdown. Curling of the host membrane has been described as part 
of egress and mechano-physical models suggested that the degradation and restructuring of the 
cytoskeleton contributes to membrane curling observed in vivo (141-143). 
As reviewed in (144-146) other models of egress have been suggested but the model 
presented here summarizes the most current information and is likely correct as all effector 
proteins involved in egress are stored in merozoite organelles and can be rapidly discharged to 
start the cascade of events that result in the release of merozoites. This ensures that degradation 
of the host cytoskeleton occurs only when merozoites have been formed, making egress a fast 
and regulated process. 
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Gametocytes 
During each intraerythrocytic developmental cycle, a few P. falciparum parasites commit to 
sexual development and develop into gametocytes. Five developmental stages have been 
defined and after completion (10-12 days) mature gametocytes re-enter the blood stream to be 
transmitted to mosquitos where they complete sexual development (1, 147). Much less is known 
of what modifications occur at the host cytoskeleton during the development of gametocytes. 
Whilst host cytoskeleton remodeling causes morphological changes in asexual stages, 
morphological changes in gametocytes seem to be caused mostly by changes of the parasite’s 
own cytoskeleton and its inner membrane complex (148). Changes of its own skeleton mostly 
seem to contribute to changes in cellular rigidity during sexual development (68, 148, 149). Also 
during gametocyte development many parasite proteins are exported but their function and 
potential role in the host cell remain elusive (147, 150). Great morphological differences between 
mature gametocytes and asexual stages suggest that different remodeling processes and targets 
might be involved in the generation of those differently shaped intracellular parasites. 
Gametocyte stages I-IV 
The cytoskeleton of gametocyte-infected erythrocytes (GIE) is targeted during sexual 
development with actin remodeling occurring when stage III and V gametocytes were 
investigated but there is no evidence of actin mining as observed in trophozoites and MCs are not 
tethered to the cytoskeleton via actin filaments. The number of actin junctions is reduced by 18% 
in stage III as compared to stage I, the size of the spectrin meshwork increases considerably until 
stage III, and lateral mobility of band 3 is reduced, all leading to decreased deformability of the 
GIEs (68). The degree of reduced deformability is similar to trophozoites (Figure 5) (148). It has 
been shown that the serine residue S324 of STEVOR, which binds to host cell cytoskeleton, is 
phosphorylated during stages I-IV (151). It has to be seen whether this PKA-mediated 
phosphorylation is the sole contributor to increased rigidity of gametocytes. 
During gametocyte development from stage I to IV morphological changes are accompanied 
by a constant increase of rigidity (152) leading to sequestration in the bone marrow and spleen 
(147). The process of gametocytes sequestration until the end of stage IV is mostly unknown but 
PfEMP1 is observed in very low levels in stage I and GIEs have no knobs on the surface. Hence, it 
is likely that STEVORs might play an essential role in gametocyte sequestration (151, 153). 
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Gametocyte stage V 
Stage V gametocytes, however must reach the blood circulation again to be taken up by 
mosquitoes during a blood meal to assure transmission. In order to circulate GIEs must become 
flexible again and previous remodeling steps up to stage III seemed to be reversed in stage V. In 
stage V the width of the spectrin network decreases (68), a sudden increase in deformability 
happens (152), and the lateral mobility of band 3 and the number of actin junctions increase again 
to levels comparable to uninfected RBCs (68). Hence, modifications in gametocytes seem to be 
mostly reversible, even the previously phosphorylated S324-residue of STEVOR becomes 
dephosphorylated (151) and dissociates from the GIE membrane (152). It becomes important to 
understand this process to identify potential targets to block transmission. 
Types and mechanisms of cytoskeleton remodeling 
Phosphorylation 
Phosphorylation and dephosphorylation by a number of human kinases such as cAMP-
dependent kinase (131) or protein kinase C (77) modulate the properties of the erythrocyte 
cytoskeleton and membrane (76, 154-157). P. falciparum hijacks the human system to alter the 
iRBC skeleton according to its needs (54) in a stage-specific manner (67, 158). In addition, the 
parasite exports some of its own kinases into the host cell such as members of the FIKK family or a 
casein kinase (159). 
During merozoite invasion phosphorylation plays an important role (24, 34, 36, 37, 50, 160) 
when phosphorylation of cytoskeletal proteins causes the cytoskeleton to locally detach from the 
membrane at the site of merozoite attachment (Figures 1, 2 and 4). This promotes membrane 
wrapping pushing the merozoite inwards (36, 52-55) and facilitates invasion without destruction of 
the cytoskeleton. Most host cytoskeleton proteins seem to be dephosphorylated during early 
parasite development (161), suggesting that phosphorylation and further modifications of 
cytoskeletal proteins does not play a major role during the first half of the life cycle.  
As described above, transition from ring to trophozoite stage is accompanied by extensive 
remodeling of the cytoskeleton and is mediated by interaction of exported parasite proteins with 
host proteins. Some of these protein-protein interactions require phosphorylation and the level of 
phosphorylation (161), such as serine and tyrosine phosphorylation increases at this time (67). 
Accordingly, Treeck et al. identified in a proteomic study hundreds of phosphoproteins, both 
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human and parasite proteins (162), including proteins associated with the cytoskeleton or knobs 
(67).  
Despite the large number of phosphorylated proteins little is known about kinases and 
phosphatases involved in this process. At least 20 parasite kinases are thought to be exported 
(159) and FIKK4.2, one of the exported kinases, shows peak expression during late ring and early 
trophozoite stages (159, 163), coinciding with the transition phase when all structural changes and 
host cell remodeling occur. Depletion of FIKK4.2 causes increased iRBC rigidity, reduced knob 
count on the iRBC surface, and impaired host cell remodeling (163). Because phosphorylation is 
linked to cytoskeleton remodeling and knob formation it was proposed to influence cytoadhesion 
(71, 78, 159).  
At the end of the intra-erythrocytic development proteins begin to become 
dephosphorylated (67), most likely partially reversing previous cytoskeleton remodeling steps and 
thus weakening of the cytoskeleton in preparation of merozoite release (67). Phosphorylation 
plays a central role in modulating host cell alterations at the beginning of the asexual life cycle 
and dephosphorylation at the end of the cycle. A similar dynamic of phosphorylation is also 
observed during gametocyte development (164-166). 
Altered Rigidity and Deformability 
The ability of a cell to change its shape under predefined conditions without hemolysis is 
defined as deformability (149) but terms such as rigidity and stiffness are used interchangeably in 
this review. The structural integrity and deformability of the host cell cytoskeleton are important 
for the survival of P. falciparum and stage-specifically modulated at each stage of the life cycle 
(Figures 4 and 5). 
During invasion a temporary increase in iRBC deformability is required (31, 50) and the 
degree thereof correlates with the success of invasion (33). As phosphorylation is reversed after 
invasion deformability is reverted to the original state. There is limited membrane stiffening 
mostly attributed to the effect of RESA interaction with the spectrin network (62). But no further 
cytoskeleton remodeling during the first half of the asexual life cycle is known and ring stage-
iRBCs circulate and passage through the spleen despite this reduced deformability (167, 168).  
In trophozoite and schizont stages the shape of the host cell changes and it sequesters to the 
endothelial capillary lining. There is an increase in phosphorylation (161) but in contrast to 
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phosphorylation during invasion, there is no partial dissociation and weakening of the 
cytoskeleton but it facilitates protein-protein interactions which contribute to increased rigidity 
(167, 168). In addition, metabolic products from the parasite exert oxidative stress which also 
contributes to the rigidification of the iRBC cytoskeleton (108, 169). 
Exported proteins 
Computer simulations suggested that the stiffening effect during the trophozoite and 
schizont stage is mainly caused by newly formed knobs providing vertical linkages between the 
spectrin cytoskeleton and the membrane rather than by direct remodeling of the spectrin network 
(124). Since several knob-resident proteins interact directly with spectrin, the formation of knobs 
seems to depend on cytoskeleton remodeling. Knobless parasites also show an increase in 
rigidity, albeit much less than knob-positive parasites (170) which suggests that other factors are 
involved in changes of cytoskeletal deformability. Over the years, reverse genetic studies have 
identified a number of interactions of exported proteins which in most cases lead to increased 
rigidity (28, 62, 109, 171, 172). 
Chaperones 
Although not directly binding to or interacting with the cytoskeleton, chaperones are also of 
importance to host cytoskeleton remodeling. Amongst the exported P. falciparum proteins are 
several chaperones (17) and seven PHISTb proteins containing a DnaJ domain (173). DnaJ 
domains have been shown to interact with or recruit parasite heat shock proteins for use in the 
remodeling process (174). A parasite cell line deficient of Hsp70-x, an exported parasite 
chaperone, showed higher retention rates in microsphiltration indicating increased rigidity (175) 
and suggests that chaperones might play a role in remodeling the cytoskeleton. 
Protein Carbonylation 
Reactive oxygen species lead to protein carbonylation (176) and although not controlled by 
the parasite, carbonylation of host membrane and cytoskeleton proteins can affect the integrity of 
the cytoskeleton. Carbonylation of iRBCs has been observed at the transition from ring to 
trophozoite and lasting throughout the entire trophozoite stage. This correlates in time with 
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hemoglobin metabolism and generation of free radicals. All major cytoskeleton proteins such as 
spectrin, actin, ankyrin, band 4.1, and band 4.2 were found to be carbonylated (177). Hence, 
through hemoglobin metabolism the parasite indirectly influences the rigidification of the host 
membrane and some of the remodeling mediated by exported parasite proteins might counteract 
the effects of carbonylation. 
Protein Features 
Many exported proteins contain motifs or charge distributions that can target exported 
parasite proteins to the cytoskeleton. The MEC motif found in MESA is present in a number of 
other exported proteins, some of which have been shown to localize to the iRBC cytoskeleton or 
to have an effect on rigidity (75). Similarly, lysine-rich repeats in a group of exported proteins were 
identified and shown or predicted to target the cytoskeleton (178). In several exported proteins 
(e.g. Pf332, SURFIN, and PfEMP1) tryptophan-rich domains interact with actin and spectrin (179, 
180). A large number of exported proteins share a Plasmodium helical interspersed subtelomeric 
(PHIST) domain and several PHISTb members with an extended PHIST domain were targeted to 
the iRBC periphery (181). Finally, other exported parasite proteins were found to contain an amino 
acid sequence which mediates binding to band 4.1 (182). Overall, many proteins have been 
identified through molecular or bioinformatics approaches to be potentially involved in 
cytoskeleton remodeling, however, there is a significant redundancy of interacting proteins and 
each might not necessarily be involved in a particular interaction. Thus, many of these direct 
interactions need to be confirmed in the future. 
Summary 
Host cell remodeling by P. falciparum with regard to the cytoskeleton can be divided into 
three different phases: invasion, the transition phase between ring and trophozoite stages, and 
egress. During invasion, the erythrocyte plasma membrane as barrier has to be crossed in a 
conservative way that restores its properties and allows intracellular growth. This also includes the 
cytoskeleton stabilization when the cell is exposed to fever-induced thermal stress. At the 
transition phase of asexual growing parasites knobs are formed, conveying cytoadhesive 
properties to the infected cell. In contrast, sequestration of gametocytes must be reversible and 
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hence requires different modifications at the host cell cytoskeleton. During egress the parasite 
crosses the cytoskeleton again but this time in a more destructive way.  
Cytoskeleton remodeling has been shown to be the key actor for these events, but little is 
known about events occurring between these steps. Available data suggest that the cytoskeleton 
is in a dynamic steady state. 
Here we have shown that the iRBC cytoskeleton is the interface of most host-parasite protein-
protein interactions that are essential for intracellular development of P. falciparum. The 
identification of key players involved in these major remodeling events could potentially provide 
new targets both to inhibit growth of the malaria parasite but also to inhibit transmission.   
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Figure Legends 
Figure 1 - Overview of intraerythrocytic cycle of P. falciparum.  
Some changes occurring at the erythrocyte cytoskeleton throughout the stages are 
highlighted.  
Figure 2 - Invasion 
Individual steps of invasion are shown, focusing on changes to the erythrocyte cytoskeleton. 
Figure 3 – Changes during transition phase 
Changes occurring during the transition from ring to trophozoite with focus on MC arrest. 
Figure in part inspired by (118) and additional information from (80, 183). 
Figure 4 – Cytoskeleton Time Course in Asexual Stages 
Changes in phosphorylation level and cellular rigidity over the course of the intraerythrocytic 
asexual development of P. falciparum (upper panel) are approximations. The lower panel depicts 
the changes occurring in the spectrin network over the course of development as described in 
(39, 84, 172). 
Figure 5 - Cytoskeleton Time Course During Gametocyte Development 
Changes in phosphorylation level and cellular rigidity over the course of gametocyte 
development (upper panel) are approximations. The lower panel depicts the changes occurring in 
the spectrin network over the course of development as described in (68). 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SUMMARY
During the asexual cycle, Plasmodium falciparum extensively re-
models the human erythrocyte to make it a suitable host cell. A
large number of exported proteins facilitate this remodeling pro-
cess, which causes erythrocytes to become more rigid, cytoadher-
ent, and permeable for nutrients and metabolic products. Among
the exported proteins, a family of 89 proteins, called the Plasmo-
dium helical interspersed subtelomeric (PHIST) protein family,
has been identified. While also found in other Plasmodium spe-
cies, the PHIST family is greatly expanded in P. falciparum. Al-
though a decade has passed since their first description, to date,
most PHIST proteins remain uncharacterized and are of un-
known function and localization within the host cell, and there are
few data on their interactions with other host or parasite proteins.
However, over the past few years, PHIST proteins have been men-
tioned in the literature at an increasing rate owing to their pres-
ence at various localizations within the infected erythrocyte. Ex-
pression of PHIST proteins has been implicated in molecular and
cellular processes such as the surface display of PfEMP1, gameto-
cytogenesis, changes in cell rigidity, and also cerebral and preg-
nancy-associated malaria. Thus, we conclude that PHIST proteins
are central to host cell remodeling, but despite their obvious im-
portance in pathology, PHIST proteins seem to be understudied.
Here we review current knowledge, shed light on the definition of
PHIST proteins, and discuss these proteins with respect to their
localization and probable function. We take into consideration
interaction studies, microarray analyses, or data from blood sam-
ples from naturally infected patients to combine all available in-
formation on this protein family.
INTRODUCTION
Malaria is an infectious disease caused by the protozoan para-site Plasmodium and is transmitted by female Anopheles
mosquitoes to humans during a blood meal. Of the five Plasmo-
dium species that cause human malaria, two are of major public
health interest: P. falciparum causes the most severe form of ma-
laria, while P. vivax is the most widespread Plasmodium species (1,
2). The success of P. vivax is due to the presence of undetectable
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hypnozoites, which represent dormant stages in the liver and pose
a huge problem for malaria control. With half of the human pop-
ulation at risk, roughly 200 million malaria cases, and an esti-
mated 438,000 deaths in 2015, malaria still remains a major threat
to public health (3).
Plasmodium has a complex life cycle, alternating between the
arthropod vector and its vertebrate host (Fig. 1) (1). During the
bite of an infected female Anopheles mosquito, sporozoites are
injected into dermal tissue and transported through the blood-
stream to the liver. There, the sporozoites penetrate and invade
hepatocytes, which is followed by several rounds of asexual repli-
cation. Subsequently, thousands of merozoites are released into
the bloodstream through so-called merosomes, starting the blood
stage cycle (4, 5).
Once in the bloodstream, merozoites invade erythrocytes and
multiply during an !48-h intraerythrocytic development cycle.
At the end of the cycle, !16 to 32 merozoites are released and
reinvade new erythrocytes, starting the cycle anew. Once a mero-
zoite has invaded the erythrocyte, it extensively refurbishes and
remodels the host cell. This remodeling of the cell ensures parasite
ion homeostasis within the cell, allows nutrient uptake, and is accom-
panied by changes in host cell membrane structure and rigidity. All
this is achieved by the export of a large number of proteins from the
parasite into the host cell, leading to dramatic changes of infected
erythrocytes. Since such a remodeled erythrocyte would be elimi-
nated in the spleen, the parasite also exports the major virulence fac-
tor P. falciparum erythrocyte membrane protein 1 (PfEMP1), which
conveys binding of infected cells to endothelial receptors such as
CD36, intracellular adhesion molecule (ICAM), or endothelial pro-
tein C receptor (EPCR) (6, 7). PfEMP1 is displayed on the surface of
the infected red blood cell (iRBC) and is considered to be the key
factor for morbidity and mortality. Overall, these refurbishing pro-
cesses are considered to be responsible for most symptoms and the
pathology of malaria (1, 8). Hence, recently, research focusing on
exported proteins and processes involved in this host cell remodeling
has attracted increased attention.
Protein Export
Because exported proteins of P. falciparum play such a central role
in the remodeling of infected red blood cells, the description of the
FIG 1 Life cycle of P. falciparum. (Right) Upon the bite of a Plasmodium falciparum-infected female Anopheles mosquito, sporozoites are injected into the dermal
tissue of the human host. Sporozoites quickly enter the bloodstream and are transported to the liver, where they invade liver cells and develop into liver schizonts.
Through merosomes, thousands of merozoites are released into the bloodstream, where they invade erythrocytes, starting the asexual replication cycle. Each
cycle, a few parasites cease replicating, commit to the sexual cycle, and develop into gametocytes. (Left) Mature gametocytes are taken up by a mosquito during
a blood meal; rapidly develop into male and female gametes, which fuse together in the gut of the mosquito; form an ookinete that penetrates the gut wall; and
undergo sexual replication in the oocyst, producing thousands of sporozoites. At the end, sporozoites migrate to the salivary gland and are ready to be transmitted
to a human host during the next blood meal. (Adapted from reference 148.)
Warncke et al.
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pentameric amino acid motif RxLxE/Q/D, called the Plasmodium
export element (PEXEL) (9, 10), was a breakthrough that allowed
the prediction of !400 exported proteins. The PEXEL motif was
recently expanded into a more relaxed PEXEL motif (RxLxxE)
(11) or a noncanonical motif (K/HxL/IxE/Q/D) (12), resulting
in a total number of "460 proteins predicted to be exported in
P. falciparum. This “exportome” provides the basis to study
exported proteins and their involvement in the pathology of
remodeled infected erythrocytes much more specifically. Besides
the defined PEXEL exportome, there are additional exported
proteins that lack a known or discernible export element, referred
to as PEXEL-negative proteins (PNEPs) (13, 14). Although the
definitive number of proteins exported into the erythrocyte is
unknown, it is without doubt that they play important roles in
pathology through the significant changes that they induce in
infected erythrocytes and that they are major contributors to
disease. Figure 2 shows a schematic representation of differences
in cytoskeleton organization between uninfected and infected
erythrocytes and the localization of exported proteins during the
asexual replicative blood stage of P. falciparum.
PHIST PROTEINS
Methodology for Review
We focused on P. falciparum and included all Plasmodium helical
interspersed subtelomeric (PHIST) proteins and genes that were
either identified by Sargeant and colleagues (15) or later identified
as PHIST proteins by Frech and Chen (16).We did not attempt to
identify new PHIST proteins but compiled only data already re-
ported. Gene identifications in PlasmoDB have changed over
time; therefore, some PHIST proteins have two or even three gene
identifications, and various articles use different gene identifica-
tions, although they refer to the same protein or gene. We also
scanned supplemental material for information on PHISTs.
which in some instances was found only there and would not be
available through a standard literature search. We compiled any
available information on each member of the PHIST family by
using all gene identifications or names used now or previously.
Complete lists of PHIST proteins or genes found in the literature
and reviewed here are shown in Tables 1 to 5 and represent an
in-depth description of this important protein family.
The PHIST Protein Family
In the large number of exported proteins, Sargeant and colleagues
(15) identified a newprotein family, which they termed the PHIST
protein family. This protein family is characterized by a conserved
domain of !150 amino acids predicted to form four consecutive
alpha helices (determined by Fugue [17]). Some members of this
family comprise little more than an export signal sequence, the
PEXELmotif, and the PHISTdomain, whereas othermembers are
substantially elongated and include additional domains, such as a
DnaJ domain (Fig. 3). Based on the presence and position of sev-
eral conserved tryptophan residues within the PHIST domain, the
PHIST protein family has been further divided into three sub-
groups: PHISTa, PHISTb, and PHISTc (15). With more recent
data included, PlasmoDB has annotated additional PHIST do-
mains in proteins, resulting in a total of 89 currently known
PHIST proteins inP. falciparum (15, 16). Some of the newly added
PHIST proteins were not grouped into the already existing sub-
groups but were classified as PHISTa-like or simply PHIST pro-
teins. Thus, PlasmoDB annotations give the impression that there
are more than three PHIST subgroups. However, a phylogenetic
tree based on a multiple-sequence alignment shows that PHISTa-
like and PHIST proteins cluster with the PHISTa subgroup and
the PHISTb-DnaJ protein group among the PHISTb subgroup,
giving rise to three distinct PHIST subgroups (Fig. 3).
When the protein family was first described, Sargeant and col-
leagues used the presence and position of conserved tryptophan
residues in the amino acid sequence of the PHIST domain to dis-
tinguish between the three subgroups (15). Comparison of mul-
tiple-sequence alignments for each subgroup in which PHISTb-
DnaJ and PHISTa-like/PHIST proteins were treated as individual
subgroups reveals a unique pattern of the conserved tryptophan
residues for each of the subgroups (Fig. 4 and 5A). For each sub-
group, a different positional pattern of conserved tryptophan res-
idues was found, with PHISTa and PHISTa-like/PHIST proteins
possessing only two conserved tryptophan residues within the
PHIST domain and the remaining subgroups having four. There
is only slight variation in the positions of these residues between
the PHISTb and PHISTb-DnaJ subgroups and between the
PHISTa and PHISTa-like/PHIST subgroups.We therefore use the
original three subgroups introduced by Sargeant and colleagues
unless otherwise stated.
Tables 1 to 5 list all 89 proteins that we identified as PHIST
proteins in P. falciparum, 64 of which contain a classical PEXEL
motif and are thus predicted to be exported (11, 15). Although
PlasmoDB lists 19 phist genes as pseudogenes in reference strain
3D7, somehave been found to be present as proteins or transcripts
in other studies. Thus, PHISTs represent a substantial group of
exported proteins comprising !14% of all PEXEL proteins or
nearly 2% of the complete P. falciparum proteome. Despite their
potentially important role in host cell remodeling and (in)direct
involvement in pathogenicity, most PHIST proteins remain com-
pletely uncharacterized, rendering it difficult to assign specific
functions or roles to the PHIST protein family and/or the three
subgroups.
Comparison of PHIST and PRESAN Domains
There has been confusion in the literature on the definition of
PHIST and Plasmodium ring-infected erythrocyte antigen (RESA)
N-terminal (PRESAN) domains, which in fact are virtually iden-
tical. The confusion was generated when, independent of the se-
quence analysis reported by Sargeant and colleagues (15), tran-
scriptome analysis of P. falciparum parasites grown at elevated
temperatures mimicking febrile conditions revealed a number of
upregulated genes that coded for proteins containing a DnaJ do-
main (Pfam family PF00226) (18). Subsequent alignments iden-
tified an extended protein family with at least 67 members, all
sharing a particular N-terminal domain, with a DnaJ domain be-
ing present in only some members. Because some of the DnaJ
domain-containing proteins showed similarity to the RESA, this
N-terminal domain was termed the PRESAN domain (Pfam
family PF09687). Examination of the sequence alignments by
Sargeant and colleagues (15) and Oakley and colleagues (18) re-
vealed that the domain boundaries of the PHIST and PRESAN
domains are virtually identical. Secondary-structure predictions
by Oakley and colleagues (18) suggested the presence of six #-he-
lices in PRESAN domains; however, these #-helices overlapped
the predicted four #-helices of the PHIST domain (15). Thus, the
PRESAN domain can be regarded as being highly similar to the
PHIST Proteins
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PHIST domain, with differences dependingmainly on the predic-
tion algorithms. An example of such close similarity is shownwith
the PHIST/PRESANprotein PF3D7_0532400 (Fig. 5B). The over-
all domain structure of all expressed PHIST proteins is shown in
Fig. 3. Crystallographic and nuclear magnetic resonance (NMR)
studies provided clear evidence that the PHIST/PRESAN domain
forms a four-helix bundle (19). Subsequently, Tarr and colleagues
(20) defined an “extended PRESAN” domain, which was N termi-
nal to the original PHIST domain and which was thought to com-
prise a domain targeting membranes. This extended domain in-
cludes additional helix-forming sequences.
Confusingly, the current InterPro database uses the term
“PHIST domain” (accession number IPR006526) to refer to a
small protein fragment spanning approximately the N-terminal
half of the PHIST/PRESAN domains, as defined by the original
authors (15, 18). In contrast, the InterPro (accession number
FIG 2 PHISTproteins in the remodeled iRBC. (A)Remodeled iRBC.During the asexual blood stage ofP. falciparum, human erythrocytes are subject to extensive
remodeling. All erythrocyte proteins are shown in gray (reviewed in reference 59). Parasite structures, compartments, and organelles are labeled in boldface type.
PHIST proteins are labeled in red boldface type, and all parasite proteins are represented by colored shapes. References for PHIST proteins are indicated in the
text. Knobs are parasite-derived protrusions in the host cellmembrane, with knob-associated histidine-rich protein (KAHRP) being a prominent protein of these
structures (149, 150). Maurer’s clefts (reviewed in reference 151) are parasite-derived membranous structures in the iRBC cytoplasm involved in protein
trafficking and are connected with knobs via actin filaments (152, 153).Maurer’s cleft-associated histidine-rich protein 1 (MAHRP1) is aMaurer’s cleft-resident
protein (154) that potentially interacts with MAHRP2, the tether protein anchoring Maurer’s clefts to the iRBC membrane (155). REX1 (156), REX2 (107),
SEMP1 (157), SBP1 (158), and PfPTP1 (159) are other exported parasite proteins that localize to Maurer’s clefts, with the latter two being located in a
high-molecular-weight complex (159) and SBP1 interacting with the erythrocyte cytoskeleton proteins spectrin and band 4.1R (160). J dots are mobile, dot-like
structures in iRBCs (161, 162). PfPTP2 is associated with exosomes, which are parasite-derived vesicles that are involved in cell-cell communication between
iRBCs (43). RhAG, rhesus-associated antigen. (B) Cytoskeleton of an uninfected red blood cell (reviewed in reference 59). (Inspired by references 42 and 100.)
Warncke et al.
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TABLE 1 PHISTa genes
Gene
identificationa
Other gene identification(s)
or name(s)b
Presence of
PEXELc
Gene
statusd
Molecular
mass (kDa)e
Length
(aa)e KOf Description (source or reference[s])g
PF3D7_0102000 PFA0100c, MAL1P1.11 PG 30.4 252
PF3D7_0115100 PFA0735w, MAL1P4.22 x 28.6 239 Only 5-aa difference compared to
PF3D7_0800600 (PlasmoDB)
PF3D7_0402000 PFD0090c, MAL4P1.18 x 41.7 357 x Interaction between band 4.1R (58), not silenced
in the 3D7 strain (28), overexpressed in
samples from patients with cerebral malaria
(34)
PF3D7_0424900 PFD1185w, MAL4P1.232 x 25.3 216
PF3D7_0425300 PFD1210w, MAL4P1.237 PG 27.5 232 Exported despite the lack of any export signal (79)
PF3D7_0425400 PFD1215w, MAL4P1.238 x 19.5 164
PF3D7_0601700 PFF0085w, MAL6P1.21 x PG 26.3 222
PF3D7_0800600 MAL8P1.163 x 28.3 237 Adjacent to a PfEMP1 variant on the gene locus;
weak binding to the ATS domain of PfEMP1
compared to other PHIST proteins tested (19),
only 5-aa difference compared to
PF3D7_0115100 (PlasmoDB)
PF3D7_1001100.1 PF10_0014, PF10_0015,
acyl-CoA binding
protein
36.5 313 x Grouped as PHISTa (15), deleted in parasites with
PfCRT mutations, annotated as a putative lipid
transporter (80), upregulated under
lumefantrine pressure and deletion of the gene
found under chloroquine pressure (81),
unusual PHIST member with an N-terminal
acyl-CoA binding protein domain (16)
PF3D7_1001100.2 PF10_0014, PF10_0015,
acyl-CoA binding
protein
31.0 267 x Same as PF3D7_1001100.1
PF3D7_1001300 PF10_0017 x 22.8 190 Diffuse localization in the RBC cytosol (20),
differentially expressed in parasites under
lumefantrine pressure (81)
PF3D7_1100600 PF11_0012 PG 33.3 281
PF3D7_1149700 PF11_0514 10.5 85 Once mentioned in relation to PHISTa structure
(58)
PF3D7_1253100 PFL2555w, MAL12P1.506 x 26.5 221 HSP40 chaperone with a DnaJ domain (82), used
as a negative control in an interaction study
(58)
PF3D7_1253300 PFL2565w, MAL12P1.508 x PG 18.3 157 Not silenced in 3D7 (28)
PF3D7_1253800 PFL2590w, MAL12P1.513 x 26.2 219
PF3D7_1253900 PFL2595w, 2600w,
MAL12P1.514
x PG 24.3 207 Once mentioned in relation to PHISTa structure
(58)
PF3D7_1301100 MAL13P1.11,
MAL13P1.11a
x PG 24.6 203
PF3D7_1301500 MAL13P1.59 37.5 308 Downstream of a clag gene, and its expression is
affected by H3K9me3 acetylation (83); not
located in the telomeric region (27)
PF3D7_1372000 MAL13P1.470 x 41.0 349 String database mining suggested interaction with
PFI1785w, PFB0115w, and PFL0050c (84)
PF3D7_1400900 PF14_0009 x PG 24.6 209
PF3D7_1477700 PF14_0748, Pfg14-748 34.5 291 Highest transcript concn in bone marrow
comparing different organs (37); marker for
early and midgametocytes, and its promoter
can drive gametocyte-specific gene expression
(36, 37); expressed in sexually committed
schizonts with !100-fold upregulation (27);
used as a marker for sexual commitment (85)
PF3D7_1478000 PF14_0752, GEXP17 x 25.5 215 Overexpressed in field samples compared to 3D7,
suggested surface protein (30); differentially
expressed in different 3D7 clones (33)
PF3D7_1478500 PF14_0757 x PG 25.1 215
PF3D7_1479200 PF14_0763 x 26.2 219
PF3D7_1479300 PF14_0764 PF14_0765 x PG 24.6 209
a Current gene identification from PlasmoDB.
b Other/previous names.
c The presence of a PEXEL motif is indicated by “x,” as identified in reference 15 or 1.
d Annotated as a pseudogene (PG) in PlasmoDB.
e For proteins with a PEXEL motif, molecular mass and length were calculated for the PEXEL-cleaved form of the protein (the molecular mass for PEXEL-cleaved proteins was
calculated by using the ExPASy Web tool [http://web.expasy.org/compute_pi/]). aa, amino acids.
f Existing viable knockout (KO) parasites or natural gene deletions are indicated by “x” (see reference 44 or the reference[s] indicated).
g Information or references referring to the corresponding gene or protein.
PHIST Proteins
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TABLE 2 PHISTb genes
Gene
identificationa
Other gene identification(s)
or name(s)b
Presence of
PEXELc
Gene
statusd
Molecular
mass (kDa)e
Length
(aa)e KOf Description (reference[s] or source)g
PF3D7_0201600 PFB0080c, PF02_0016 x 48.0 394 x Affected by large chromosome break, which causes a
loss of cytoadherence and permanent expression
of var2csa, regulates var2csa and var gene
expression (86); displayed on iRBC surface (86);
cytosolic localization with weak accumulation at
the erythrocyte periphery (20); PHISTb domain-
containing RESA-like protein 1 (PlasmoDB);
overexpressed in samples from patients with
cerebral malaria (34)
PF3D7_0401800 PFD0080c, MAL4P1.16,
PfD80
x 54.8 512 Upregulated within 90 min after artesunate
treatment (87), suggested to interact with
PFD0985w based on data mining (88), putative
Maurer’s cleft protein (89, 90), differentially
expressed in Pf-FRC parasites selected for CSA or
CD36 binding (91), among the most significantly
upregulated genes in children with P. falciparum
malaria (92), discrepancy observed between RNA
and protein levels (93, 94)
PF3D7_0402100 PFD0095c, MAL4P1.19 x 61.7 522 var gene chr4var7 showed recombination with
PFD0100c (95), essential for in vitro growth (44),
apparently linked to invasion ligand RH1
abundance in FCR3 (80, 95), contains a MEC
motif (39)
PF3D7_0424600 PFD1170c, MAL4P1.229 x 26.2 221 x Required for correct KAHRP transport and knob
formation, and deletion has an effect similar to
that in KAHRP KO parasites but does not affect
PfEMP1 transport (44); protein shows peripheral
localization (20); no interaction with the ATS of
PfEMP1 (19); involved in knob formation and
cytoadherence (96); present in peripheral blood
of malaria patients (77)
PF3D7_0424800 PFD1180w, MAL4P1.231 x 31.1 266
PF3D7_0532300 PFE1600w, MAL5P1.314 x 49.9 419 Exported and tyrosine phosphorylated in the RBC
cytoplasm (97), shown on immunoblots with
candidate vaccine antigens (98), shown in an
interaction cluster with PFE1605w (99)
PF3D7_0532400 PFE1605w, MAL5P1.315,
LyMP
x 50.6 439 Showed interaction with ATS of PfEMP1 variants
localized to the knobs (19); localization at
membrane cytoskeleton between knobs (40);
recently reviewed, indicating both knob and
membrane localizations (100); referred to as
Hsp40 protein, with interaction with MSP1 (101);
HSP40 protein with J domain (102); yeast two-
hybrid interaction with SBP1 and PFE1600w
(102); also computationally predicted to be a
nuclear pore protein and to be part of a signaling
pathway in the FIKK protein family (103)
PF3D7_0601500 PFF0075c, MAL6P1.19 x 50.0 417 Has two MEC motifs, with only a 1-aa difference
compared to PF3D7_0631100 (39)
PF3D7_0631100 PFF1510w x 49.9 416 Has two MEC motifs, with only a 1-aa difference
compared to PF3D7_0601500 (39)
PF3D7_0702100 MAL7P1.7 x PG 69.1 586 Part of an interaction network with SBP in the
center (99), hexadecyl-trimethyl-ammonium
bromide treatment changed its expression (104),
identified as a RESA-like protein (82), identified
as a RESA-like protein but not HSP40 (105)
PF3D7_0731300 MAL7P1.174, Pfg174 x 31.6 263 x Putative Maurer’s cleft protein (89, 90), suggested
location of a surface protein (106), soluble
protein (107)
PF3D7_0831000 MAL8P1.2, GEXP09 51.0 426 Listed as an HSP40 chaperone with a J domain (102)
PF3D7_0902700 PFI0130c x PG 44.0 372 Silencing of this gene resulted in inhibition of
apoptosis without affecting parasite growth (108),
potentially links an unknown surface protein to
the iRBC cytoskeleton (109), contains a MEC
motif (39)
PF3D7_0936900 PFI1785w x PG 32.9 274 Particularly abundant protein in samples from
pregnant women but not in samples from
children (49, 110, 111), affected by deletions on
chromosome 9 (112, 113), String database mining
suggested interaction with var2csa and
MAL13P1.470-1 (84), one of the earliest-
upregulated genes in the asexual cycle (28), often
mentioned together with PFD1140w
(Continued on following page)
Warncke et al.
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IPR019111) and Pfam (family PF09687) entries for the PRESAN
domain are identical to these original alignments. This discrep-
ancy needs correction urgently. In this review, we refer to this
conserved domain type as the PHIST domain.
PHIST Proteins in Other Plasmodium Species
PHIST proteins are found exclusively in the genus Plasmodium,
and the protein family has been significantly expanded in P. fal-
ciparum and in the laveranian species P. reichenowi, in which there
is a one-to-one representation of the PHIST genes (21). While
little is known about PHIST proteins in P. falciparum, even less is
known about PHIST proteins in other Plasmodium species. There
are fewer PHISTproteins in other plasmodia, but their exact num-
ber is not yet clear, and different publications report various
counts. Initially, Sargeant et al. reported 39 PHIST proteins for P.
vivax (15), but the complete analysis of the P. vivax genome (22)
revealed the presence of a gene family (Pv_fam_e), which con-
tained 44 rad genes and 21 phist genes, with both groups showing
structural similarities. However, PlasmoDB currently has only 18
genes annotated as phist (PlasmoDB) for P. vivax. Supplemental
material in two publications provided expression data for P. vivax
PHIST proteins (23, 24). For P. knowlesi, Sargeant and colleagues
(15) initially reported 27 PHIST proteins, but this has been rean-
notated to 38 proteins by Pain et al. (25), and PlasmoDB currently
lists 39 records. For the monkey malaria parasite P. cynomolgi, 21
PHIST genes were identified, while the number of PHIST genes in
the rodent malaria parasite is unclear and varies in different pub-
lications or databases. For P. berghei, 1 to 3 phist genes have been
found, and 1 to 2 have been found in both P. chabaudi and P. yoelii
(15, 16, 26). Moreira et al. recently characterized two PHIST pro-
teins in P. berghei and demonstrated potentially similar roles for
these PHIST proteins, as has been attributed to P. falciparum
PHIST proteins (26). So far, to our knowledge, no phist genes have
been identified in the avian Plasmodium lineage. Whether there
are other gene families with a similar structure or function in these
species remains to be seen.
Except for CVC-8195, a PHIST protein of P. vivax that has been
investigated in more detail, we do not further discuss PHIST pro-
teins in other plasmodia.
The PHIST Subfamilies
PHISTa. Proteins of the PHISTa subgroup are very short and
besides the PHIST domain consist of only a signal sequence and a
PEXEL motif if present. PHISTa proteins are found exclusively in
P. falciparum (15) and currently amount to 26 different proteins
(Table 1). In contrast to the other subgroups, PHISTa and
PHISTa-like proteins possess only two conserved tryptophan res-
idues (Fig. 4). These proteins were previously grouped together
and described as a subtelomeric protein superfamily (27), al-
though two of them, PF3D7_1301500 and PF3D7_1301300, are
not located subtelomerically and are referred to as PHISTa-like
proteins today (Table 5).
Except for PF3D7_0402000 and PF3D7_1253300, PHISTa
proteins have been reported to be transcriptionally silent in refer-
ence strain 3D7 (15, 28). Initially, it was proposed that this tran-
scriptional silencing might be caused by mutually exclusive ex-
pression (15). However, as shown in the heatmap in Fig. 6, several
studies recently showed that other PHISTa proteins are upregu-
TABLE 2 (Continued)
Gene
identificationa
Other gene identification(s)
or name(s)b
Presence of
PEXELc
Gene
statusd
Molecular
mass (kDa)e
Length
(aa)e KOf Description (reference[s] or source)g
PF3D7_0937000 PFI1790w 43.0 357 x Yeast two-hybrid interaction with band 4.1R (99,
114), potential involvement in host cytoskeleton
remodeling (39), located in a region prone to
deletion in P. falciparum strains IT and FCR3
(113), contains a MEC motif (39)
PF3D7_1102500 PF11_0037, GEXP2 x 64.6 547 x Immunoprecipitation using this protein pulled
down Plasmodium translocon of exported
proteins (PTEX) components HSP101, PTEX150,
and EXP2 (45); differentially expressed in HP1-
depleted parasites (53); involved in cytoadherence
(109)
PF3D7_1201000 PFL0050c, MAL12P1.10 x 71.7 605 x Putative Maurer’s cleft protein (89, 90), String
database mining suggests interaction with var2csa
and MAL13P1.470-1 (84)
PF3D7_1252700 PFL2535w, MAL12P1.502 x 42.1 363 RESA-like protein (115)
PF3D7_1252800 PFL2540w, MAL12P1.503 x 66.6 559 Contains a MEC motif (39)
PF3D7_1372100 MAL13P1.475, GEXP04 x 67.0 558 x Frequently deleted in field samples, affected by the
same deletion as HRP2 and HRP3 (116, 117)
PF3D7_1401600 PF14_0018 x 45.7 391 x Knockout resulted in less rigid but viable parasites
(39, 44), putative TM domain or GPI anchor
(118), contains a MEC motif (39)
PF3D7_1476200 PF14_0731 or PF14_0730 x 49.3 410 Upregulated in vitro when cultured with human
serum compared to AlbuMAX (119)
PF3D7_1476300 PF14_0732 x 61.5 514 x Frequently deleted in HB3 and other strains (120)
PF3D7_1477500 PF14_0746 x 49.9 411
a Current gene identification from PlasmoDB.
b Other/previous names.
c The presence of a PEXEL motif is indicated by “x,” as identified in reference 15 or 1.
d Annotated as a pseudogene (PG) in PlasmoDB.
e For proteins with a PEXEL motif, molecular mass and length were calculated for the PEXEL-cleaved form of the protein (the molecular mass for PEXEL-cleaved proteins was
calculated by using the ExPASy Web tool [http://web.expasy.org/compute_pi/]).
f Existing viable knockout (KO) parasites or natural gene deletions are indicated by “x” (see reference 44 or the reference[s] indicated).
g Information or references referring to the corresponding gene or protein. TM, transmembrane; GPI, glycosylphosphatidylinositol.
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lated in pregnancy-associated malaria or in cerebral malaria (29–
34). Additional studies reported that members of the PHISTa
group are differentially expressed in parasites committed to be-
coming gametocytes (27, 35–37). Whether the transcriptional si-
lencing of PHISTa proteins in 3D7 is an adaptation to in vitro
growth remains to be tested, but PHISTa proteins in natural in-
fections seem to play an important role in pathogenesis.
PHISTb. With 24 members, PHISTb proteins make the second
largest subgroup (Table 2). Members of this subgroup are slightly
longer than PHISTa proteins, with 300 to 600 residues. Charac-
teristic of the PHISTb subgroup is a unique, long, C-terminal
amino acid stretch that follows the PHIST domain (15) and that
might indicate a unique and different function of these proteins
compared to that of proteins of the other PHIST subgroups. It
is conceivable that the PHIST domain provides a general bind-
ing motif, while the C terminus might provide a more specific
interaction domain. Such a dual binding capacity was recently
shown by Oberli and colleagues (38) for the PHIST protein
TABLE 3 PHISTb genes with a DnaJ domain
Gene
identificationa
Other gene identification(s)
or name(s)b
Presence of
PEXELc
Gene
statusd
Molecular
mass (kDa)e
Length
(aa)e KOf Description (reference[s] or source)g
PF3D7_0102200 PFA0110w, MAL1P1.13,
Pf155, RESA
126.5 1,085 x RESA-KO iRBCs have reduced cell rigidity (44, 65),
RESA stiffens iRBCs and protects them from cell
damage at febrile temperatures (71), binds to
spectrin (68), expressed in ring stages of early
gametocytes (51), part of an interaction network
with SBP in the center (99), found in peripheral
blood of malaria patients (77), RESA-positive
and parasite-free RBCs observed (121), subject
of research in vaccine development (search term,
Plasmodium Pf155 vaccine)
PF3D7_0201700 PFB0085c, PF02_0017 x 99.7 846 x Part of an upregulated gene cluster in C4S binding
parasites but suggested to be nonessential for
PfEMP1 expression (86); HSP40 chaperone with
a DnaJ domain, RESA-like protein (82);
chromosomal deletion also affecting KAHRP
and resulting in the absence of knobs and
reduced cytoadherence (15, 122)
PF3D7_0220100 PFB0920w, PF02_0188 x 106.8 909 x Identified as type III HSP40 (105, 123), deletion
leads to increased rigidity and increased CS2
binding (44), putative DnaJ protein (PlasmoDB)
PF3D7_1038800 PF10_0378 x 96.8 822 x Coprecipitated full-length band 4.1R (39),
identified as type III HSP40 (123), RESA-like
protein with PHIST and DnaJ domains
(PlasmoDB)
PF3D7_1149200 PF11_0509, RESA 3 x 117.2 1,003 Part of an interaction network with SBP in the
center but also present in a different interaction
network with RESA, SBP1, and other PHISTs
(99); identified as type IV HSP40 (105); absent
in parasites treated with T4, which causes arrest
of the cell cycle (124); less abundant in
proteomic data than RESA (65); described as an
essential gene by Maier et al. (44); expression
peak in late ring, early trophozoite stage (125);
high level of sequence homology with RESA
(126)
PF3D7_1149500 PF11_0512, RESA 2 x PG 89.0 839 x Although annotated as a pseudogene, it has been
found to be poorly translated, with very low
protein levels, function is not known, protein
might be degraded (127); identified as RESA2
(65); mutation T1526C frequently found in cases
of severe malaria, upregulated in vivo (128);
identified as type IV HSP40 (105); not expressed
in laboratory strains according to Maier et al.
(42) but highly upregulated when two isogenic
3D7 strains were compared (33); peak
expression in trophozoite stage (125);
overexpressed in in vivo samples (30); transcript
found at high levels in samples from patients
with cerebral malaria from Malawi (129) (data
not shown)
PF3D7_1201100 PFL0055c, MAL12P1.11 x 96.2 806 Identified as type III HSP40 (105, 123), RESA-like
protein with PHIST and DnaJ domains
(PlasmoDB), contains a MEC motif (39)
a Current gene identification from PlasmoDB.
b Other/previous names.
c The presence of a PEXEL motif is indicated by “x,” as identified in reference 15 or 1.
d Annotated as a pseudogene (PG) in PlasmoDB.
e For proteins with a PEXEL motif, molecular mass and length were calculated for the PEXEL-cleaved form of the protein (the molecular mass for PEXEL-cleaved proteins was
calculated by using the ExPASy Web tool [http://web.expasy.org/compute_pi/]).
f Existing viable knockout (KO) parasites or natural gene deletions are indicated by “x” (see reference 44 or the reference[s] indicated).
g Information or references referring to the corresponding gene or protein.
Warncke et al.
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PF3D7_0532400. C-terminal interaction motifs have indeed been
identified in several other PHISTb proteins (39). In this respect, it
is important to note that all PHISTb proteins characterized today
were localized at andmight interact with the host cell cytoskeleton
(19, 20, 39, 40).
The non-PHIST protein mature parasite-infected erythrocyte
surface antigen (MESA) (PF3D7_0500800) interacts via an N-ter-
minal 19-amino-acid motif with band 4.1R. This motif has been
termed the MESA erythrocyte cytoskeleton binding (MEC) motif
(39) and has been found in 14 other exported P. falciparum pro-
TABLE 4 PHISTc genes
Gene
identificationa
Other gene identification(s)
or name(s)b
Presence of
PEXELc
Gene
statusd
Molecular
mass (kDa)e
Length
(aa)e KOf Description (reference[s] or source)g
PF3D7_0202100 PFB0105c, LSAP2 x 25.4 216 Not recognized by pooled immune sera (98); continuously upregulated,
with predicted TM, granular pattern in immunofluorescence assays
(IFA) of older parasites, expressed in liver stages (130); located at
periphery in liver stage parasites similarly to circumsporozoite
protein (CSP) (131); polymorphic gene with SNPs (80); differentially
expressed in parasites under lumefantrine pressure (81)
PF3D7_0219700 PFB0900c, PF02_0184,
GEXP20
35.3 295
PF3D7_0219800 PFB0905c, PF02_0185 x 31.9 263
PF3D7_0424000 PFD1140w, MAL4P1.223 x 35.2 296 x Antigenic properties, antibody recognition in several reports, potential
vaccine candidate (29, 49, 111, 132, 133); stronger expression in
culture supplemented with albumin instead of human serum (119);
String database mining suggests interaction with var2csa and
PFB0115w (84); often referred to together with PFI1785w
PF3D7_0532200 PFE1595c, MAL5P1.313 27.3 226 Involved in response to chloroquine treatment (134, 135)
PF3D7_0731100 MAL7P1.172, GEXP11
PfPTP2
x 92.5 799 x Involved in cell-cell communication and plasmid transfer, located on
budding vesicles from Maurer’s clefts (43); knockout with very
reduced levels of surface PfEMP1, which was trapped in Maurer’s
clefts, no cytoadherence to CSA (44); indirect evidence for PfPTP2
being located inside the lumen of Maurer’s clefts (44); coprecipitated
with plasmepsin V (136); RESA-like protein found among soluble
proteins from parasitophorous vacuole (PV) lumen and iRBC
cytosol (82)
PF3D7_0801000 PF08_0137 x 147.1 1,127 Found among soluble proteins from PV lumen and iRBC cytosol (82),
coprecipitated PTEX components such as HSP101 and PTEX150
(45), associated with J dots (J. Przyborski, personal communication),
P. yoelii orthologue is annotated as a putative dentin phosphoryn
protein possibly involved in mineral nucleation or functions as an
extracellular matrix protein (137), contains a relaxed PEXEL motif
(1), elicits an immune response (138)
PF3D7_0830600 MAL8P1.4 x 45.1 380 Located in Maurer’s clefts, no interaction with the ATS of PfEMP1 (19);
expression downregulated in HB3, 3D7, and Dd2 (28); expression
upregulated with treatment with histone deacetylase inhibitors
(trichostatin A, suberoylanilide hydroxamic acid) (139)
PF3D7_0936600 PFI1770w, GEXP5 x 25.2 212 Originally classified as PHISTb (15); reclassified as PHISTc (16); sole
“PHISTb” that showed only cytosolic localization (20); upregulated
in gametocytes (107, 140); earliest-known postinvasion gametocyte
marker, expressed at 14 h postinvasion and independent of major
gametocyte marker, cannot promote gametocyte maturation alone
when other factors are not present (51)
PF3D7_0936800 PFI1780w x 38.6 324 Protein of unknown function, several TM domains predicted (15);
interacts with the ATS of PfEMP1 (56); located at the iRBC
periphery with PfEMP1 but not cotransported with PfEMP1 (19);
stuttering motif identified not found in any other PHIST protein
(141); noncanonical PEXEL motif that is correctly cleaved (12);
suggested presence in figure displaying exported proteins (100)
PF3D7_1001700 PF10_0021 x 27.6 226 Significantly downregulated after chloroquine treatment (80)
PF3D7_1001800 PF10_0022 x 23.8 204 Corrected gene model with adjusted exon and intron sizes (142, 143)
PF3D7_1016500 PF10_0161 x 81.3 675 Wrongly annotated as PF3D7_1016600 previously (15), evidence for
sumoylation (144)
PF3D7_1016600 PF10_0161 or PF10_0161a x 27.8 226 Had been annotated together with PF3D7_1016500 (15), evidence for
sumoylation (144), IFA shows bright punctuate pattern in iRBCs
(20)
PF3D7_1016700 PF10_0162 98.8 830
PF3D7_1016800 PF10_0163 x 30.0 241
PF3D7_1148700 PF11_0503, GEXP12 x 38.1 323
PF3D7_1200900 PFL0045c, MAL12P1.9 x 37.6 310 Noncanonical PEXEL, localizes to small dotted structures in iRBCs (12)
a Current gene identification from PlasmoDB.
b Other/previous names.
c The presence of a PEXEL motif is indicated by “x,” as identified in reference 15 or 1.
d Annotated as a pseudogene (PG) in PlasmoDB.
e For proteins with a PEXEL motif, molecular mass and length were calculated for the PEXEL-cleaved form of the protein (the molecular mass for PEXEL-cleaved proteins was
calculated by using the ExPASy Web tool [http://web.expasy.org/compute_pi/]).
f Existing viable knockout (KO) parasites or natural gene deletions are indicated by “x” (see reference 44 or the reference[s] indicated).
g Information or references referring to the corresponding gene or protein. LSAP2, liver stage-associated protein 2; SNPs, single-nucleotide polymorphisms.
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teins, 9 of which belong to the PHISTb/PHISTb-DnaJ subfamily
(Tables 2 and 3). Each of these 9 PHIST proteins has aMECmotif
in the C terminus downstream of the PHIST domain and in two
cases is followed by aDnaJ domain. Three of these PHIST proteins
also have been found to bind to inside-out vesicles (IOVs), sug-
gesting an interaction between the MECmotif and a cytoskeleton
interaction partner. Coprecipitation with the MEC motif of the
PHISTb-DnaJ protein PF3D7_1038800 revealed band 4.1R as an
interaction partner (39). Although these PHIST proteins were not
further functionally characterized, the presence of a MEC motif,
with its capacity to bind to band 4.1R, suggests their involvement
in the remodeling of the iRBC cytoskeleton and, thus, a possible
contribution to the pathology of malaria.
Seven PHISTb members (Table 3), including the well-known
RESA, also comprise a DnaJ domain referred to as PHISTb-DnaJ.
Proteins with a DnaJ domain belong to the HSP40 family. The J
domains can act as cochaperones for proteins of the DnaK/HSP70
families and can associate with unfolded polypeptide chains to
prevent their aggregation (18, 41). PHISTb and PHISTb-DnaJ
differ in only one of the four conserved tryptophan positions (Fig.
4 and 5A), indicating their close relatedness. Another characteris-
tic that sets the PHISTb-DnaJ proteins apart from the PHISTb
subgroup is the extended length ranging from !800 to 1,100
amino acids (15).
Several PHISTb proteins have been shown to localize at the
host cell periphery, and solubility assays with green fluorescent
TABLE 5 PHISTa-like and PHIST proteins
Gene
identificationa
Other gene identification(s)
or name(s)b
Presence
of
PEXELc
Gene
statusd
Molecular
mass (kDa)e
Length
(aa)e KOf Description (reference[s] or source)g
PF3D7_0831300 MAL8P1.205, GEXP13 (x) 93.0 770 Classified as a PHIST protein (16),
although no PHIST domain
identified in InterPro; detected in
early gametocytes (35); has a
PEXEL motif (RKLSE), although
this is not yet indicated in any
publication
PF3D7_0831500 39.1 335
PF3D7_0831750 PG 34.0 288
PF3D7_0831900 MAL7P1.230 PG 33.5 287 x Deletion in field samples from South
America (116), no deletion in
samples from Central America
(117)
PF3D7_0832200.1 MAL7P1.225 33.5 286 One of the earliest-upregulated
genes in the asexual cycle (28),
one splice form of MAL7P1.225
(GeneDB)
PF3D7_0832200.2 MAL7P1.225 34.3 293 Same as PF3D7_0832200.1
PF3D7_0832300 MAL7P1.224 30.8 259 Upregulated during the
commitment phase for the sexual
developmental cycle (53, 145)
PF3D7_0832700 MAL7P1.220 PG 30.8 260
PF3D7_1000700 PF10_0007, PF10_0008 x PG 26.1 209 Both old gene identifications have
different domains (27), PHISTa
protein with N-terminal PHIST
domain (15)
PF3D7_1201200 PFL0060w, MAL12P1.12 x 16.0 134 Downregulated in several strains
(28), PHISTa-like protein (15)
PF3D7_1301300 MAL13P1.58 PG 28.9 247 Not located in telomeric region (27)
PF3D7_1372300 24.2 206
PF3D7_1477300 PF14_0744, Pfg14-744 x 22.8 196 Strongly upregulated at
gametocytogenesis (27);
expression peak in stage I
gametocytes but also present at
stage II (85, 145, 146); grouped as
PHIST or PHISTa-like protein (1,
15, 16); tested as a gametocyte
marker (129); expressed as early
as in committed schizont stage,
regulated by AP2-G, and HP1 is
reported to have a silencing effect
(54)
PF3D7_1477400 PF14_0745 36.2 303 Expressed in parasites committed to
the sexual cycle (27), found in the
nuclear proteomic fraction (147),
classified as a PHIST protein (16)
a Current gene identification from PlasmoDB.
b Other/previous names.
c The presence of a PEXEL motif is indicated by “x,” as identified in reference 15 or 1. A newly identified PEXEL is indicated by “(x).”
d Annotated as a pseudogene (PG) in PlasmoDB.
e For proteins with a PEXEL motif, molecular mass and length were calculated for the PEXEL-cleaved form of the protein (the molecular mass for PEXEL-cleaved proteins was
calculated by using the ExPASy Web tool [http://web.expasy.org/compute_pi/]).
f Existing viable knockout (KO) parasites or natural gene deletions are indicated by “x” (see reference 44 or the reference[s] indicated).
g Information or references referring to the corresponding gene or protein.
Warncke et al.
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protein (GFP)-tagged PHISTb proteins suggested an interaction
with components of the host cytoskeleton (20). The authors of this
study also investigated sequence requirements for peripheral lo-
calization and showed that the PHIST domain or the N-terminal
region of the PHIST domain alone is not sufficient for peripheral
localization. The PHIST domain together with parts of the N-ter-
minal region, however, conferred peripheral localization (20).
This was shown for the PHISTb protein PF3D7_0401800 and the
PHISTb-DnaJ protein PF3D7_0102200, and it remains to be con-
firmed whether this applies to all PHISTb proteins and the precise
sequence or structural requirements that are necessary. It also
needs to be shown whether PHIST proteins of the other subfam-
ilies have similar requirements for correct localization. Although
localization does not predict function, these observations in gen-
eral confirm that PHISTb proteins tend to associate with the iRBC
cytoskeleton.
PHISTc. Most information is available for the PHISTc sub-
group, which is entirely shared with P. vivax and P. knowlesi (15),
indicating that the expansion of this subgroup occurred before the
lineage diverged. The PHISTc subgroup is also the most diverse
group in length, with lengths varying from!200 to"1,200 amino
acids. In most of the 18 PHISTc proteins (Table 4), the PHIST
domain is found very near the C terminus of the protein (Fig. 3),
similarly to the PHISTa subgroup. In contrast to PHISTb pro-
teins, which are associated mostly with the iRBC cytoskeleton,
several PHISTc proteins have been found at structures such as
Maurer’s clefts (19, 42) and exosome-like vesicles (43) and are
thought to be involved in protein trafficking (44, 45). There is
recent evidence for PF3D7_0936800 (PFI1780w) to also be local-
ized at the host cell membrane (19).
Other PHIST proteins. PlasmoDB lists 14 additional proteins
that are annotated as PHISTa-like or simply PHIST proteins but
originally were not included in the PHIST family (Table 5). Some
of the PHISTa-like proteins were included in the subtelomeric
protein superfamily identified by Eksi et al. (27), most of which
have now been included in the PHISTa subgroup. There seems to
be a close relationship between the PHISTa and the PHISTa-like
proteins, indicated by sequence alignment and the pattern of con-
served tryptophan residues (Fig. 4 and 5A).
PHIST Gene Expression
Transcriptome analysis of the P. falciparum 3D7 strain showed
that most phist genes were expressed at an early stage during the
intraerythrocytic development cycle. Throughout the second half
of the cycle, almost all phist genes were switched off, while some
were upregulated again toward the very end of the cycle (Fig. 6)
(46). Genes with similar expression patterns were described to be
involved in parasite-specific processes such as host cell invasion
(47). In Plasmodium, the presence of the protein is often delayed
after transcription, and the appearance of PHIST proteins was
delayed on average by#11 h (48). Thus, most PHIST proteins are
present and exported during the first half of the intraerythrocytic
development cycle, again strongly suggesting an important role of
PHIST proteins in host cell remodeling.
Some phist genes have been reported to be differentially ex-
pressed, for example, during gametocytogenesis (35), in pregnan-
cy-associated malaria (29, 49), or in cerebral malaria (32). Vari-
able expression generally has also been observed in field isolates
(50).
Figure 6 presents expression data obtained only from asexual
blood stage parasites, but a proteomic study revealed that a num-
ber of PHIST proteins are enriched in early gametocytes, the sex-
ual blood stage of P. falciparum. Of 26 putatively exported pro-
teins enriched during early gametocyte stages, 9 belong to the
PHIST protein family (35) (Fig. 6, yellow boxes). Two of these
proteins, namely, GEXP5 (PF3D7_0936600) and PfEMP1-traf-
ficking protein 2 (PfPTP2) (PF3D7_0731100), have been shown
by microscopy to localize to gametocytes, with the former having
been shown to be expressed exclusively in gametocytes (51). A
function during sexual development remains to be shown (43,
51). The presence of some PHIST proteins in gametocytes sug-
gests transcriptional upregulation, and indeed, the expression of
#20 phist genes, including GEXP5 (PF3D7_0936600), was shown
to be under PfHP1 regulation (52). HP1 is a negative regulator of
AP2-G, a transcription factor needed for sexual conversion, which
binds to a promoter motif common to several early gametocyte
genes, including the phist genePF3D7_1477300 (53, 54). This pro-
vides strong evidence that gene regulation by HP1 affects the ex-
pression of phist genes and their involvement in gametocytogen-
esis.
Almelli et al. (32) compared transcriptional differences of sam-
ples frompatients with cerebralmalaria and samples from asymp-
tomatic malaria cases from the 3D7 reference strain. A number of
phist genes from all subfamilies were differentially either up- or
downregulated (Fig. 6).
Mackinnon et al. (50) compared gene expression levels of the P.
falciparum 3D7 strain with those of field isolates and also showed
that a number of genes were differentially expressed. Among the
20 most regulated genes were also 7 phist genes (PF3D7_0202100,
PF3D7_0424000, PF3D7_0702100, PF3D7_0832200.1, PF3D7_
0936600, PF3D7_0936800, and PF3D7_1477700), suggesting that
some PHIST proteins might be dispensable in culture but not for
in vivo growth.
It has also been shown that 14 phist genes were variably ex-
pressed in P. falciparum 3D7 (Fig. 6) (55), indicating an active role
FIG 3 Phylogenetic tree and protein domain prediction for PHIST proteins. The amino acid sequences of all 89 PHIST proteins were obtained from PlasmoDB.
Of 19 PHIST proteins annotated as pseudogenes, 16 contained one or more premature stop codons in the amino acid sequence and were removed from the list.
All those of the remaining 73 PHISTproteinswith a PEXELmotif were PEXEL cleaved in silico by using the PEXELmotifs provided by Sargeant et al. (15), Boddey
et al. (11), or Schulze et al. (12). The amino acid sequences were aligned with MUSCLE (163). The alignment is represented in a phylogenetic tree using the
phylogenic tree tool built into MUSCLE at the EMBL-EBI website (164). The branch lengths are drawn in cladogram style and do not represent actual
phylogenetic distances. The colored bars next to the gene identifications represent different PHIST subgroups, as indicated. The structure of the amino acid
sequences was then analyzed with InterPro (https://www.ebi.ac.uk/interpro/) (165). A schematic representation of the results for each PHIST protein is shown
next to its respective gene identification. The following different domains are highlighted: the PHIST domain, the DnaJ domain as defined by Pfam (family
PF00226), the DnaJ-containing protein with an X domain as defined by InterPro (accession number IPR026894) or Pfam (family PF14308), the acyl coenzyme
A (CoA) binding protein domain as defined by Pfam (family PF00887), coil domains as identified by InterPro, signal peptides as defined by SignalP or
transmembrane domains, and the MEC motif as defined by Kilili and LaCount (39).
Warncke et al.
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in adaptation to changing environments such as heat shock (fe-
brile illness) or nutrient depletion.
All of these studies were performed on the transcriptome or
proteome level and reported general patterns and trends in gene
expression or protein abundance. These studies repeatedly
showed that phist genes or proteins are involved in different pro-
cesses and support the notion that PHIST proteins play a central
role in host cell remodeling. However, the functional and physical
characterization of these proteins lags far behind. So far, we know
that PHIST proteins are involved in cellular processes in iRBCs
and in disease-associated functions, but our understanding of
their actual function and interactions is very limited, at least for
the large majority of them.
Below, we review and discuss individual PHIST proteins for
which more detailed information is available, with most of them
belonging to the PHISTb or PHISTc subgroup. Further informa-
tion on other PHIST proteins is summarized in Tables 1 to 5.
PF3D7_0532400 (LyMP)
The PHISTb lysine-rich membrane-associated protein (LyMP)
(PF3D7_0532400 or PFE1605w) is a PEXEL-containing PHISTb
protein that is exported during the first half of the intraerythro-
cytic development cycle to the erythrocyte membrane, where it
can localize at parasite-induced protrusions on the red blood cell
membrane called knobs. Its transient localization at Maurer’s
clefts prior to its final destination correlates in space and timewith
FIG 4 Sequence alignment of PHIST proteins. The processed amino acid sequences as described in the legend of Fig. 3 were sorted into PHIST subgroups, and
individual alignments for each subgroup were obtained with CLUSTAL (166). The output was analyzed by using BioEdit (167). Conserved amino acids at a
threshold of 83% are highlighted. Shown is the core of the alignment using the position of the first conserved tryptophan to align the different alignment blocks
of the subgroups. Tryptophan residues conserved above or below the 83% threshold are marked as indicated.
PHIST Proteins
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that of PfEMP1 (19). The PHIST domain of LyMP (amino acids
122 to 335) interacts with the intracellular acidic terminal segment
(ATS) of PfEMP1. Conditional downregulation of LyMP reduced
binding to CD36 by !60%, indicating that the interaction be-
tween the PHIST domain of LyMP and the ATS domain of
PfEMP1 is important for the cytoadhesive properties of iRBCs
(19, 38, 40, 56). A similar conditional downregulation of LyMP in
iRBCs preselected for binding to different adhesion receptors dis-
playing different PfEMP1 variants on the surface strongly differed
in the reduction of cytoadherence (38), which led to the hypoth-
esis that different PHIST proteins might be responsible for an-
choring different PfEMP1 variants to the cytoskeleton.
It was further shown that the C-terminal segment of LyMP
(amino acids 319 to 528) was able to bind IOVs, which are used to
study protein interactions involving cytoskeletal proteins (40).
Recently, we were able to show that this part of LyMP binds di-
rectly to human membrane protein band 3, which is linked to the
cytoskeleton via ankyrin (38). Together with the ATS interaction
mediated by the LyMP PHIST domain (19), it is evident that
LyMP can act as a linker between the virulence complex of P.
falciparum PfEMP1 and the host cytoskeleton.
PF3D7_0936800
PF3D7_0936800 (PFI1780w) is a PHISTc protein that was also
shown to interact with the ATS domain of PfEMP1 albeit much
more weakly than LyMP (56). A crystallographic structure of its
PHIST domain (residues 85 to 247) has been obtained and is the
first available structure for any PHIST protein. It confirms the
predicted four-alpha-helix structure of the PHIST domain
with a very short first alpha helix. The remaining three helices
form a three-helix bundle with weak structural similarity to
spectrin (19, 56).
PF3D7_0936800 has been classified as a noncanonical PEXEL
protein with the first position of its PEXELmotif rendered fromK
to R, which was recently shown to be correctly cleaved and N-
acetylated, confirming that this PHIST protein is correctly ex-
ported from parasites into iRBCs (12).
PF3D7_0936800 localizes underneath the iRBCmembrane but
is absent from knobs (19). It is speculated that it contains an in-
teraction epitope for binding of iRBC membrane/cytoskeleton
components (12). Here it is also noteworthy that PF3D7_0936800
has been found to be variantly expressed in 3D7 (55) and that there
has been no reported PF3D7_0936800 knockout (PF3D7_
0936800-KO) parasite.
PF3D7_0731100 (PfPTP2)
The PHISTc protein PF3D7_0731100 (PfEMP1 trafficking pro-
tein 2, PfPTP2) seems to play a role in PfEMP1 trafficking or
surface display. Depletion of this protein leads to PfEMP1 accu-
mulation in Maurer’s clefts and its absence from knobs. Under
flow conditions, PfPTP2-KO parasites do not adhere to chon-
droitin sulfate A (CSA), suggesting that the main role of
PfPTP2 might be the trafficking of PfEMP1 from Maurer’s clefts
to knobs (42, 44).
Recently, PfPTP2 was also described to be located at exo-
some-like vesicles of "70 nm that are involved in cell-cell com-
munication and allow nucleic acid transfer between Plasmo-
dium parasites. PfPTP2-deficient parasites showed reduced
cell-cell communication, and Regev-Rudzki et al. (43) suggested
that PfPTP2 is essential for cell-cell communication between P.
falciparum-infected erythrocytes, leading to increased gametocy-
togenesis in vitro. PfPTP2 was the only protein involved in knob
formation or PfEMP1 display (besides skeleton binding protein 1
[SBP1] [57]) but was also found to be enriched in early gameto-
cytes (35, 43). In contrast, transcriptional analysis shows that Pf-
PTP2 is downregulated in gametocytes; thus, PfPTP2 abundance
in early gametocytesmight be acquired through exosome-like ves-
icles, and this might in turn induce sexual conversion. Such a
hypothetical model would accommodate the fact that PfPTP2 is
upregulated in asexual stages but also enriched in gametocytes.
Immunoelectron microscopy and proteinase K assays revealed
the localization of PfPTP2 on the cytosolic face of Maurer’s clefts,
on budding vesicles, and on the surface of exosome-like vesicles
(43, 44).
FIG 5 PHIST domainmodeling. (A) Visual representation of the positions of the conserved tryptophan residues of the PHIST subgroups, treating PHISTb and
PHISTb-DnaJ as well as PHISTa and PHISTa-like/PHIST domains as separate subgroups to show the slight variations between them. A consensus sequence was
generated for each subgroup alignment fromFig. 4. The consensus sequence was then split into blocks of 10 residues represented by gray boxes (boxes containing
no tryptophans were shortened). The positions of the tryptophan residues conserved within a subgroup are marked by yellow bars. (B) To exemplify the
differences in structure prediction, the Jpred4 (168, 169) output is shown for the PHIST protein PF3D7_0532400. The top sequence is the consensus sequence
used for PHIST identification by Sargeant et al. (15). JNetPRED displays the consensus prediction: helices are marked with red tubes. JNetCONF provides
confidence estimates for the prediction. High values mean high confidence. For the JNetHMM profile-based prediction, the six predicted helices are marked as
red tubes. For the JNETPSSM-based prediction, the four helices are marked as red tubes, and sheets are marked with a green arrow.
Warncke et al.
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PF3D7_0402000
The PHISTa protein PF3D7_0402000 was identified in a yeast
two-hybrid assay to determine potential interaction partners of
the human erythrocyte cytoskeleton protein band 4.1R. The pro-
tein interacted with the N and alpha lobes of the FERM (four-
point-one, ezrin, radixin, and moesin) domain (Pfam family
PF00373) of band 4.1R through helices 2 and 3 of the PHIST
domain, but the entire domain was required for maximal interac-
tion (58). The host cytoskeleton protein band 4.1R binds to actin
filaments and links these to membrane proteins such as band 3
and glycophorin C, maintaining the biconcave shape (reviewed in
references 58 and 59). In this context, it is noteworthy that otherP.
falciparum proteins, e.g., MESA (PF3D7_0500800), which is not a
PHIST protein, bind to this host cell cytoskeleton interaction hub
(60). In immunofluorescence imaging analyses, subpopulations
of both band 4.1R and PF3D7_0402000 were shown to colocalize
at the parasitophorous vacuole membrane (58). The role that
PF3D7_0402000 plays in changes of membrane rigidity or host
actin recruitment remains unclear.
PF3D7_0936600 (GEXP5)
GEXP5 (gametocyte exported protein 5) was originally classified
as PHISTb (15) but is now grouped among the PHISTc proteins
(16), which is confirmed by the position of its conserved trypto-
phan residues (Fig. 4). GEXP5 was the first PHIST protein de-
tected in gametocytes. A GEXP5-GFP fusion protein, when epi-
somally expressed under the control of the endogenous promoter
in asexual stages, was not detected by fluorescence imaging (51)
but could be detected when expressed under the pfcam promoter,
confirming a cytosolic localization (20). This indicated that en-
dogenous GEXP5 is expressed and exported only in sexual stages
and is found in the iRBC cytosol of stage I to IV gametocytes. Its
uniform distribution throughout the iRBC and its presence in the
soluble protein fraction suggest that it is a soluble protein (51).
GEXP5 is already found at 14 h postinvasion in ring stage parasites
committed to gametocytogenesis and is now considered to be the
earliest gametocyte marker (51). This early appearance of GEXP5
in committed parasites might explain the presence of transcripts
in the expression data sets in PlasmoDB.
The expression and export of GEXP5 are independent of tran-
scription factors normally associated with gametocytogenesis,
such as PfAP2-G, but GEXP5 is not able to drive gametocyte mat-
uration alone in the absence of these transcription factors (51). It
is therefore assumed that GEXP5 is not involved in processes driv-
ing gametocytogenesis but is used to remodel or prepare the host
cell to accommodate sexual development.
PF3D7_0102200 (RESA)
RESA (ring-infected erythrocyte surface antigen) contains both
PHIST and DnaJ domains and is one of seven members of the
PHISTb-DnaJ subgroup. Its name is a misnomer since RESA is an
intracellular exported protein (20).
RESA is expressed in mature-stage parasites (61) and is stored
in the dense granules of newly formed merozoites (62). Within
minutes after the invasion of a merozoite into an erythrocyte, the
contents of the dense granules, including RESA, are discharged
into the parasitophorous vacuole (63–65). From there, RESA is
then exported to the iRBC and localizes at the iRBC cytoskeleton,
where it remains for !24 h (64, 65). At the cytoskeleton, RESA is
phosphorylated (66, 67) and interacts with spectrin (68). A frag-
ment of 108 amino acids has been identified to interact with repeat
16 of the "-chain of spectrin (here it is important to note that
residues 663 to 770 correspond to only a partial DnaJ X domain
and not to the DnaJ J domain). As a result of this interaction, the
spectrin tetramers are stabilized and rigidify the iRBC (69); how-
ever, it needs to be provenwhether this interaction and the accom-
panying rigidification would also occur with the full-length do-
main or full-length RESA protein.
There is controversy regarding whether this interaction impairs
the invasion of merozoites, since one study with erythrocytes pre-
packed with a recombinant form of RESA showed that the RESA-
spectrin interaction had no significant effect on invasion (70). The
recombinant RESA used in this study contained residues 322 to
1073 and lacked the entire PHIST domain (residues 174 to 294)
(70) (Fig. 3). However, using a similar setup, Pei et al. showed that
an even shorter fragment of RESA (residues 663 to 770)was able to
reduce the invasion efficiency (69). Importantly, this recombinant
peptide lacked both the PHIST domain and the DnaJ domain and
hence might have created an artificial inhibitory interaction.
A domain of 70 amino acids found in RESA shares 39% homol-
ogy with the DnaJ heat shock protein of Escherichia coli (41). Pro-
teins with a DnaJ domain belong to the HSP40 family and act as
cochaperones to the DnaK/HSP70 chaperones, which are in-
volved in protein assembly and trafficking (18, 41). Proteins with
a DnaJ domain have been described to be membrane associated
(41), a feature shared by RESA. Initially, it was proposed that
RESA destabilizes the RBC cytoskeleton (64), but now there is
evidence that RESA in fact does the contrary, namely, stabilizing
the cytoskeleton with the effect that it rigidifies ring stage infected
parasites (65, 69, 71). It has been shown that the RESA-spectrin
interaction protects iRBCs from thermal damage (65, 69, 70), and
it has been speculated that the DnaJ domain of RESA might pre-
vent spectrin from unfolding at elevated temperatures, or it might
directly bind to hydrophobic regions of partially unfolded spec-
trin molecules (70). This rigidification of ring stage parasite-in-
fected erythrocytes, potentially impairing passage through the
spleen (72), is rather surprising, but this might simply be a side
effect of the protective function of RESA against thermal damage
to the host cell.
At the end of each 48-h cycle, the iRBC ruptures and releases
FIG 6 Heat maps. (A) Heat map of phist gene expression of the P. falciparum 3D7 strain over the course of 53 h. Microarray data on transcript abundance were
reported previously (46) (accessed through PlasmoDB, release 28, 31 March 2016). The heat map was constructed by using TMeV4.9 (170). phist genes were
clustered into their respective subgroups and were then ordered by gene identification. Genes annotated “phista-like” or as “phist” genes were grouped together
as “phist others.” Yellow boxes to the right of the heat map indicate PHIST proteins present in the early gametocyte proteome (35), differentially expressed phist
genes in pregnancy-associatedmalaria (29, 49, 50, 84, 92, 112) and in cerebralmalaria (32, 34), or if variant expression has been reported (55). Green to red colors
represent fold changes (log fold changes from #3 to 3). (B) For a number of phist genes, no expression data were available in the data set, and these genes were
grouped first by PHIST subgroup and then by gene identification. Additional information for selected PHIST proteins is provided in Tables 1 to 5. The colored
bars next to the gene identifications indicate the PHIST subgroup.
Warncke et al.
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new merozoites. This event is accompanied by fever peaks that last
for a few hours (73, 74). During these fever episodes, the parasites
are in ring stages, and this correlates with the time when RESA
interacts with the cytoskeleton, protecting it from thermal damage
caused by fever. After !24 h, RESA dissociates from spectrin (61),
and other proteins might be responsible for further rigidification
of the cytoskeleton (71). This apparent functional contradiction
might be an evolutionary tradeoff between the need for survival
during fever and costs of increased cell rigidity to a level that still
allows passage through the spleen. The fact that less deformable
ring stage parasite-iRBCs are cleared by the spleen supports this
idea of a tradeoff (72).
While the function of the DnaJ domain in RESA has been de-
scribed in much detail, the function of the PHIST domain still
remains enigmatic.
PVX_093680 (CVC-8195)
The only PHIST protein not from P. falciparum that has been
further characterized is the P. vivax PHIST CVC-8195 (PVX_
093680). Caveola-vesicle complexes (CVCs) are parasite-induced
indentations in P. vivax-infected erythrocyte cell membranes. The
exact structure, protein composition, and function are not yet
fully understood, but CVC-8195 is exported, is a predominant
protein in these CVCs, and is found on tubular extensions going
inwards from the CVC (75, 76). Its orthologue in P. cynomolgi
shows a similar localization (75). CVC-8195 was found by Acharya
et al. (77) in P. vivax-infected peripheral blood, and another study
showed that over 80% of patient sera reacted positively with CVC-
8195 (78). Based on these findings, CVC-8195 was suggested to be
involved in immune evasion (78), as the PHIST protein family was
previously suggested to be involved in this process (24). There-
fore, in P. vivax, PHIST proteins also seem to be localized to par-
asite-induced structures in iRBCs and might be essential for host-
parasite interactions. However, more functional analyses are
required to fully understand the role of this PHIST protein in the
CVC of P. vivax.
phist Gene Knockout Study
In a large gene knockout study in P. falciparum to functionally
characterize exported proteins, 17 phist genes were targeted for
deletion (44). These genes included 1 phista gene, 7 phistb genes, 6
phistb-dnaJ genes, and 3 phistc genes. Of these, all but four
(PF3D7_0936800, PF3D7_0401800, PF3D7_0402100, and PF3D7_
1149000) were successfully disrupted, indicating that the majority
was dispensable for in vitro growth. Except for PF3D7_0731100
(PfPTP2), none of the phist knockout parasites from this study were
analyzed in greater detail. Some were reported to have an influence
on altered knob morphology (PF3D7_0424600-KO) or reduced
(PF3D7_0102200/RESA-KO) or increased (PF3D7_0220100-KO)
iRBC rigidity (44). Further phenotypic characterization of these par-
asite lines is urgently needed to better understand the role of PHIST
proteins in host cell remodeling.
Structure and Function
It is highly conceivable that PHIST proteins might fulfill similar
roles as chaperones, since a number of chaperones also contain
DnaJ domains. They may also be responsible for the close associ-
ation with the host cytoskeleton and cell membrane due to the
intrinsic positive charge of many PHIST proteins. The few studies
on PHISTs have looked mostly at the PHIST domain only; how-
ever, Tarr et al. (20) suggested that the PHIST domain alone is not
sufficient to correctly target the protein to its destination, at least
for those PHIST proteins investigated. Mayer et al. (56) analyzed
the binding affinities of various PHIST domains for a number of
ATS domains, but only the PHIST protein PF3D7_0532400 has
been studied in greater detail with respect to structure and func-
tion (19, 56). This is rather surprising for a protein family com-
prising a large proportion of the complete exportome of P. falcip-
arum.
CONCLUSION
The three major PHIST subfamilies not only differ in sequence but
also seem to differ in function. PHISTb proteins mostly interact
with and localize to the iRBC cytoskeleton and seem to be involved
in changes of cell properties such as rigidity. PHISTc proteins
seem to be involved mostly in protein trafficking of other exported
proteins, while the PHISTa subfamily remains enigmatic, and
there is not yet sufficient information available to draw a conclu-
sion on function.
The presence of PHIST proteins at various localizations in the
host cell makes them highly interesting candidates as interaction
partners for other exported proteins, and therefore, it would be
important to understand what determines the destination of
PHIST proteins. The identification of export requirements for
PHIST proteins would increase our understanding of the interac-
tion network of exported proteins.
It seems that some PHIST proteins have at least two binding
domains, the PHIST domain and a second one toward the C ter-
minus, e.g., the MEC motif, the spectrin binding site, the band 3
interaction epitope, or a DnaJ domain. This would make PHIST
proteins ideal molecules for multifunctional interactions at the
iRBC cytoskeleton or in protein export with the PHIST domain
serving as a general adaptor, while the C-terminal domain could
function as a highly specific binding site. However, only a few
additional binding motifs have been identified in some PHIST
proteins, and more PHIST proteins remain to be studied.
Our knowledge of PHIST proteins is still very limited and
based mainly on studies of the 3D7 laboratory strain, which does
not suffice to understand the full extent of PHIST protein func-
tions for in vivo parasite survival and malaria-associated disease
and pathology. PHIST proteins should be studied in various dis-
ease presentations from mild to severe malaria as well as in preg-
nancy-associated malaria. Furthermore, the role of PHIST pro-
teins in gametocytogenesis and also in mosquito stages remains
completely enigmatic. Since many PHIST proteins seem to be
central for host cell remodeling, it is essential to understand their
function in this crucial process.
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Chapter 4: PHIST BioID and Protein Interaction Network       
Summary 
Remodeling of the erythrocyte is a hallmark feature of the asexual blood stages of 
Plasmodium falciparum and is the cause of all malaria-associated morbidity and mortality. 
Exported parasite proteins are the effectors facilitating this remodeling process. Plasmodium 
helical interspersed subtelomeric (PHIST) proteins, a family of exported proteins, have previously 
been suggested to play a role in host cell remodeling and particularly in cytoskeleton interactions. 
To elucidate their interactions and to better understand processes involved in remodeling, we 
selected 9 PHIST proteins for comprehensive analyses. We showed their localization at the 
erythrocyte cytoskeleton which was further confirmed for most candidates by solubilization studies 
and immuno-electron microscopy. Through a BioID approach and co-immunoprecipitations with 
subsequent mass spectrometry we identified potential interaction partners. Using this data we 
generated a network of PHIST protein interactions at the erythrocyte cytoskeleton involving both 
host and exported parasite proteins. We identified a number of so far uncharacterized exported 
parasite proteins that might also act as key players in host cell remodeling. The generation of this 
network of protein interactions of exported parasite proteins at the erythrocyte cytoskeleton adds 
to our better understanding of host cell remodeling and provides opportunities for further 
hypothesis driven studies. 
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Introduction 
Upon invasion into the human erythrocyte, the malaria parasite Plasmodium falciparum 
extensively refurbishes its host cell. One hallmark of this refurbishment is the appearance of 
knobs, electron-dense protrusion on the surface of the infected red blood cell (iRBC) (1). PfEMP1, 
the major virulence protein of P. falciparum which is encoded by var genes is anchored in those 
knobs and mediates cytoadhesion to endothelial cells. This leads to sequestration of iRBCs in the 
microvasculature of human organs and is the cause of malaria-associated morbidity and mortality 
(2).  
This host cell remodeling depends on the export of approximately 10% of the entire parasite 
proteome into the host cell. There are about 460 PEXEL-carrying proteins (3, 4) and an unknown 
number of PEXEL-negative exported proteins (PNEPs) (5, 6) destined for export into the host cell. 
Both classes of proteins are translocated into the parasitophorous vacuolar space and finally 
exported in the host cytosol through the Plasmodium translocon of exported proteins (PTEX) (7-9). 
A large number of the Plasmodium helical interspersed subtelomeric (PHIST) protein family 
members are amongst these exported proteins, which possess a ~150 amino acid domain which 
forms four consecutive alpha helices referred to as PHIST domain. Based on the presence and 
position of conserved tryptophan residues, the PHIST family is divided into several subgroups (10, 
11).  
Several PHISTb proteins previously have been shown to localize to the iRBC membrane or 
cytoskeleton (12). It was therefore suggested that PHIST proteins act as cross-linkers at the 
cytoskeleton, which was based on the capacity of the PHIST domain to target these proteins to 
the cytoskeleton and mediate binding to it (12). The PHISTb protein PF3D7_0532400 (Lysine-rich 
membrane-associated protein, LyMP) was specifically shown to bind to the intracellular ATS 
domain of PfEMP1 and seems to act as cross-linker to the remodeled iRBC cytoskeleton. 
Depletion of PF3D7_0532400 significantly affected anchoring of PfEMP1 and thus the strength of 
cytoadhesion (13-15).  
Nine PHISTb proteins contain a cytoskeleton-binding motif first identified in MESA (16) and 7 
PHISTb proteins possess a DnaJ domain which could assist in protein interactions at the 
cytoskeleton (11). One of these PHISTb-DnaJ proteins is RESA which has been shown to bind to 
spectrin and provides resistance to thermal stress during febrile episodes (17-19), emphasizing the 
importance of PHIST proteins for the parasite’s survival. The PHISTc protein PfPTP2 
(PF3D7_0731100) has been shown to be involved in trafficking of PfEMP1 to its final destination 
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within the host cell (20) whilst another PHISTc protein, PF3D7_0936800 (PFI1780w), was shown to 
interact at the host cytoskeleton similar to PHISTb proteins (13).  
The cytoskeleton of the iRBC is a major target in the remodeling process and acts as interface 
between exported parasite and erythrocyte proteins. We therefore set out to investigate the role 
of PHIST proteins in this host cell remodeling process. Through pull-down experiments we 
identified potential interactions partners of selected PHITS proteins. As we expected a number of 
cytoskeletal proteins to be involved in these interactions that would be difficult to solubilize for 
immunoprecipitations, we used the proximity-dependent biotin identification (BioID) approach 
(21, 22). With the identification of potential interaction partners we were able to establish a 
network of protein interactions at the remodeled iRBC cytoskeleton which to our knowledge is the 
first network of exported parasite proteins at the erythrocyte cytoskeleton interface reported.  
Methods 
Parasite culture 
In vitro culturing and transfection of P. falciparum 3D7 parasites was performed as described 
(23). Parasites were synchronized either with sorbitol treatment (24) or by a Percoll density 
gradient (23). Gelatin flotation was frequently used to select for presence of knobs on the parasite 
surface (25). Transgenic cell lines were cultured in 10 nM WR99210 (Jacobs Pharmaceuticals, 
Cologne, Germany) or 5 mg/ml Blasticidin S (Sigma). 
Cloning 
P. falciparum 3D7 cDNA was prepared using the ImProm-II Reverse transcriptase System 
(Promega, Switzerland). For the PHIST-GFP parasites, the coding region of the selected PHIST 
genes was amplified from cDNA and cloned into the pARL vector (26) using AflII and ClaI. To 
express PHIST-BirA*-3xHA-2A-BSD under the endogenous promoter, the SLI approach was used 
(27). For each PHIST, the last 300-600 bp of the coding region were selected as homology region 
(referred to as 3’HR) and cloned into the pSLI vector (27) which already contained the BirA* and 
HA tags. For the 0830600-3xHA cell line, the coding sequence was cloned via BamHI and NheI 
into the pBcamR plasmid containing the 3xHA tag. Primers are listed in Table S1. 
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Cell lysates, solubility assay, and Western blot 
To obtain lysates, 10 ml cell culture of about 5% parasitemia were pelleted, lysed in 4 ml 
0.03% Saponin/PBS for 10 min on ice, washed in PBS, and then resuspended in 100-200 μl 
Laemmli buffer. Sample preparation for the solubility assay was done as described (28). Parasite 
lysates were boiled at 95°C for 5 min, and 10-15 μl were loaded onto a 4-12% NOVEX NuPAGE 
Bis-Tris gel and run in MOPS or MES buffer and then blotted with the iBlot 2 (all from Life 
Technologies). Membranes were blocked in 5% milk/TNT (100 mM Tris, 150 mM NaCl, 43 mM 
HCl, and 0.1% Tween 20). All antibodies were diluted in 5% milk/TNT: rat anti-HA (1:500; Roche), 
mouse anti-GFP (1:250; Roche), mouse anti-GAPDH (1:10’000), and mouse anti-MAHRP1 (1:500). 
Goat anti-mouse-HRP (1:10’000; Pierce), goat anti-rabbit-HRP (1:5000; Jackson Immunology), and 
goat anti-rat-HRP (1:10’000; Southern Biotech) were used as secondary antibodies.  
Immunofluorescence assays (IFA) 
Thin smears were prepared, fixed in methanol/acetone (60:40) for 2 min at -20°C and then 
blocked with 3% BSA/PBS followed by antibody staining. To retain the three dimensional 
structure, cell were cross-linked with 4% paraformaldehyde/0.01% glutaraldehyde as described by 
Tonkin et al. (29) and then probed with antibodies. Primary antibodies used for IFA were rat anti-
HA (1:100; Roche), rabbit anti-GFP (1:200; Abcam), mouse anti-GFP (1:250; Roche), mouse anti-
MAHRP1 (1:500), rabbit a-MAHRP2 (1:500), rabbit anti-MESA (1:200), and mouse anti-KAHRP 
(1:100). Goat anti-mouse, anti-rabbit, or anti-rat conjugated with one of the Alexa Flourophores 
405, 488, or 594 (all 1:200; Invitrogen) were used as secondary antibodies. Nuclei were stained 
with DAPI (Vector Laboratories, Inc.) and membranes with Cellmask deep red plasma membrane 
stain (Invitrogen). Images were acquired with a Leica DM 5000 B in combination with the LAS 
4.9.0 software or with a Zeiss LSM700 upright confocal microscope, using the ZEN 2010 software 
and processed with Omero 5.3.3, Imaris 8.4, and ImageJ 1.48v. Deconvolution of confocal images 
was done with Huygens Remote Manager 3.4 and colocalization analysis was then performed 
using the JACoP plugin for ImageJ (30). 
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Electron microscopy  
For immunoelectron microscopy (iEM), mature iRBCs were knob-selected and subsequently 
purified by Percoll density gradient,fixed in 2% PFA/0.2% glutaraldehyde in phosphate buffer 
pH7.4, and then embedded according to Tokuyasu et al. (31). Ultrathin sections (70 nm) were 
prepared on a FC7/UC7-ultramicrotome (Leica) at -120°C. The sections were immuno-labeled with 
rabbit anti-HA (dilution 1:30; Invitrogen) and rabbit anti-mouse (1:350; Rockland) antibodies and 
finally decorated with 5 or 10 nm protein A-gold (1:70; UMC, Utrecht, The Netherlands). Sections 
were stained with 4% uranyl acetate/methylcellulose (1:9) and examined with a Tecnai G2 Spirit or 
CM100 Philips transmission electron microscope at 80 kV (31). 
BioID and co-Immunoprecipitation (Co-IP) 
For BioID assays, biotin was added to 150 ml ring stage parasite culture (~7-8% parasitemia) 
to a final concentration of 50 μM to for 24 hours. An equal cell culture volume was left untreated 
to be used as negative control. Trophozoite-iRBCs were harvested by Percoll flotation, pelleted, 
and washed once in PBS. Cells were pelleted, lysed in 2 ml lysis buffer (50 mM Tris-HCl (pH 7.4), 
500 mM NaCl, 0.2% SDS, 2% Triton X-100, 1x Protease Inhibitor Cocktail (PIC), 1 mM DTT), and 
sonicated in 30 s intervals for 15 min at setting ‘high’ (Bioruptor, Diagenode). After centrifugation 
(20’000 g, 4°C) 500 μl supernatant was added to 50 μl Pierce streptavidin magnetic beads 
(Thermo Fisher), which were washed three times in lysis buffer. Four identical technical replicates 
were set up for both the BioID and the negative control IP. Samples were incubated over night at 
4°C on a rotator, the beads were collected using a magnetic stand and the supernatant was 
removed. Beads were washed three times with 500 μl lysis buffer and then two times with 500 μl 
wash buffer (50 mM Tris (pH 7.4), 150 mM NaCl) and then resuspended in 30 μl 1x LDS sample 
buffer (Pierce), boiled for 5 min, and processed for LC-MS/MS analysis. 
For Co-IP assays, Percoll isolated trophozoite stage iRBCs from 300 ml cell culture at 5% 
hematocrit and ~7-8% parasitemia were used. Cells were resuspended in 20 ml 1% 
paraformaldehyde/PBS. After 30 min at 37°C, the reaction was stopped by adding 4.1 ml 2.5 M 
glycine. Cells were pelleted, lysed in 150 μl 0.03% Saponin in PBS for 10 min at 4°C, washed, 
resuspended in 5.2 ml sonication buffer (50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 1% SDS, 1x PIC), 
and sonicated in 30 s intervals for 15 min at setting ‘high’ (Bioruptor, Diagenode). After 
centrifugation (20’000 g, 4°C) 650 μl supernatant was added to 50 μl Pierce anti-HA magnetic 
beads (Thermo Fisher), which were washed three times in 1x binding buffer. Four identical 
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technical replicates were set up for both the PHIST co-IP and the negative control co-IP. For the 
PHIST co-IP, 650 μl 2x binding buffer (50 mM Tris (pH 7.4), 300 mM NaCl, 2% Nonidet P40, 1x PIC) 
were added to the supernatant/bead suspension. The negative control co-IP was supplemented 
with 450 μl 2x binding buffer and 200 μl HA peptide in 1x binding buffer at 0.5 mg/ml. Samples 
were incubated over night at 4°C on a rotator, the beads were collected using a magnetic stand 
and the supernatant was removed. Beads were washed three times with 500 μl wash buffer (50 
mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% Nonidet P40, 1x PIC). Proteins were eluted in a 
molar excess of HA-peptide (30 μl of 0.5 mg/ml HA-peptide in 1x binding buffer) while rotating 
for two hours. The eluate was transferred to a new tube containing 6 μl 4x LDS sample buffer 
(Pierce). Samples were boiled for 5 min and processed for LC-MS/MS analysis. 
Mass-spectrometry 
Samples were loaded onto a 4%-12% gradient Bis-Tris gel (Thermo) and run in 1x MOPS 
buffer at 180 V for 10 min. Each lane was sliced, minced and transferred to a reaction tube. In-gel 
digest with trypsin was performed as previously described (32), and samples were stored on 
StageTips (33) until measurement. Digested peptides to be measured were separated on a 25 cm 
reverse-phase capillary (75 µM inner diameter, New Objective) packed with Reprosil C18 material 
(Dr. Maisch GmbH) and peptides were eluted with a 2 h gradient from 2%-40% acetonitrile buffer 
followed by a 95% acetonitrile wash-out at 200 nl/min on the Easy LC1000 HPLC system 
(Thermo). Mass spectrometry measurements were performed with a Q Exactive Plus mass 
spectrometer (Thermo) operated with a Top10 data-dependent MS/MS acquisition method per 
full scan. Spray voltage was set to 2.2-2.4 kV. 
Raw MS data was analyzed using MaxQuant v1.5.2.8 (34) with standard settings and activated 
match between runs and LFQ quantitation features. The search was performed against the human 
Uniprot database (81,194 entries) and the Plasmodium falciparum database (PlasmoDB 9.3, 5,538 
entries). The proteinGroups file was filtered for known contaminants and proteins identified from 
the reversed database were removed prior to statistical analysis. Non-measured data points were 
imputed by a beta distribution at the limit of quantitation. Data was plotted as a volcano plot 
using the R environment with in-house scripts: log2 fold enrichment was calculated as median 
from the four replicates and the p-value was determined by a two-sided unpaired t-test Welch. 
The threshold line for enriched proteins is defined with p = 0.05, enrichment = 2 and s0 = 1. 
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Generation of protein interaction network 
First, the exportome of Plasmodium falciparum was defined by creating a table containing all 
known PEXEL proteins (35, 36) and published PNEPs (5, 28, 37-42). PlasmoDB Release 40 was 
searched for “PfEMP1”, “PNEP”, and “exported”. In total, we assigned 739 proteins as part of 
the P. falciparum exportome (Table S2).  
To focus on protein interactions occurring within the iRBC involving exported parasite and 
human RBC proteins, the complete list of all proteins found to be positively enriched in MS 
experiments (Table S3) was filtered using the previously defined exportome to remove all non-
exported P. falciparum proteins, leaving only human and exported parasite proteins in the final 
selection for the network. Proteins from each IP were sorted by the –log10 (p-value) and from each 
IP the top 15 entries were included in the network which was generated using Cytoscape 3.6.  
Results 
Subcellular localization of PHIST proteins 
To confirm export and determine localization of the nine selected PHIST proteins, cell lines 
were generated episomally expressing the respective PHIST-GFP fusion protein (Figure 1A). All 
PHIST proteins were exported to the iRBC periphery as shown by Immunofluorescence assays 
(Figure 1B). A dotted pattern alongside the iRBC membrane was observed for most of these 
PHISTs and KAHRP was used for co-labeling to test whether the dotted pattern was similar to that 
of knobs. In some transgenic parasites, the signal was partially overlapping but none co-localized 
completely (Figure S1). 
Solubility of each PHIST-GFP fusion protein was tested by sequential protein extractions to 
obtain fractions of soluble, membrane-associated, transmembrane, and insoluble proteins. Six out 
of the selected PHIST proteins were membrane-associated and soluble in carbonate buffer 
(0401800-GFP, 0402000-GFP, 0424600-GFP, 0937000-GFP, 1038800-GFP, and 1476200-GFP). The 
PHIST protein 0201600-GFP was found insoluble whilst 0402100-GFP and 0830600-GFP were 
never detected in any of the fractions (Figure 1C). This could be expected for 0830600 as the 
episomally expressed 0830600-3xHA protein was previously found to be soluble and washed out 
of the iRBC during saponin lysis (Figure 1D).  We therefore concluded that all 9 PHIST proteins are 
exported into the host cell, and localize to the proximity of the erythrocyte cytoskeleton, but are 
most likely not part of the knob structures.  
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Time course expression pattern 
After we had confirmed that all 9 PHISTs were exported, we wanted to identify interaction 
partners by performing immunoprecipitations. For this we generated new cell lines with the 
endogenous PHISTs tagged with a biotin-ligase and a 3xHA tag (BirA*-3xHA) under the 
endogenous promoter followed by the viral 2A split peptide, giving rise to a co-translational 
cleaved off Blasticidin S deaminase (BSD) and conferring resistance to Blasticidin S (27) (Figure 
S2A-C). The promiscuous BirA* was fused to the 3’ of the PHIST genes and allowed proximity-
dependent biotin identification (BioID) followed by immunoprecipitation and mass-spectrometry 
to identify potential interaction partners (21). We successfully established 5 transgenic cell lines 
(0201600-BirA*-HA, 0402000-BirA*-HA, 0830600-BirA*-HA, 1038800-BirA*-HA, and 1476200-
BirA*-HA) but were unable to obtain the other 4 cell lines (0401800-BirA*HA, 0402100-BirA*-HA, 
0424600-BirA*-HA, and 0937000-BirA*-HA) after at least three independent transfections. They 
were then removed from the study as well as 1038800-BirA*-HA which grew in culture but plasmid 
integration into the endogenous locus could not be proven. For the remaining four parasite lines, 
correct integration of the plasmid into the endogenous gene locus was confirmed by PCR (Figure 
S2). 
To determine the expression time and localization pattern of each of the four remaining 
PHIST-BirA*-HA proteins, we prepared IFA slides and lysates for Western blot every eight hours 
over the course of the 48 hour intra-erythrocytic development cycle. Smears were fixed and 
probed with anti-HA antibodies. Fluorescence images were acquired from all eight time points of 
each parasite line and processed with identical microscope settings to compare signal intensities. 
All PHIST-BirA*-HA proteins were found to be expressed and exported latest 17-24 hpi. The 
localization for 0402000-BirA*-HA and 1476200-BirA*-HA was similar to the episomally expressed 
GFP-tagged proteins whilst 0201600-BirA*-HA and 0830600-BirA*-HA showed a dotted pattern 
throughout the iRBC (Figure 2) unlike in the respective IFAs. Parasite lysates of the same time 
points were used for Western blots and labeled with anti-HA antibody. Throughout the life cycle, 
increasing protein abundance was observed for each cell line. In most cases, a double band was 
observed corresponding to the predicted sizes of the PHIST-BirA*-HA and the uncleaved PHIST-
BirA*-HA-2A-BSD, indicating that a proportion of the fusion proteins were not successfully 
cleaved at the 2A split peptide (Figure S3). 
To study the peripheral localization of the PHIST-BirA*-HA proteins in more detail ultra-thin 
sections from the two parasite lines 0201600-BirA*-HA and 0402000-BirA*-HA were immuno-gold 
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labeled and visualized by electron microscopy. In both cases the gold labeling of was found 
underneath the iRBC membrane (Figure 3). The immuno-labelling for 0201600-BirA*-HA 
resembled the IFA pattern observed with the episomally expressed GFP tagged protein but was 
discrepant to the IFA observed with the endogenous 0201600-BirA*-HA PHIST which was rather 
dotted and spread throughout the iRBC (Figure 2). 
Identification of interaction partners 
We performed BioID and Co-IP experiments with trophozoite stage infected iRBCs when the 
respective PHIST proteins have reached their destination and most likely interact with their 
potential binding partners. As control for a protein with known interaction partners we included a 
cell line expressing MESA-BirA*-HA (PF3D7_0500800). MESA is an exported P. falciparum protein 
binding to the erythrocyte cytoskeleton but does not belong to the PHIST family (11, 43). With all 
established parasite lines we performed BioID or co-IP followed by mass spectrometry for protein 
enrichment to identify potential interaction partners. The respective bait protein together with a 
larger number of additional proteins was enriched in all positive immunoprecipitations when 
compared to negative control fractions (Figure 4A, Table S3).  
Based on these data we generated a network of protein interactions occurring at the 
remodeled iRBC cytoskeleton. We included all proteins that were found in the previously defined 
P. falciparum exportome (Table S2) and all proteins derived from the human host. Thereby, all non-
exported P. falciparum proteins were excluded as they do not contribute to protein interactions at 
the remodeled iRBC cytoskeleton (Table S3). From each co-IP the fifteen candidates with the 
highest p-value were included in the network (Figure 4B), resulting in a network comprising 55 
nodes and 58 edges with an arbitrary edge length.  
With this network we show that the three PHIST proteins (0201600, 0830600, and 1476200) 
are not directly connected but share common potential interaction partners that mediate a 
connection. In contrast, 0830600 and MESA were the only two bait proteins that shared a 
significant direct, uni-directional connection in the present network. There was also evidence that 
the two bait proteins 1476200 and MESA directly interacte as they pulled down each other but 
this is not represented in the network because this interaction fell below the significance 
threshold.,Six subunits of the TCP-1 complex were found amongst the top fifteen candidates of 
0830600 and MESA. Two of these subunits (TCP-1 eta and TCP-1 theta) were shared between the 
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two parasite proteins. 1476200 was the only bait to pull down TCP-1 theta (not part of the top 
fifteen candidates) while subunit alpha was never identified. 
The PHIST protein 0201600-BirA*-HA was co-labeled with MAHRP1 and MAHRP2 in 
immunofluorescence. Although MAHRP2 was found amongst the top fifteen potential interaction 
partners of 0201600 it could not be shown to colocalize (Figure 4C). In contrast, a high degree of 
colocalization was found between 0201600-BirA*-HA and MAHRP1 (Figure 4C) which was also 
detected in the co-IP but reached a lower significance level and was excluded from the network. 
The interaction with MAHRP1 and MAHRP2 of 0201600 suggests that it might be a Maurer’s cleft 
protein.  
Discussion 
PHIST proteins comprise almost 20% of the known exportome of Plasmodium falciparum. It 
has been suggested that PHIST proteins are involved in host cell remodeling by targeting the 
erythrocyte cytoskeleton that already has been confirmed in some cases (13-15). Here we selected 
9 PHIST proteins and showed that they were exported into the host cell in blood stage parasites. 
In most cases they localized to the vicinity of the iRBC membrane or cytoskeleton. We also 
identified potential interaction partners for three of the PHIST proteins as well as for MESA, 
another exported P. falciparum protein to generate an interaction network of human and exported 
parasite proteins at the iRBC cytoskeleton.  
We were primarily interested in interactions occurring at the iRBC cytoskeleton and probably 
involved in its modification. Because the BioID system requires incubation times of 20h with biotin 
(44) proteins from young ring stage to mid-trophozoites were biotinylated. Hence we expected 
that proteins along the export pathway probably would be also biotinylated in a 10 nm radius of 
the BirA* ligase, resulting in positive enrichment of non-exported proteins. This pitfall of the BioID 
method could have been overcome with the availability of a much faster BirA* variant that has 
been recently published (45, 46). To remove those non-exported parasite proteins from the 
network, we defined the Plasmodium falciparum exportome and used this to filter the prey 
proteins identified by mass spectrometry.  
Since cytoskeleton remodeling upon infection is a dynamic process, a more rapid 
biotinylation would allow the creation of a proteomic time series to investigate the temporal 
modification of this process. In addition, smaller versions of BirA* seem to improve localization of 
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fusion proteins (46). Wrongly targeted BirA* fusion proteins could explain the differences seen 
between GFP-tagged and BirA*-tagged 0201600 and 0402000 fusion proteins, and it also could 
explain the export deficiency in 1252700.  
Amongst the prey proteins detected in the different co-IP were subunits of the group II 
chaperonin T-complex polypeptide-1 (TCP-1 complex). TCP-1 was reported to interact with the 
erythrocyte cytoskeleton during elevated temperature (47). The strong presence of almost all 
TCP-1 subunits amongst the potential binding partners suggests that these exported parasite 
proteins seem to interact with the human TCP-1 complex. However, the role of this chaperonin 
complex during the remodeling process of the erythrocyte cytoskeleton remains elusive but it is 
strong evidence for its interaction with parasite proteins. The P. falciparum TCP-1 complex called 
PfTRiC was previously reported to traffic exported proteins to their final destination in the iRBC 
(48) but a later report argued that PfTRiC is not exported and thus could not shuttle proteins 
inside the iRBC cytosol (49).  
One third of the parasite proteins shown in the network belong to the PHIST protein family. 
Their strong presence at the remodeled iRBC cytoskeleton supports the hypothesis that PHIST 
proteins play a central role in erythrocyte cytoskeleton remodeling during a P. falciparum infection. 
The elucidation of their detailed function and interaction can pave the path of understanding the 
role of the massively expanded gene family in P. falciparum.  
Despite the limitations of our approach the dataset clearly shows that a large number of 
exported proteins target the iRBC cytoskeleton. To the best of our knowledge this is the first 
protein interaction network on the iRBC cytoskeleton and provides the basis for further research. 
Reverse co-IPs as well as additional colocalization and interaction studies are required to confirm 
these protein interactions. Identification of parasite proteins that target the erythrocyte 
cytoskeleton and determination of essential interactions provide a deeper insight and 
understanding of the host cell remodeling process and could lead to new targets to interfere with 
intracellular parasite growth and survival. 
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Figure legends 
Figure 1 – Over-expression of PHIST-GFP fusion proteins from episomes 
 (A) Schematic representation of the plasmid used for transfection. (B) IFA of PHIST-GFP cell 
lines probed with anti-GFP. Nuclei were stained with DAPI. Differential interference contrast (DIC) 
and an overlay of all channels (columns 3 and 4) (scale bar = 5 μm). (C) Four fractions obtained 
from solubility assays (hypotonic lysis, Carbonate, Triton X-100, and SDS) were probed in Western 
blots with anti-GFP for the presence of the PHIST-GFP fusion proteins. Anti-GAPDH and anti-
MAHRP1 were used as the controls for the soluble and transmembrane fractions, respectively. (D) 
Supernatant and pellet from saponin lysed PF3D7_0830600-3xHA iRBCs were probed in a 
Western blot with anti-HA and anti-GAPDH.  
Figure 2 - Time Course IFA of PHIST-BirA*-HA parasite lines 
PHIST-BirA*-HA-tagged proteins were labeled with anti-HA (first column). The second column 
shows nuclei stained with DAPI, followed by a merge of the fluorescent channels and an overlay of 
all channels. Each row corresponds to an 8 hour time interval (scale bar = 5 μm). 
Figure 3 - Electron microscopy images of two PHIST-BirA*-HA parasite lines 
Immuno-gold labeling of ultrathin sections of iRBCs were probed with anti-HA antibodies and 
imaged with an electron microscope. (A) 0201600-BirA*-HA and (B) 0402000-BirA*-HA (scale bars 
= 500 nm). 
Figure 4 - BioID and mass spectrometry data 
(A) Volcano plots indicating protein enrichment from BioID assays after immunoprecipitation 
and mass-spectrometry. The right side of each plot indicates proteins enriched in the experiment, 
the left side shows proteins enriched in the control. Red: bait proteins; blue: significantly enriched 
proteins (p < 0.05, enrichment > 2, s0 = 1); green: background. (B) Interaction network of host 
cytoskeleton and exported parasite proteins. Dark blue: parasite proteins; light blue inlay: PHIST 
proteins; red: erythrocyte proteins. Bait proteins are indicated by a larger circle. Edge length is 
random and not to scale. (C) IFA co-labeling of PF3D7_0201600-BirA*-HA with antibodies as 
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indicated. Pearson’s correlation and the two Mander’s coefficients for colocalization are provided 
in the table (scale bars = 5 μm). 
Figure S1 - Co-labeling of GFP and KAHRP in IFA 
The first column shows the DIC, followed by fluorescence images with anti-GFP and anti-
KAHRP antibodies, a merge of the fluorescence images and an overlay of all channels (scale bar = 
5 μm). 
Figure S2 – PCR-confirmation of PHIST-BirA*-HA integration into the wild-type locus 
Schematic representations indicating primer binding sites for (A) the PHIST locus in 3D7 wild-
type parasites, (B) the plasmid used for transfection and integration, and (C) the modified PHIST 
locus with the integrated plasmid. (D) to (G) PCR was done on DNA extracted from the transgenic 
PHIST-BirA*-HA parasites (lanes 1-3), the 3D7 wild-type (Lanes 4-6), and the transfection plasmid 
(lane 7). The primers correspond to those indicated in (A and B). (H) Table showing the expected 
lengths of the PCR products.  
Figure S3 - Time course Western blot 
Over the course of one intra-erythrocytic cycle, cell lysates were prepared every eight hours 
and then probed in Western blots with anti-HA.  
Table S1 – List of primers 
Summary of all cloning and sequencing primers used to generate the cell lines included in 
this project. Restriction sites and additional descriptions for the primers are included.  
Table S2 – Exportome Table 
List of all exported P. falciparum proteins that were used for the filtering of protein for the 
network. 
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Table S3 – Complete Mass Spec Data Table 
All proteins found to be enriched in the positive or negative co-IP fractions of all 
immunoprecipitation experiments are listed in this table along with descriptive information such 
as protein accession number, name, p-value, and fold change. This table is accessible under the 
following DOI: 10.5281/zenodo.2582949.  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Figure 4 
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Table S1 
Primer Name Sequence (5’ -> 3’)
Cloning Primers pARL constructs
PF3D7_0201600 ataactcgagcttaagATGAAGACCTATAATAGGAATAATAATTGT
cctttactcatatcgatTAAATTAAATCTTACTTTTTTTATTGGTTT
PF3D7_0401800 ataactcgagcttaagATGAAGATAATAAGCAACCTAGGAAGTATG
cctttactcatatcgatATCTTGTATCATGACTTTAGATTCTTCTTG
PF3D7_0402000 ataactcgagcttaagATGTGTAATAAATTGTCAAGGGGTAGTAAT
cctttactcatatcgatATTGTTTTTTTTTAATTCTTTTTTCACCTCTT
PF3D7_0402100 ataactcgagcttaagATGGGAAAAGCATTTTTATTTAAATCTTTA
cctttactcatatcgatTTGCTCATCATTCAAAGTTGACATATTATTTCC
PF3D7_0424600 ataactcgagcttaagATGAAGTTTTTTAACGGATCAAGCTTT
cctttactcatatcgatTATATCAATAAAATTTTTACTACGCATGA
PF3D7_0601500 ataactcgagcttaagATGAGTCAAGGAACATATTTTAATTGGTTGT
cctttactcatatcgatATTATTTATAATGTTATGCATATATACCTCAT
PF3D7_0830600 ataactcgagcttaagATGGAATATTTAAAAAAGACTTTATTTATTTCTG
cctttactcatatcgatTTGTACATAATTTTTAAAATTTTTTTCGAGT
PF3D7_0937000 ataactcgagcttaagATGAAAGGAATGAATTTTTTTAGAAGTATTTCAC
cctttactcatatcgatTTCTTCATCTATATATGGTGCATTTATTAGAC
PF3D7_1038800 ataactcgagcttaagATGAAATGTTTAAAATTATTTTCTTTTAAATCAT
cctttactcatatcgatATCCTTTTGGTTCCTACTCCTTATTCT
PF3D7_1476200 ataactcgagcttaagATGTGTATTAGGTATATAAATATTATTAAAATTA
cctttactcatatcgatTTTCCAAGTTTTAATTTTATTTTTAGTTTCC
Cloning Primers BirA*-HA constructs
pH_BirA*-3xHA ctgaaaaaagcggccgctacccgtacgacgtc
pH_BirA*-3xHA ccctagatgagtcgacttaggcataatctggaac
PF3D7_0201600 cagggtaggcggccctgcagCAAAAATAATGTATATTTAGATG
tgctagcacaggatccTAAATTAAATCTTACTTTTTTTATTGGTTTATCT
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PF3D7_0401800 cagggtaggcggccctgcagGAAGGTAGTAACGTAGATATTA
tgctagcacaggatccATCTTGTATCATGACTTTAGATTCTTCTTG
PF3D7_0402000 cagggtaggcggccctgcagGTTCATGAAAATGATTATACTG
tgctagcacaggatccATTGTTTTTTTTTAATTCTTTTTTCACCTCTTC
PF3D7_0402100 cagggtaggcggccctgcagGATTTGGAATATGAAAAAGAAG
tgctagcacaggatccTTGCTCATCATTCAAAGTTGACATATTATTTCC
PF3D7_0424600 cagggtaggcggccctgcagACCATTGGTAATTTATTTGAAG
tgctagcacaggatccTATATCAATAAAATTTTTACTACGCATGATAG
PF3D7_0601500 cagggtaggcggccctgcagATTTATTAAAAGAAGAACTAC
tgctagcacaggatccATTATTTATAATGTTATGCATATATACCTCATC
PF3D7_0830600 cagggtaggcggccctgcagATAATAATAATATTAGATCAAC
tgctagcacaggatccTTGTACATAATTTTTAAAATTTTTTTCGAGTG
PF3D7_0937000 cagggtaggcggccctgcagGATATATTCTTTAAATTCAAATG
tgctagcacaggatccTTCTTCATCTATATATGGTGCATTTATTAGAC
PF3D7_1038800 cagggtaggcggccctgcagTAAATAATTGTAGTAAGGTTAC
tgctagcacaggatccATCCTTTTGGTTCCTACTCCTTATTCTTG
PF3D7_1476200 cagggtaggcggccctgcagAATAGACTATAATAATTTGTCT
tgctagcacaggatccTTTCCAAGTTTTAATTTTATTTTTAGTTTCCTTC
Cloning Primers SLI constructs
PF3D7_0201600 gtaggcggccatcgctgcagCAAAAATAATGTATATTTAGAT
PF3D7_0401800 gtaggcggccatcgctgcagGAAGGTAGTAACGTAGATAT
PF3D7_0402000 gtaggcggccatcgctgcagGTTCATGAAAATGATTATAC
PF3D7_0402100 gtaggcggccatcgctgcagGATTTGGAATATGAAAAAG
PF3D7_0424600 gtaggcggccatcgctgcagACCATTGGTAATTTATTTGAAG
PF3D7_0830600 gtaggcggccatcgctgcagATAATAATAATATTAGATCAAC
PF3D7_0937000 gtaggcggccatcgctgcagGATATATTCTTTAAATTCAAATG
PF3D7_1038800 gtaggcggccatcgctgcagTAAATAATTGTAGTAAGGTTAC
Primer Name Sequence (5’ -> 3’)
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PF3D7_1476200 gtaggcggccatcgctgcagAATAGACTATAATAATTTGTCT
all cgctaccataactagtggcataatctggaacatcgtaag
Sequencing Primers
PF3D7_0201600 TATTATATGTTATCAGGAAATAGTG
PF3D7_0401800 TTCAACAACACGATCAGCATCAACA
PF3D7_0402000 AATTAAGTCAGGACTATAATGATGT
PF3D7_0402100 GAAGAAAATATGAAAATCTGAGAGA
PF3D7_0601500 TGATGAGATATGTAAAAAATATTGC
PF3D7_0830600 CCGAAAGTAACGTAGATTATGTTGT
PF3D7_1038800 TCTAAATATTTATCTTTAATACATC
PF3D7_1038800 AGTCCATCCTATAGATTTTAAAATG
PF3D7_1476200 AAAGAATTTATGGAATGGGATGATG
pARL_fwd TATTTTTAGACTATAATATCCG
5'GFP_rev (pARL) ATTTGTGCCCATTAACATCACCATC
pH_BirA_fwd gagacagctcaattctttatgtcca
pH_BirA_tag_rv ctattattaaataagcttaatcattc
pH_BirA_ins_rv cctaatgtttcacctaattgttcacctg
pH_BirA_fwd2 atgagaagagtagaagaatcagtag
pH_BirA_ins_rv2 ccaatctcttaatgtttgtatatgt
pH-2A-fw caattctttatgtccacaacatcatc
pH-2A-rv after BSD gcttaatcattcttctcatatacttc
seq of BirA gctagcatgaaagataatacagtac
0830600-3xHA ATTAggatccATGGAATATTTAAAAAAGACTTTATTTATTTC
0830600-3xHA ATATgctagcTTGTACATAATTTTTAAAATTTTTTTCGAG
Primer Name Sequence (5’ -> 3’)
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Table S2 
PF3D7_0100100 
PF3D7_0100300 
PF3D7_0100500 
PF3D7_0100600 
PF3D7_0100700 
PF3D7_0100800 
PF3D7_0100900 
PF3D7_0101000 
PF3D7_0101100 
PF3D7_0101200 
PF3D7_0101300 
PF3D7_0101400 
PF3D7_0101500 
PF3D7_0101600 
PF3D7_0101700 
PF3D7_0101800 
PF3D7_0101900 
PF3D7_0102000 
PF3D7_0102300 
PF3D7_0102600 
PF3D7_0102700 
PF3D7_0104000 
PF3D7_0104400 
PF3D7_0106000 
PF3D7_0106100 
PF3D7_0107300 
PF3D7_0107400 
PF3D7_0107700 
PF3D7_0111400 
PF3D7_0112100 
PF3D7_0112800 
PF3D7_0112900 
PF3D7_0113000 
PF3D7_0113200 
PF3D7_0113300 
PF3D7_0113400 
PF3D7_0113700 
PF3D7_0113900 
PF3D7_0114000 
PF3D7_0114100 
PF3D7_0114200 
PF3D7_0114300 
PF3D7_0114400 
PF3D7_0114500 
PF3D7_0114600 
PF3D7_0114700 
PF3D7_0114800 
PF3D7_0114900 
PF3D7_0115100 
PF3D7_0115150 
PF3D7_0115200 
PF3D7_0115300 
PF3D7_0115400 
PF3D7_0115500 
PF3D7_0115600 
PF3D7_0115700 
PF3D7_0200100 
PF3D7_0200200 
PF3D7_0200300 
PF3D7_0200400 
PF3D7_0200500 
PF3D7_0200600 
PF3D7_0200700 
PF3D7_0200800 
PF3D7_0201000 
PF3D7_0201100 
PF3D7_0201200 
PF3D7_0201300 
PF3D7_0201400 
PF3D7_0201500 
PF3D7_0201600 
PF3D7_0201700 
PF3D7_0201800 
PF3D7_0201900 
PF3D7_0202000 
PF3D7_0202100 
PF3D7_0202200 
PF3D7_0202300 
PF3D7_0202900 
PF3D7_0207000 
PF3D7_0210800 
PF3D7_0215000 
PF3D7_0215300 
PF3D7_0217000 
PF3D7_0219300 
PF3D7_0219700 
PF3D7_0219800 
PF3D7_0219900 
PF3D7_0220000 
PF3D7_0220100 
PF3D7_0220200 
PF3D7_0220300 
PF3D7_0220400 
PF3D7_0220500 
PF3D7_0220600 
PF3D7_0220700 
PF3D7_0220900 
PF3D7_0221000 
PF3D7_0221100 
PF3D7_0221200 
PF3D7_0221300 
PF3D7_0221400 
PF3D7_0221600 
PF3D7_0221650 
PF3D7_0221700 
PF3D7_0221900 
PF3D7_0222000 
PF3D7_0222100 
PF3D7_0222200 
PF3D7_0222300 
PF3D7_0222500 
PF3D7_0222700 
PF3D7_0222800 
PF3D7_0222900 
PF3D7_0223100 
PF3D7_0223200 
PF3D7_0223300 
PF3D7_0223400 
PF3D7_0223500 
PF3D7_0300100 
PF3D7_0300300 
PF3D7_0300400 
PF3D7_0300500 
PF3D7_0300600 
PF3D7_0300700 
PF3D7_0300800 
PF3D7_0300900 
PF3D7_0301100 
PF3D7_0301200 
PF3D7_0301300 
PF3D7_0301400 
PF3D7_0301500 
PF3D7_0301600 
PF3D7_0301700 
PF3D7_0301800 
PF3D7_0302200 
PF3D7_0302300 
PF3D7_0302500 
PF3D7_0304600 
PF3D7_0310400 
PF3D7_0312500 
PF3D7_0315900 
PF3D7_0316300 
PF3D7_0318300 
PF3D7_0321200 
PF3D7_0323900 
PF3D7_0324000 
PF3D7_0324100 
PF3D7_0324200 
PF3D7_0324300 
PF3D7_0324400 
PF3D7_0324500 
PF3D7_0324600 
PF3D7_0324700 
PF3D7_0324800 
PF3D7_0324900 
PF3D7_0400100 
PF3D7_0400200 
PF3D7_0400300 
PF3D7_0400400 
PF3D7_0400600 
PF3D7_0400800 
PF3D7_0400900 
PF3D7_0401000 
PF3D7_0401100 
PF3D7_0401300 
PF3D7_0401400 
PF3D7_0401500 
PF3D7_0401600 
PF3D7_0401600 
PF3D7_0401700 
PF3D7_0401800 
PF3D7_0401900 
PF3D7_0402000 
PF3D7_0402100 
PF3D7_0402400 
PF3D7_0402500 
PF3D7_0402600 
PF3D7_0402800 
PF3D7_0404900 
PF3D7_0408800 
PF3D7_0408900 
PF3D7_0410000 
PF3D7_0412400 
PF3D7_0412700 
PF3D7_0412900 
PF3D7_0413100 
PF3D7_0413200 
PF3D7_0413300 
PF3D7_0413400 
PF3D7_0420700 
PF3D7_0420900 
PF3D7_0421100 
PF3D7_0421200 
PF3D7_0421300 
PF3D7_0421500 
PF3D7_0421600 
PF3D7_0422000 
PF3D7_0424000 
PF3D7_0424500 
PF3D7_0424600 
PF3D7_0424700 
PF3D7_0424800 
PF3D7_0424900 
PF3D7_0425000 
PF3D7_0425100 
PF3D7_0425200 
PF3D7_0425250 
PF3D7_0425300 
PF3D7_0425400 
PF3D7_0425500 
PF3D7_0425800 
PF3D7_0426000 
PF3D7_0500100 
PF3D7_0500200 
PF3D7_0500400 
PF3D7_0500500 
PF3D7_0500600 
PF3D7_0500800 
PF3D7_0500900 
PF3D7_0501000 
PF3D7_0501100 
PF3D7_0501100 
PF3D7_0501200 
PF3D7_0501300 
PF3D7_0505300 
PF3D7_0530500 
PF3D7_0532200 
PF3D7_0532300 
PF3D7_0532400 
PF3D7_0532500 
PF3D7_0532600 
PF3D7_0532700 
PF3D7_0532900 
PF3D7_0533100 
PF3D7_0600100 
PF3D7_0600200 
PF3D7_0600400 
PF3D7_0600500 
PF3D7_0600600 
PF3D7_0600800 
PF3D7_0601000 
PF3D7_0601100 
PF3D7_0601200 
PF3D7_0601300 
PF3D7_0601400 
PF3D7_0601500 
PF3D7_0601700 
PF3D7_0601900 
PF3D7_0603400 
PF3D7_0607300 
PF3D7_0608100 
PF3D7_0609100 
PF3D7_0611000 
PF3D7_0615300 
PF3D7_0617400 
PF3D7_0617600 
PF3D7_0617700 
PF3D7_0624700 
PF3D7_0625400 
PF3D7_0631100 
PF3D7_0631200 
PF3D7_0631300 
PF3D7_0631400 
PF3D7_0631500 
PF3D7_0631600 
PF3D7_0631800 
PF3D7_0631900 
PF3D7_0632000 
PF3D7_0632100 
PF3D7_0632200 
PF3D7_0632300 
PF3D7_0632400 
PF3D7_0632500 
PF3D7_0632600 
PF3D7_0632800 
PF3D7_0700100 
PF3D7_0700200 
PF3D7_0700400 
PF3D7_0700500 
PF3D7_0700600 
PF3D7_0700800 
PF3D7_0700900 
PF3D7_0701000 
PF3D7_0701400 
PF3D7_0701500 
PF3D7_0701600 
PF3D7_0701700 
PF3D7_0701800 
PF3D7_0701900 
PF3D7_0702000 
PF3D7_0702100 
PF3D7_0702300 
PF3D7_0702400 
PF3D7_0702500 
PF3D7_0702600 
PF3D7_0703100 
PF3D7_0707300 
PF3D7_0710300 
PF3D7_0711700 
PF3D7_0712000 
PF3D7_0712300 
PF3D7_0712400 
PF3D7_0712500 
PF3D7_0712600 
PF3D7_0712800 
PF3D7_0712900 
PF3D7_0713000 
PF3D7_0713100 
PF3D7_0713200 
PF3D7_0713300 
PF3D7_0716300 
PF3D7_0717000 
PF3D7_0719800 
PF3D7_0721100 
PF3D7_0726100 
PF3D7_0726700 
PF3D7_0726800 
PF3D7_0730800 
PF3D7_0730900 
PF3D7_0731100 
PF3D7_0731200 
PF3D7_0731300 
PF3D7_0731400 
PF3D7_0731700 
PF3D7_0732000 
PF3D7_0732100 
PF3D7_0732200 
PF3D7_0732300 
PF3D7_0732400 
PF3D7_0732500 
PF3D7_0732600 
PF3D7_0732700 
PF3D7_0732800 
PF3D7_0733000 
PF3D7_0800100 
PF3D7_0800200 
PF3D7_0800300 
PF3D7_0800500 
PF3D7_0800600 
PF3D7_0800750 
PF3D7_0800800 
PF3D7_0800900 
PF3D7_0801000 
PF3D7_0807700 
PF3D7_0808600 
PF3D7_0808700 
PF3D7_0808800 
PF3D7_0808900 
PF3D7_0809100 
PF3D7_0823800 
PF3D7_0824700 
PF3D7_0825200 
PF3D7_0825300 
PF3D7_0827900 
PF3D7_0830300 
PF3D7_0830400 
PF3D7_0830500 
PF3D7_0830600 
PF3D7_0830700 
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PF3D7_0830900 
PF3D7_0831000 
PF3D7_0831300 
PF3D7_0831400 
PF3D7_0831500 
PF3D7_0831600 
PF3D7_0831700 
PF3D7_0831750 
PF3D7_0831900 
PF3D7_0832000 
PF3D7_0832200 
PF3D7_0832200 
PF3D7_0832250 
PF3D7_0832300 
PF3D7_0832400 
PF3D7_0832500 
PF3D7_0832700 
PF3D7_0832900 
PF3D7_0833000 
PF3D7_0833200 
PF3D7_0833300 
PF3D7_0833400 
PF3D7_0833500 
PF3D7_0900100 
PF3D7_0900200 
PF3D7_0900300 
PF3D7_0900400 
PF3D7_0900500 
PF3D7_0900600 
PF3D7_0900700 
PF3D7_0900800 
PF3D7_0900900 
PF3D7_0901000 
PF3D7_0901100 
PF3D7_0901200 
PF3D7_0901300 
PF3D7_0901400 
PF3D7_0901500 
PF3D7_0901600 
PF3D7_0901700 
PF3D7_0901800 
PF3D7_0902100 
PF3D7_0902300 
PF3D7_0902400 
PF3D7_0902600 
PF3D7_0902700 
PF3D7_0904200 
PF3D7_0904700 
PF3D7_0907800 
PF3D7_0908300 
PF3D7_0910300 
PF3D7_0916200 
PF3D7_0918000 
PF3D7_0927900 
PF3D7_0928200 
PF3D7_0929400 
PF3D7_0929800 
PF3D7_0931500 
PF3D7_0935500 
PF3D7_0935700 
PF3D7_0935800 
PF3D7_0935900 
PF3D7_0936000 
PF3D7_0936200 
PF3D7_0936300 
PF3D7_0936400 
PF3D7_0936500 
PF3D7_0936600 
PF3D7_0936800 
PF3D7_0936900 
PF3D7_0937000 
PF3D7_0937100 
PF3D7_0937300 
PF3D7_0937400 
PF3D7_0937600 
PF3D7_0937800 
PF3D7_1000100 
PF3D7_1000300 
PF3D7_1000400 
PF3D7_1000500 
PF3D7_1000600 
PF3D7_1000700 
PF3D7_1000900 
PF3D7_1001000 
PF3D7_1001300 
PF3D7_1001400 
PF3D7_1001600 
PF3D7_1001700 
PF3D7_1001800 
PF3D7_1001900 
PF3D7_1002000 
PF3D7_1002100 
PF3D7_1002300 
PF3D7_1005000 
PF3D7_1016300 
PF3D7_1016400 
PF3D7_1016500 
PF3D7_1016600 
PF3D7_1016700 
PF3D7_1016800 
PF3D7_1016900 
PF3D7_1018300 
PF3D7_1019600 
PF3D7_1024800 
PF3D7_1028100 
PF3D7_1028200 
PF3D7_1028700 
PF3D7_1029500 
PF3D7_1029700 
PF3D7_1031600 
PF3D7_1034800 
PF3D7_1038400 
PF3D7_1038500 
PF3D7_1038600 
PF3D7_1038700 
PF3D7_1038800 
PF3D7_1039000 
PF3D7_1039100 
PF3D7_1039200 
PF3D7_1039400 
PF3D7_1039600 
PF3D7_1039700 
PF3D7_1039800 
PF3D7_1039900 
PF3D7_1040000 
PF3D7_1040100 
PF3D7_1040200 
PF3D7_1040300 
PF3D7_1040400 
PF3D7_1040500 
PF3D7_1040600 
PF3D7_1040700 
PF3D7_1040800 
PF3D7_1040900 
PF3D7_1041000 
PF3D7_1041100 
PF3D7_1041300 
PF3D7_1100100 
PF3D7_1100200 
PF3D7_1100400 
PF3D7_1100500 
PF3D7_1100600 
PF3D7_1100800 
PF3D7_1100900 
PF3D7_1101000 
PF3D7_1101200 
PF3D7_1101300 
PF3D7_1101500 
PF3D7_1101600 
PF3D7_1101700 
PF3D7_1101800 
PF3D7_1101900 
PF3D7_1102100 
PF3D7_1102200 
PF3D7_1102300 
PF3D7_1102500 
PF3D7_1102600 
PF3D7_1102900 
PF3D7_1104100 
PF3D7_1104800 
PF3D7_1106100 
PF3D7_1108700 
PF3D7_1109900 
PF3D7_1110000 
PF3D7_1112000 
PF3D7_1116000 
PF3D7_1116700 
PF3D7_1116800 
PF3D7_1121000 
PF3D7_1121600 
PF3D7_1125000 
PF3D7_1127400 
PF3D7_1127500 
PF3D7_1133300 
PF3D7_1136900 
PF3D7_1148700 
PF3D7_1148800 
PF3D7_1148900 
PF3D7_1149000 
PF3D7_1149100 
PF3D7_1149200 
PF3D7_1149300 
PF3D7_1149400 
PF3D7_1149500 
PF3D7_1149600 
PF3D7_1149700 
PF3D7_1149800 
PF3D7_1149900 
PF3D7_1150000 
PF3D7_1150200 
PF3D7_1150400 
PF3D7_1200100 
PF3D7_1200200 
PF3D7_1200300 
PF3D7_1200400 
PF3D7_1200500 
PF3D7_1200600 
PF3D7_1200800 
PF3D7_1200900 
PF3D7_1201000 
PF3D7_1201100 
PF3D7_1201200 
PF3D7_1201300 
PF3D7_1201400 
PF3D7_1210000 
PF3D7_1212100 
PF3D7_1215900 
PF3D7_1219300 
PF3D7_1219400 
PF3D7_1219500 
PF3D7_1221700 
PF3D7_1221900 
PF3D7_1225100 
PF3D7_1232000 
PF3D7_1233800 
PF3D7_1234400 
PF3D7_1239500 
PF3D7_1240100 
PF3D7_1240200 
PF3D7_1240300 
PF3D7_1240400 
PF3D7_1240600 
PF3D7_1240900 
PF3D7_1241600 
PF3D7_1250100 
PF3D7_1252200 
PF3D7_1252300 
PF3D7_1252500 
PF3D7_1252700 
PF3D7_1252800 
PF3D7_1252900 
PF3D7_1253000 
PF3D7_1253100 
PF3D7_1253300 
PF3D7_1253500 
PF3D7_1253700 
PF3D7_1253800 
PF3D7_1253900 
PF3D7_1254000 
PF3D7_1254100 
PF3D7_1254200 
PF3D7_1254300 
PF3D7_1254400 
PF3D7_1254500 
PF3D7_1254600 
PF3D7_1254900 
PF3D7_1255000 
PF3D7_1255100 
PF3D7_1255200 
PF3D7_1300100 
PF3D7_1300200 
PF3D7_1300300 
PF3D7_1300400 
PF3D7_1300500 
PF3D7_1300600 
PF3D7_1300700 
PF3D7_1300800 
PF3D7_1300900 
PF3D7_1301100 
PF3D7_1301200 
PF3D7_1301300 
PF3D7_1301400 
PF3D7_1301500 
PF3D7_1301700 
PF3D7_1301900 
PF3D7_1302000 
PF3D7_1302300 
PF3D7_1303000 
PF3D7_1306200 
PF3D7_1316300 
PF3D7_1323700 
PF3D7_1330700 
PF3D7_1333200 
PF3D7_1334300 
PF3D7_1334400 
PF3D7_1334500 
PF3D7_1334600 
PF3D7_1334700 
PF3D7_1335900 
PF3D7_1338900 
PF3D7_1346100 
PF3D7_1351300 
PF3D7_1352900 
PF3D7_1353100 
PF3D7_1353200 
PF3D7_1367800 
PF3D7_1368000 
PF3D7_1369000 
PF3D7_1370300 
PF3D7_1371700 
PF3D7_1371800 
PF3D7_1371900 
PF3D7_1372000 
PF3D7_1372100 
PF3D7_1372200 
PF3D7_1372300 
PF3D7_1372500 
PF3D7_1372700 
PF3D7_1372800 
PF3D7_1372900 
PF3D7_1373000 
PF3D7_1373200 
PF3D7_1373300 
PF3D7_1373400 
PF3D7_1373500 
PF3D7_1400100 
PF3D7_1400200 
PF3D7_1400300 
PF3D7_1400400 
PF3D7_1400500 
PF3D7_1400600 
PF3D7_1400700 
PF3D7_1400800 
PF3D7_1400900 
PF3D7_1401000 
PF3D7_1401050 
PF3D7_1401100 
PF3D7_1401200 
PF3D7_1401300 
PF3D7_1401600 
PF3D7_1404300 
PF3D7_1404700 
PF3D7_1404800 
PF3D7_1407800 
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Abstract 
The extensive host cell remodeling of human erythrocytes during the course of Plasmodium 
falciparum infection is facilitated by a large number of exported parasite proteins. The function of 
the majority of these proteins remains elusive but we showed by immunoprecipitation that 
erythrocyte cytoskeleton proteins are potential interaction partners for many exported parasite 
proteins. Reverse precipitations to confirm these interactions are a major challenge due to the 
lack of a nucleus in the terminally differentiated erythrocyte. We constructed transgenic parasite 
lines which express and export different tagged human cytoskeleton proteins. These human 
proteins were designed to be soluble within the cytosol of the infected erythrocyte. They are 
expected to bind their putative parasite binding partners either during transport to or at their final 
destination within the erythrocyte. This approach allows us to use human proteins as bait for 
immunoprecipitations but also to potentially modify these proteins within the infected cell. Here 
we show the expression and export of these transgenic proteins and show that several different N-
terminal export sequences can be used to successfully target the proteins for export into the host 
cytosol. This humanized parasite approach thus offers immense potential for studying interactions 
between human cytoskeleton and exported parasite proteins. 
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Introduction 
During the course of intraerythrocytic asexual development, the malaria parasite P. falciparum 
extensively remodels the red blood cell to make it a suitable host cell. This is facilitated by ~550 
parasite proteins known or predicted to be exported. The majority of these proteins possess the 
Plasmodium Export Element (PEXEL), a pentameric N-terminal amino acid motif which targets 
them for export (1-3). Inside the endoplasmic reticulum (ER), the PEXEL motif is co-translationally 
cleaved by the parasite protease Plasmepsin V and the new N-terminus is acetylated (4-6). Once 
discharged into the parasitophorous vacuole, PEXEL proteins are translocated across the 
parasitophorous vacuole membrane (PVM) by the Plasmodium translocon of exported proteins 
(PTEX) (7). PEXEL-negative exported proteins (PNEP) lack a known export motif (8, 9). Less is 
known about their export pathway, but it also seems to include translocation by the PTEX (10). 
Once inside the cytosol of the infected red blood cell (iRBC), chaperones assist in refolding and 
exported proteins are trafficked to their final destination such as Maurer’s clefts, the iRBC 
cytoskeleton or membrane, or remain as soluble proteins inside the iRBC cytosol (reviewed in 
(11)). 
Exported proteins are central to surface presentation of the major virulence factor PfEMP1 
(12, 13). On the cytoplasmic side, exported proteins such as KAHRP and PHIST family members 
make up surface protrusions called knobs in which PfEMP1 is anchored to the cytoskeleton (14, 
15). PfEMP1 confers binding to the endothelial cells of the deep vasculature, a process referred to 
as cytoadhesion, sequestering the iRBCs and preventing their passage through the spleen. This 
process not only allows the parasite to rapidly multiply in its host but is also the major contributor 
to pathology and morbidity (16). To understand essential mechanism of the erythrocyte 
remodeling could provide new strategies to interfere with these crucial processes. 
Studies of host-parasite protein interactions often used co-immunoprecipitations (co-IP) to 
identify potential interaction partners for proteins of interest. Mostly in these studies parasite 
proteins were used as bait since they are easily tagged or manipulated by molecular cloning 
techniques (7, 14). Using tagged erythrocyte cytoskeleton proteins as bait is more of a challenge 
because the lack of a nucleus in the erythrocyte makes it refractory to genetic manipulation. To 
circumvent this, erythrocyte precursor cells have been genetically manipulated and subsequently 
differentiated into erythrocytes (17). While genetic manipulation of hematopoietic stem cells with 
CRISPR/Cas9 or Zink finger nuclease–based approaches has shown promising results in correcting 
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the sickle cell trait (18) and hemoglobinopathies (19), the cost of producing larger amounts of 
erythrocytes required for cell culture and co-IP remain very high at the moment. 
Alternatively, we created a versatile system that allows for genetic manipulation of human 
cytoskeleton proteins to be used for reverse co-IPs to confirm potential interactions with exported 
parasite proteins. We transfected P. falciparum parasites with plasmids to overexpress fusion 
proteins containing a N-terminal export sequence of a PEXEL protein and the codon optimized 
coding sequence of human cytoskeleton proteins fused to a molecular tag. Fusion proteins were 
designed to be soluble in the iRBC cytosol and we removed transmembrane domains or 
truncated the proteins to express only fragments implicated to interact with parasite proteins. 
Here we show that a number of different export sequences successfully target human proteins 
expressed by P. falciparum into the iRBC cytosol. 
Methods 
Parasite Culture 
In vitro culturing of P. falciparum 3D7 parasites was performed according to Moll et al., 2008 
(20). Parasites were synchronized either by sorbitol treatment (21) or by using a Percoll density 
gradient (22) and were selected for presence of knobs by gelatin flotation (23). Transfection was 
performed on ring stages (24) and transgenic cell lines were cultured on 10 nM WR99210 (Jacobs 
Pharmaceuticals, Cologne, Germany) or 5 mg/ml blasticidin (Sigma). 
Cloning 
Genes were synthesized by Eurofins (Munich, Germany) and GenScript (Piscataway, NJ, USA) 
and the sequences codon-optimized for expression in P. falciparum: band 3 (nucleotides 1-1137 
coding for amino acids 1-379), band 4.1 (full length), band 4.2 (full length), band 7 (full length), 
and ankyrin (nucleotides 1-2481 coding for amino acids 1-827). 
To generate overexpression constructs, the pARL vector was used (Figure S1A) (24). 
Band3_1-379 was first inserted into a cloning plasmid containing the HA-tag- Band3_1-379_HA 
was then cloned into the pARL vector with AflII and KpnI (Figure S1B). To generate a 
band3_1-379_myc, the HA-tag was replaced by the myc-tag through multiple PCR reactions and 
then inserted via the AflII and KpnI restriction sites (Figure S1C). The band3_1-379_myc plasmid 
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was digested with SpeI and NheI/BmtI to insert band4.1_FL, band4.2_FL, band7_FL, and 
Ankyrin_1-827. For the GFP-tagged constructs, the amplified genes were cloned into pARLmGFP, 
using AflII and ClaI (Figure S1D). In addition, truncated versions of band 7 lacking the 
transmembrane domain were generated: band7_55-288_GFP/myc.  
To test different export sequences, PF13_0275 of pARL_band3_1-379_myc was replaced via 
XhoI and SpeI cloning with three other sequences: PFI1780w (aa 1-90), PFE1605w (aa 1-111 and 
aa 1-149) (Figure S1E). The export signal from REX3 (aa 1-70) was cloned into pARL_band3_1-379, 
4.2_FL, 7_55-288, and Ankyrin_1-827 (all myc-tagged) via XhoI and SpeI (Figure S1F). The export 
sequences were amplified from P. falciparum 3D7 cDNA that was prepared using the ImProm-II 
Reverse transcriptase System (Promega, Switzerland).  
Truncations of Ankyrin_myc containing only aa 1-400 or aa 401-827 were generated using 
SpeI and BmtI. Band7_myc was further reduced to aa 85-218 (SpeI and BmtI). A V197P point 
mutation in band7_55-288_myc was generated and inserted via SpeI and KpnI (Figure S1G). The 
glmS sequence was inserted after the myc-tag for band 3 and band 4.1 via XhoI and SpeI (Figure 
S1H). All ligations were done via InFusion ligation (Clontech, USA). Primers are listed in Table S1. 
Western blot 
iRBCs obtained from Percoll purification (20) were lysed in 0.03% Saponin/PBS for 5 or 10 min 
on ice and then centrifuged (5 min, 20’000 g, 4°C). Supernatant and pellet were separated and 
each resuspended in 100-200 μl Laemmli-buffer supplemented with 1 x Protease Inhibitor 
Complete (PIC) (Roche, Switzerland) and DNase (1:100; Sigma). Lysates were sonicated for 5 min 
(30 sec intervals and high intensity) and stored at -20 °C until further use. Sample preparation for 
the solubility assay was done as previously described (25). For SDS-PAGE parasite lysates were 
heated at 95 °C for 5 min, pulse-vortexed and centrifuged at full speed for 1 min. 10-15 μl were 
loaded onto a NOVEX NuPAGE Bis-Tris gel (12% or 4-12%), run in MOPS or MES buffer, and then 
blotted with the iBlot2 (all from Life Technologies). Membranes were blocked in 5% milk/TNT (100 
mM Tris, 150 mM NaCl, 43 mM HCl, and 0.1% Tween 20). All antibodies were diluted in 5% milk/
TNT. The following primary antibodies were used: rat anti-HA (1:500; Roche), mouse anti-GFP 
(1:500; Roche), rat anti-myc (1:1000; Abcam), mouse anti-GAPDH (1:10’000), and rabbit anti-
PFE1605w (1:1000). Goat anti-mouse-HRP (1:10’000; Pierce), goat anti-rabbit-HRP (1:5000; 
Jackson Immunology), and goat anti-rat-HRP (1:10’000; Southern Biotech) were used as secondary 
antibodies.  
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Microscopy 
For immunofluorescence assays (IFA) thin smears were prepared, fixed in methanol/acetone 
(60:40) for 2 min at -20°C and then blocked with 3% BSA/PBS followed by antibody staining. For 
confocal microscopy and to retain the three dimensional structure, cells were treated with 
paraformaldehyde (26) and then stained with antibodies. Primary antibodies were rat anti-HA 
(1:100; Roche), mouse anti-GFP (1:100; Roche), and rat anti-myc (1:100; Abcam). Goat anti-mouse, 
anti-rabbit, or anti-rat with Alexa Fluorophores 405, 488, or 594 (all 1:200; Invitrogen) were used 
as secondary antibodies, respectively. Nuclei were stained with DAPI (Vector Laboratories, Inc.) 
and membranes were stained with Cellmask deep red plasma membrane stain (1:200, Invitrogen). 
Images were acquired with a Leica DM 5000 B in combination with the LAS 4.9.0 software or with 
a Zeiss LSM700 upright confocal microscope, using the ZEN 2010 software and processed with 
Omero 5.3.3 and Imaris 8.4.  
Microsphiltration 
Microsphiltration was performed as described by Lavazec et al. (27) with ring stages (12-16 
hpi) and trophozoites (36-40 hpi) that had been cultured for at least four cycles with or without 2.5 
mM glucosamine (GlcN; Sigma). Parasite cultures were adjusted to approximately 3-4% 
parasitemia at 1.5% hematocrit in culture medium supplemented with 0.5 % Albumax II. Six 
hundred μl were injected per column and washed through the column with 5 ml medium at a flow 
rate of 60 ml/h. For each experiment and parasite line, six columns were loaded. Parasitemia was 
determined by FACS. Input and flow through samples were centrifuged and the pellet was 
resuspended in 100 μl SYBR® green (Sigma) diluted 1:5,000 in FACS Flow (Becton Dickinson) and 
incubated in the dark at 37°C for 15 min. The pellet was subsequently washed once in 850 μl 
FACS Flow, resuspended in 850 μl FACS Flow, and then subjected to measurement. Per sample, 
100,000 events were measured on a FACS Calibur (Becton Dickinson) and analyzed using Cell 
Quest V5.2.1 (BD Biosciences). 
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Results 
To target recombinant human cytoskeleton proteins expressed by Plasmodium falciparum for 
export into the host cell, an export sequence was added. The N-terminal part of PF13_0275 
comprising residues 1-110, which includes the signal peptide and PEXEL motif, has been 
previously used to target the ATS domain of PfEMP1 variants for export into the iRBC (14). We 
therefore fused this export sequence upstream of the N-terminus of selected human cytoskeleton 
proteins and fused an HA-, GFP-, or myc-tag to the C-terminus. For band 3 we selected the N-
terminal intracellular loop up to the first transmembrane (TM) domain (nucleotides 1-1137 coding 
for residues 1-379) which was previously shown to interact with the PHIST protein PF3D7_0532400 
(PFE1605w/LyMP) (14). As band 4.1 and band 4.2 do not contain any TM domains, both were 
used as full length proteins. The TM of band 7 was removed and the remaining residues 55-288 
(nucleotides 166-864) were selected. Ankyrin was truncated to contain only residues 1-827 
(nucleotides 1-2481), a region that has been shown to be involved in interactions with membrane 
protein band 3 and cytoskeleton protein band 4.2 (28) (Figure S1 B-D). 
Band3_1-379 was tested with each of the three tags while band4.1_FL, band4.2_FL, 
band7_55-288, and Ankyrin_1-827 were only tested with GFP- and myc-tags. Except for parasites 
transfected with band4.2_FL_GFP or _myc all transgenic parasites lines could be expanded after 
transfection.  
The correct size of each fusion protein was tested by lysing the cells and analyzing the 
resulting supernatants and pellets by Western blot using the respective antibodies against the 
tags. The supernatant fractions were supposed to contain soluble proteins while membrane 
associated or insoluble complexes should remain in the pellet. All of our fusion proteins were 
detected near the predicted molecular weight. For most fusion proteins, bands were detected in 
both fractions. Band4.1_FL_GFP was only present in the supernatant fraction. Ankyrin_1-827_GFP 
and band7_55-288_myc were mostly detected in the pellet. For Ankyrin_1-827_myc, detected 
bands sowed at a much lower molecular weight than expected. The GAPDH loading control was 
detected in both fractions indicating partial lysis of late stage parasite (Figure 1A). 
Next we wanted to determine the localization of the exported human fusion proteins. Initially, 
we hardly detected band3_1-379_GFP/myc in IFAs on methanol/acetone fixed parasites (Figure 
S2). Since previous Western blots had shown that the fusion proteins were partially soluble and 
washed out of the iRBC during lysis we cross-linked the proteins with paraformaldehyde prior to 
lysis and antibody labeling, also retaining the three dimensional shape of the iRBC. Confocal 
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microscope revealed band 3 and band 4.1 fusion proteins to be exported. Fusion proteins 
expressed from all three band 3 constructs were evenly distributed in the iRBC cytosol. The 
pattern observed for band 4.1 was also evenly distributed but showed a more granular 
distribution. Ankyrin_1-827_GFP showed a very weak signal at the iRBC membrane but most of 
the signal was detected within the parasite, Ankyrin_1-827_myc as well as band7_55-288_GFP 
and _myc were not exported (Figure 1B).  
We performed a solubility assay for band3_1-379_GFP and _myc and sequentially extracted 
proteins from the iRBC based on their solubility characteristics. When analyzing all fractions by 
Western blot, we detected band3_1-379_GFP or _myc in the Saponin supernatant which contains 
soluble proteins from the iRBC cytosol. There was no GAPDH in this fraction indicating that the 
parasites membranes were not lysed. Thus, the band3_1-379_GFP and _myc proteins were 
exported and soluble in the iRBCs cytosol. No signal for these two proteins was detected after 
hypotonic lysis which ruptures all membranes, indicating that no soluble fusion protein was 
retained within the parasite. Band3_1-379_GFP and _myc fusion proteins were again detected in 
the following carbonate fraction, identifying them to be cytoskeleton or membrane associated 
(Figure 1C). Based on these findings we conclude that the band3_1-379_GFP and _myc fusion 
proteins occupy two different subcellular localizations within the host cell as some of the protein is 
capable of binding to the cytoskeleton while some remains soluble in the iRBC cytosol. 
From the previous transfection series, not all fusion proteins were exported and one cell line 
never grew after transfection. We therefore wanted to test other N-termini of PEXEL proteins to 
see if they would also qualify as export sequences. Having achieved good export for band 3, we 
tested these other N-termini with band3_1-379 first, to be able to compare the new export 
sequences to the previously used PF13_0275 sequence. We replaced the export sequence of 
PF13_0275_band3_1-379_myc with the N-termini the two previously investigated PHIST proteins 
PFI1780w (PF3D7_0936800) and PFE1605w (PF3D7_0532400). As PFE1605w possesses two 
PEXEL motives, two versions were designed including only the first or both of the PEXEL motives 
(Figure S1E). Correct molecular masses of the fusion proteins were confirmed by Western blot 
(Figure 2A) and export was confirmed by confocal microscopy, showing the same homogenous 
distribution of the signal throughout the entire iRBC (Figure 2B) as observed with 
PF13_0275_band3_1-379_myc. This data demonstrate that four different N-termini from three 
different PEXEL proteins were able to target human proteins for export from the parasite into the 
iRBC. 
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We next selected the N-terminus of the non-canonical PEXEL protein REX3, which is exported 
and soluble. Residues 1-70 suffice to export GFP into the iRBC cytosol (29, 30) and were therefore 
used as export sequence for band4.2_FL, band7_55-288, and Ankyrin_1-827, with the myc-tag 
was added to each fusion protein. Band3_1-379 was included in this group as control (Figure S1F). 
The correct molecular sizes were confirmed by Western blot. For each of the fusion proteins, most 
signal was detected in the pellet fraction with the exception of the band 3 fusion protein which 
showed most signal in the supernatant fraction (Figure 2A). Only band3_1-379_myc was clearly 
exported. Ankyrin_1-827_myc showed signal at the iRBC membrane and within the parasite. 
Band4.2_FL_myc and band7_55-288_myc were again not exported (Figure 2C). So far, band 
3_1-379 was exported into the host cell with any of the tested export sequences while the 
different Ankyrin_1-827 and band7_55-288 constructs showed only little or no export.  
To test if shorter fragments would enhance export, we split Ankyrin_1-827 into two fragments 
(amino acids 1-400 and  401-827; Figure S1G).. Both showed the correct molecular weight in 
Western blot (Figure 3A), but only PF13_0275_Ankyrin_401-827_myc was found to be exported to 
the iRBC in confocal microscopy, similar to the PF13_0275_Anykrin_1-827_GFP and 
REX3_Ankyrin_1-827_myc parasite lines. In agreement with findings from the PF13_0275_Ankyrin 
_1-827_GFP and REX3_Ankyrin_1-827_myc cell lines, the signal presented as a ring around the 
iRBC which overlaps with the iRBC membrane stain Cellmask (Figure 3B). 
We reduced the recombinant band 7 protein to contain only the stomatin domain (amino 
acids 85-218) and also generated a construct expressing band7_55-288 with a V197P point 
mutation which was reported to prevent band 7 dimerization (31). Both were fused to the 
PF13_0275 export sequence and a myc tag (Figure S1G). Confirmation of correct molecular 
weight by Western blot (Figure 3A) was followed by confocal microscopy to test for protein 
export. Band7_85-218_myc was found to be evenly distributed throughout the entire iRBC while 
Band7_55-288_V197P_myc was not exported (Figure 3B).  
To assure that overexpression of the recombinant human proteins is not detrimental to 
intracellular parasite growth we included an inducible expression system into our approach. We 
established this system with those two proteins that were exported in previous experiments and 
also with band 4.2, which was never exported so far. We added the glmS ribozyme sequence to 
the band3_1-379,  band4.1_FL, and band4.2_FL constructs with the PF13_0275 export sequence 
and the myc tag (Figure S1H). When treated with glucosamine (GlcN), glmS is activated and the 
mRNA self-cleaves, resulting in fast and efficient reduction of protein levels (32). Without GlcN we 
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detected the proteins by Western blot and showed that they were exported by confocal 
microscopy (Figure 4A-B). Upon addition of GlcN, band band4.1_FL_myc_glmS was not detected 
and protein levels of band3_1-379_myc_glmS were strongly reduced (Figure 4A-B).  
Since Band 4.1 has no transmembrane domain we expressed it as a non-truncated version 
and the recombinantly expressed band4.1_FL protein could potentially bind to band 4.1 binding 
sites competing with the endogenous erythrocyte band 4.1 for binding to its partners. In contrast, 
band 3 is a multipass transmembrane protein and we therefore expressed only the N-terminal 
cytosolic part comprising amino acids 1-397. Since this cytosolic part is involved in the interaction 
with Ankyrin (33, 34) and also has been shown to interact with PHIST proteins (14), the 
recombinant band3_1-379 could also compete with its endogenous erythrocyte counterpart. 
Because these additional interactions could have an effect on iRBC cytoskeleton rigidity we 
performed microsphiltration experiments with the conditional knock-down clones expressing 
band3_1-379_myc_glmS and band4.1_FL_myc_glmS, at two time points in the asexual cycle (12 
and 36 hpi) to measure potential changes in iRBC deformability. There was no substantial 
difference at both time points with both parasite lines with or without GlcN (Figure 4C).  
Discussion 
Here we present a transgenic system which allows expression and export of human 
erythrocyte proteins by P. falciparum. Several different P. falciparum export sequences were able 
to target these fusion proteins with different molecular tags for export. The glmS ribozyme-based 
conditional expression system also worked well. 
In summary, fusion proteins band3_1-379 and band4.1_FL were always exported into the host 
cell, irrespective of export sequence or molecular tag. Transgenic cell lines expressing band4.2_FL 
could either not be established or the fusion protein was not exported. A band 7 fusion protein 
(residue 55-288) was expressed from various plasmids with different export sequences and tags, 
but none were exported. In contrast, the stomatin domain comprising only residues 85-218 was 
exported into the iRBC cytosol. We were unable to identify sequence signatures determining 
whether a protein is exported or not. It is conceivable that certain sequences prevent unfolding as 
is required to translocate through the PTEX (7, 35). It is interesting to note that the tag fused to 
the chimeric protein seems to strongly influence the destination of the protein. Band4.1_FL 
protein fused to a GFP tag was completely soluble whilst the same protein expressed from a 
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construct with a myc tag was to a large degree found membrane associated as shown by Western 
blot. It is possible that the larger GFP-tag might sterically hinder the interaction of band4.1_FL 
with its binding partners at the cytoskeleton. 
We obtained inconclusive results with Ankyrin when only weak signals from the 
PF13_0275_Ankyrin_1-827 GFP-tagged fusion protein were seen exported whilst the same 
construct with a myc-tag was not exported. In contrast, when the export sequence was changed, 
REX3_Ankyrin_1-827_myc and PF13_0275_Ankyrin_401-827_myc showed much better export 
signals, however, the other half of the shortened Ankyrin molecule (PF13_0275_ 
Ankyrin_1-400_myc) was not exported. From these experiments it is clear that yet no prediction 
can be made for whether a transgenic protein will be exported or not. Whether this is determined 
by structure, sequence, or other features of respective proteins remains elusive. Transport across 
the plasma and parasitophorus vacuole membranes has been shown to be complex and partially 
unknown (11). It is clear that a number of other proteins such as chaperons or heat shock proteins 
(36-38) are interacting with export cargo, and this process might be disturbed generally with the 
addition of a tag (39) or with fragments of chimeric and heterologous proteins. It also has been 
shown that correct folding and unfolding might be highly specific for a particular protein and 
these conditions might not be available in the system presented (40).  
Once exported, these recombinant human proteins could engage with the iRBC cytoskeleton 
by binding to additional free binding sites which in turn might alter cytoskeleton rigidity. 
Microsphiltration to test for such changes showed that there was no difference in rigidity in the 
presence of recombinantly expressed exported cytoskeleton proteins. Except for the 
band4.1_FL_myc_glmS parasite strain at 36 hpi we obtained retention rates similar to what had 
been previously reported in the range of 15-25% and 80-100% for the 12 and 36 hpi time points, 
respectively (41, 42). The difference at 36 hpi might be explained by the fact that we used the 
3D7 strain cultured in Albumax and not the NF54 cultured in serum 
We showed that the presented humanized parasite approach could be a versatile system to 
study function and interaction of a number of human erythrocyte proteins that mostly are 
nonmalleable by genetic means.  
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Figure legends 
Figure 1  
Characterization of human fusion proteins expressed from the pARL_PF13_0275 vector. (A) 
Western blot of supernatants (SN) and pellets (P) from each lysed parasite line were probed with 
antibodies as indicated. Expected molecular weights of the fusion proteins are indicated 
underneath the blots. Anti-GAPDH was used as loading control. (B) Confocal images of transgenic 
parasite lines. Differential interference contrast (DIC) and DAPI images are shown in the first 
column followed by anti-myc, anti-GFP, or anti-HA staining. Column three depicts Cellmask 
staining and column 4 and 5 the merge of fluorescence channels and overlay of all channels, 
respectively (scale bar = 5 μm). (C) Solubility assay of selected exported recombinant human 
cytoskeleton proteins. Fusion proteins were labeled with anti-myc. GAPDH and PFE1605w were 
used as controls for the saponin and carbonate fractions, respectively. PFE1605w was also found 
occasionally in the SDS fraction. 
Figure 2 
Characterization of exported human cytoskeleton fusion proteins with different export 
sequences. (A) Western blots of supernatants (SN) and pellets (P) from lysed parasites were 
probed with anti-myc antibodies. Anti-GAPDH was used as loading control. Expected molecular 
weights of the fusion proteins are indicated underneath the blots. (B) and (C) Confocal images of 
transgenic cell lines. Differential interference contrast (DIC) and DAPI images are shown in the first 
column followed by anti-myc staining. Column three depicts Cellmask staining and column 4 and 
5 the merge of fluorescence channels and overlay of all channels, respectively (scale bar = 5 μm). 
Figure 3 
Characterization of humanized parasites with truncated or mutated cytoskeleton proteins (A) 
Western blots of supernatants (SN) and pellets (P) from lysed parasites were probed with anti-myc 
antibodies. GAPDH was used as loading control. The expected molecular weights of the fusion 
proteins are indicated underneath the blots. (B) Differential interference contrast (DIC) and DAPI 
images are shown in the first column followed anti-myc staining. Column three depicts Cellmask 
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staining and column 4 and 5 the merge of fluorescence channels and overlay of all channels, 
respectively (scale bar = 5 μm).  
Figure 4 
Characterization of humanized parasites with conditionally expressed cytoskeleton proteins. 
(A) Western blots of supernatants (SN) and pellets (P) from lysed parasites were probed with anti-
myc antibodies. GAPDH was used as loading control. The expected molecular weights of the 
fusion proteins are indicated underneath the blots. (B) Differential interference contrast (DIC) and 
DAPI images are shown in the first column followed anti-myc staining. Column three depicts 
Cellmask staining and column 4 and 5 the merge of fluorescence channels and overlay of all 
channels, respectively (scale bar = 5 μm). (C) Microsphiltration of parasites with conditionally 
expressed and exported recombinant human cytoskeleton proteins. The small bar indicates the 
mean of the six technical replicates. The mean values from the six technical replicates are 
summarized for both time points and cell lines in the table. Hpi: hours post invasion. On and off 
refers to the presence or absence of GlcN in the cell culture medium, respectively. 
Figure S1 
Schematic representation of all types and variations of plasmids used to transfect P. 
falciparum 3D7 parasites. GOI: gene of interest, export seq.: export sequence, glmS: 
glucosamine-6-phosphate riboswitch ribozyme. The dashed lines in (C) to (H) represent the 
plasmid backbone from (B). The arrow indicates the start codon and the circle the stop codon. 
Restriction sites that were used for cloning are indicated. 
Figure S2 
Immunofluorescence images of methanol/acetone fixed PF13_0275_band3_1-379_GFP/myc 
cells that were probed with antibodies against the respective molecular tags. DIC (first column) is 
followed by anti-GFP or anti-myc signal, the nuclear stain DAPI, a merge of the fluorescence 
images and finally an overlay of all channels (scale bar = 5 μm). 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Table S1 
Primer Name Sequence (5’ -> 3’)
Cloning Primers pARL constructs
band3_1-379_GFP/
HA/myc
ATAACTCGAGCTTAAtccATGAAGACATACAATTC
band3_1-379_GFP CCTTTACTCATATCGATAAACAATTGACCAGTTTGCTG
band3_1-379_HA CCTCGACCCGGGATGGTACCTCAGGCATAATCTGGAACATCG
band3_1-379_myc CCTCGACCCGGGATGgtacctcataaatcttcttcacttattaatttttg
band3_1-379_myc TCATAAATCTTCTTCACTTATTAATTTTTGTTCCCTAAGCACCACGCTA
G
band3_1-379_myc TCTTCACTTATTAATTTTTGTTCCCTAAGCACCACGCTAG
band_4.2_FL_myc TGGAGAACGTACTAGTATGGGACAAGGAGAACCAAGTCAAAG
band_4.2_FL_myc TAAGCACCACGCTAGCGGCACTTAACTCTGGTGCTAC
band 7_FL_myc TGGAGAACGTACTAGTATGGCAGAAAAGAGACATACAAGAGATAG
band 7_FL_myc TAAGCACCACGCTAGCCCCTAAATGTGAATGTTTAGCAC
band 7_55-288_myc TGGAGAACGTACTAGTAAAATTATTAAAGAGTATGAAAGAGCC
band 7_55-288_myc CCTCGACCCGGGATGGTACCTC
band4.1_FL_myc TGGAGAACGTACTAGTATGACAACAGAAAAAAG
band4.1_FL_myc tccctaagcaccacgctagcTTCATCAGCTAT
Ankyrin_1-827_myc TGGAGAACGTACTAGTATGCCATATAGTGTTGG
Ankyrin_1-827_myc tccctaagcaccacgctagcAAATGATATTAATTCTTC
band4.2_FL and 
7_FL_GFP
ataactcgagcttaagATGAAGACATACAATTCTTTAAAT
band4.2_GFP cctttactcatatcgatGGCACTTAACTCTGGTG
band7_FL_GFP cctttactcatatcgatCCCTAAATGTGAATGTTTAG
band 7_55-288_GFP TGGAGAACGTACTAGTAAAATTATTAAAGAGTATGAAAGAGCC
band 7_55-288_GFP CCTCGACCCGGGATGGTACCAG
band4.1_FL and 
Ankyrin_1-827_GFP
ataactcgagcttaagATGAAGACATACAATTCTTTAAAT
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band4.1_FL_GFP cctttactcatatcgatTTCATCAGCTATTTCTGTTTC
Ankyrin_1-827_GFP cctttactcatatcgatAAATGATATTAATTCTTCTCCTTC
band3_1-379 and 
4.1_FL_myc_glms
AAGAAGATTTATGAGGTACCTCTTGTTCTTATTTTCTCAATAG
band3_1-379 and 
4.1_FL_myc_glms
TATCCCTCGACCCGGGATTTTTCTTCCTCCTAAGATTG
Cloning Primers Export Sequences
1780_b3_1-379_myc aaactcgagATGGCTGTTAGTACATATAATAATAC
1780_b3_1-379_myc aaaactagtTATTTCGTCACTTAATGATTTC
1605_1/2_band3_myc AAACTCGAGATGAGGTTTACTAATTCATTATATTCG
1605_1_band3_myc AAAACTAGTAGATGCAATAAACATATCAGG
1605_2_band3_myc ATATATACACTAGTATAAGGTACTTTATTATG
band3,4.2,7,Ank_myc TTACATATAACTCGAGATGCAAACCCGTAAATATAATAAGATG
band7_55-288_myc TAATAATTTTACTAGTTGCTTCTATATGTGATGACTCTGC
band4.2_FL_myc CTGTTGTCATACTAGTTGCTTCTATATGTGATGACTCTGC
band3_1-379_myc ATTCTTCCATACTAGTTGCTTCTATATGTGATGACTCTGC
ankyrin1-827_myc TATATGGCATACTAGTTGCTTCTATATGTGATGACTCTGC
Cloning Primers Mutations and Truncations
band7_85-218_myc TGGAGAACGTACTAGTCTTCCATGTACAGATAGTTTTATAAAAGTAG
band7_85-218_myc taagcaccacgctagcTCTTGCTTCACGACTAGCTTCTGC
b7_55-288_myc_V179
P
GAAGTTGTACAGGTAATTTTGGGTCTTTTATC
b7_55-288_myc_V179
P
GACTAGCTTCTGCTTCTGCAGCCATTGCTCTTTGAAGTTGTACAGGTA
Ankyrin_1-400_myc TGGAGAACGTACTAGTATGCCATATAGTGTTGGTTTTAGAG
Primer Name Sequence (5’ -> 3’)
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Ankyrin_1-400_myc taagcaccacgctagcAACAGCATCAATACTTGCACCTG
Ankyrin_401-827_myc TGGAGAACGTACTAGTACAGAATCAGGATTAACACCATTAC
Ankyrin_401-827_myc taagcaccacgctagcAAATGATATTAATTCTTCTCCTTCATC
Sequencing Primers
pARL_fwd TATATATATATATATATTTATAATATGTATATTTTAAACTAGAAAAGG
pARL_rv AAAAATTCATATGTATTTTTTTTGTAATTTCTGTGTTTATG
multiple CATACTAGCCATTTTATGTGTGTAAAG
pARL_fwd TATTTTTAGACTATAATATCCG
5'GFP_rev (pARL) ATTTGTGCCCATTAACATCACCATC
pARL_rv GTTCATAATTTTAGCTATTTACATG
band 4.2 CATTTCCCATATCTTCATTAGGTG
band 4.2 TGTTAGGAAGTTGTGATTTAGTAC
band 7 TTCGATTAGGTAGGATATTACAAG
band 3 AGAGTATTTACCAAAGGAACTGTG
b4.1FL_GFP GATTTACATTCATTAAGTTCAG
b4.1FL_GFP TTTAGGAGTTTGTAGTTCAG
Ank_1-827_myc AGGTCATGAAAATGTTGTAG
Ank_1-827_myc AAATGCAAAAGCTAAAGATG
Primer Name Sequence (5’ -> 3’)
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Abstract 
A hallmark of the biology of Plasmodium falciparum blood stage parasites is their extensive 
host cell remodeling, facilitated by parasite proteins which are exported into the erythrocyte. 
Although this area has received extensive attention, only a few exported parasite proteins have 
been analyzed in detail and much of this remodeling process remains unknown, particularly for 
gametocyte development. Recent advances to induce high rates of sexual commitment enable 
the production of large numbers of gametocytes. We used this approach to study 
the  Plasmodium  helical interspersed subtelomeric (PHIST) protein GEXP02, which is expressed 
during sexual development. We show by immunofluorescence that GEXP02 is exported to the 
gametocyte-infected host cell periphery. Co-immunoprecipitation revealed potential interactions 
between GEXP02 and components of the erythrocyte cytoskeleton as well as other exported 
parasite proteins. This indicates that GEXP02 targets the erythrocyte cytoskeleton and is likely 
involved in its remodeling. GEXP02 knock-out parasites show no obvious phenotype during 
gametocyte maturation, transmission through mosquitoes, and hepatocyte infection, suggesting 
auxiliary or redundant functions for this protein. In summary, we performed a detailed cellular and 
biochemical analysis of a sexual stage-specific exported parasite protein using a novel 
experimental approach that is broadly applicable to study the biology of P. falciparum 
gametocytes. 
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Introduction 
Despite major elimination efforts, the death toll due to malaria was more than 400,000 in 
2017, mostly attributed to Plasmodium falciparum and occurring in Sub-Saharan Africa (1). A 
major hurdle in elimination programs is the transmission of parasites to the anopheline vector. 
While pathogenicity of malaria is exclusively linked to asexually replicating blood-stage parasites, 
gametocytes are required for malaria transmission (2). In each replication cycle during blood 
infection, a small sub-population of schizont stage parasites commit to sexual development, 
releasing merozoites that will differentiate into either male or female gametocytes upon red blood 
cell (RBC) invasion (3-6). During gametocytogenesis, P. falciparum parasites differentiate through 
five distinct morphological stages within approximately 10 to 12 days (7) into mature stage V 
gametocytes that are infective to the mosquito vector. 
Proteins which are exported from the parasite into the host cell play a central role in P. 
falciparum biology and are important for parasite survival and virulence. During export, they have 
to cross the parasite plasma membrane and parasitophorous vacuole membrane. A pentameric 
amino acid motif termed Plasmodium export element (PEXEL) is found in most exported proteins 
and targets them for export (8, 9). These proteins enter the secretory pathway and are discharged 
into the parasitophorous vacuole from where they are translocated by the Plasmodium translocon 
of exported proteins (PTEX) into the erythrocyte cytosol (10). Some exported PEXEL-negative 
proteins (PNEP) have been identified. While less is known about the export pathway of PNEPs, it 
seems to converge with that of PEXEL proteins. Once in the host cell cytosol, exported proteins 
are further trafficked to their final destination where they are involved in processes such as 
remodeling of the cytoskeleton, formation of knobs, rigidification, and cytoadhesion in asexual 
intraerythrocytic stages (11-13). Amongst the proteins known or predicted to be exported are 89 
which belong to the Plasmodium helical interspersed subtelomeric (PHIST) family (8, 9, 14, 15). 
Several PHIST proteins have been shown to localize to and interact with the erythrocyte 
cytoskeleton in asexual stages of P. falciparum (15-18) and have thus been proposed to play a role 
in the remodeling of the erythrocyte cytoskeleton. 
While little is known about the role of exported proteins in asexual stages, even less is known 
about their function during gametocytogenesis. However, it seems that the cytoskeleton of the 
gametocyte-infected erythrocyte (GIE) is extensively remodeled from early stage I to mature stage 
V. Host cell rigidity increases to reach its maximum in stage III and then drops during maturation 
from stage IV to stage V (19, 20). Only the deformable banana-shaped stage V gametocytes are 
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found in peripheral circulation whilst stage I-IV gametocytes sequester in the bone marrow 
(21-23). Gametocyte sequestration and the resulting protection from host immunity might be 
facilitated by this cytoskeleton remodeling, enabling the parasite to complete its sexual 
maturation. Understanding the processes underlying the changes in GIE rigidity and sequestration 
properties could lead to new ways of interfering with malaria transmission. Although, exported 
Plasmodium proteins are expected to drive many of the involved modifications and interactions 
with the GIE cytoskeleton, there is a clear lack of knowledge about the role of exported proteins 
in host cell remodeling during gametocyte development (24, 25).  
Here, we studied PF3D7_1102500 (GEXP02), one of several early gametocyte exported 
proteins, which belongs to the PHISTb protein family (26). We show that GEXP02 is expressed 
throughout gametocyte development and demonstrate that it localizes at and associates with the 
GIE cytoskeleton. Through co-immunoprecipitation (co-IP) followed by liquid chromatography 
tandem mass spectrometry (LC-MS/MS), we identified potential GEXP02 interaction partners and 
validated two of these interactions with dual-labeling confocal imaging. gexp02 knock-out 
parasites showed no changes in cell deformability, retained the capacity to exflagellate, infect 
mosquitoes, and produce viable sporozoites that were able to infect liver cells. Hence, GEXP02 
seems to be another dispensable exported protein in P. falciparum, which underpins the point that 
parasites employ redundant mechanisms for crucial biological processes. 
Methods 
Parasite Culture 
Parasites were cultured according to established standard methods (27). Synchronous 
parasites were obtained by sorbitol lysis of late stage asexual parasites (28) or Percoll density 
gradient centrifugation (29). 3D7/GDV1-GFP-DD parasites (30) (here renamed 3D7GDV1) were 
cultured in parasite culture medium (PCM) supplemented with 0.5% Albumax II (Gibco) in 
presence of 5 nM WR99210 (Jacob Pharmaceuticals, Cologne, Germany). 3D7GDV1/GEXP02-HA, 
3D7GDV1/GEXP02-tdTomato, 3D7/GEXP02-HA/0424600-GFP and 3D7GDV1/GEXP02-KO 
parasites were cultured on 5 nM WR99210 and 2.5 μg/ml Blasticidin-S-hydrochloride (BSD) 
(Sigma). NF54/GEXP02-KO was cultured in PCM supplemented with 10% heat-inactivated human 
serum (AB+) on 2.5 μg/ml BSD (Sigma).  
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Induction of gametocytogenesis of 3D7GDV1, 3D7GDV1/GEXP02-HA and 3D7GDV1/
GEXP02-KO was performed as described previously (30). Briefly, synchronized ring stage parasites 
were seeded to a parasitemia of 1.5% at 5% hematocrit and treated with 337.5 nM Shield-1 for 48 
hours to stabilize GDV1-GFP-DD expression. During re-invasion, cultures were kept under shaking 
conditions at 45 rpm to enrich for single parasite RBC infections. After re-invasion, parasites were 
cultured without selection drug in PCM supplemented with 50 mM GlcNAc for five days to 
eliminate asexual stages. Gametocyte cultures were then maintained in PCM until the desired 
gametocyte stages were observed in Giemsa smears. 3D7/GEXP02-HA/0424600-GFP 
gametocytes were generated by overgrowing a synchronous parasite population leading to the 
death of asexual parasites and the survival of developing gametocytes. 
For NF54 and NF54/GEXP02-KO parasites, gametocytogenesis was induced as previously 
published (31). In brief, late stage parasites were obtained using a Percoll density gradient, 
allowed to re-invade fresh RBCs and synchronized eight hours later by sorbitol treatment. At 
24-30 hours post invasion (hpi), parasites were washed once and then cultured in minimal fatty 
acid medium (RPMI-1640 medium supplemented with 25 mM HEPES, 100 μM hypoxanthine, 24 
mM NaHCO3, 390 mg/100 ml fatty acid-free BSA, 30 μM palmitic acid, 30 μM oleic acid). Upon 
re-invasion, parasites were fed with serum-supplemented PCM containing 50 mM GlcNAc for five 
days to eliminate asexual stages and afterwards parasites were fed every second day with serum-
supplemented PCM. 
Cloning 
3D7GDV1/GEXP02-HA parasites were obtained by single crossover integration of the 
pB_GEXP02-HA plasmid into the parasite genome. To obtain pB_GEXP02-HA, pBcam(3xHA)M1 
(32) was digested with BglII and BmtI and the vector backbone pB_3xHA was purified from an 
agarose gel to remove the fragment containing the promoter and mahrp1 coding sequence. The 
1,600 bp 3’ homology region from gexp02 was PCR amplified using primers GsePb1 forward (#1) 
and GsePb1 reverse (#2) and cloned into the purified pB_3xHA backbone using T4 ligase. After 
transfection, parasites were selected on 2.5 μg/ml BSD until a stable population was obtained. To 
enrich for parasites carrying the integrated plasmid BSD pressure was removed for four weeks 
(OFF BSD) followed by re-challenge with 2.5 μg/ml BSD (ON BSD). This OFF/ON BSD cycle was 
repeated two more times. After PCR confirmation of plasmid integration, these parasites were 
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transfected with pHcam-GDV1-GFP-DD (30) to obtain the GEXP02-HA-tagged inducible 
gametocyte producing cell line 3D7GDV1/GEXP02-HA. 
3D7GDV1/GEXP02-tdTomato parasites were generated as described above by single 
crossover integration of the pARL_GEXP02-tdTomato plasmid. pARL_GEXP02-tdTomato was 
cloned by replacing the crt promoter and gfp in the pARL_mGFP vector (33) with a multi-cloning 
site into which the 3’ homology region of gexp02 (primers GsePb1 forward tomato (#3) and 
GsePb1 reverse tomato (#4)) was inserted using PstI/SalI, followed by insertion of a synthetic P. 
falciparum codon-optimized tdtomato sequence PCR-amplified from pEX-K4-Tomato_opt 
(Eurofins genomics, Germany) with primers TdT_F_SalI (#21) and TdT_R_KpnI (#22) (Document S1) 
using SalI/KpnI. Upon PCR confirmation of plasmid integration, these parasites were transfected 
with pHcam-GDV1-GFP-DD (30) to obtain the GEXP02-tdTomato-tagged inducible gametocyte 
producing cell line 3D7GDV1/GEXP02-tdTomato. 
To generate 3D7GDV1/GEXP02-KO and NF54/GEXP02-KO parasites, the respective wild 
type parasites were transfected with the CRISPR-Cas9 plasmid p_gC-GEXP02KO. To obtain p_gC-
GEXP02KO, three PCR products comprising 5’ (346 bp) and 3’ (331 bp) homology boxes flanking 
a blasticidin deaminase resistance cassette were inserted into EcoRI/HindIII-digested p_gC (30) 
using Gibson cloning (34). The homology regions were amplified from 3D7 gDNA (5’ box, primers 
#5 and #6; 3’ box, primers #9 and #10) and the resistance cassette was amplified from 
pBcam(3xHA)M1 (32) (primers #7 and #8). Finally, two complementary oligonucleotides (#11 and 
#12) encoding the guide RNA (nucleotides +811 to +831 with respect to gexp02 start codon) and 
appropriate single-stranded overhangs were annealed and ligated into the gRNA expression 
cassette in this intermediate BsaI-digested vector using T4 ligase. After transfection with this 
CRISPR-Cas9 KO vector parasites were selected on 2.5 μg/ml BSD until drug-resistant stable 3D7/
GEXP02-KO and NF54/GEXP02-KO populations were obtained. The successful gexp02 knock-out 
was confirmed by PCR. 3D7/GEXP02-KO parasites were further transfected with pHcam-GDV1-
GFP-DD (30) to obtain the inducible gametocyte producing GEXP02-KO cell line 3D7GDV1/
GEXP02-KO. For the PF3D7_0424600-GFP construct, P. falciparum 3D7 cDNA was prepared using 
the ImProm-II Reverse transcriptase System (Promega, Switzerland). The coding region of 
pf3d7_0424600 was amplified from cDNA and cloned into the pARL_mGFP vector (33) using AflII 
and ClaI. The episomal pARL_0424600-GFP vector was transfected into 3D7/GEXP02-HA 
parasites followed by selection on 5nM WR99210 and 2.5 μg/ml BSD until stably propagating 
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double transgenic 3D7/GEXP02-HA/0424600-GFP parasites were obtained. All primers are listed 
in Table S1. 
Western blots 
For Western blots, 500 μl blood pellets from ring stage, trophozoite, schizont, and stage I to 
III gametocyte cultures were harvested and lysed, whereas 1.5 ml and 3 ml blood pellets were 
harvested for stage IV and stage V gametocytes, respectively. RBC pellets were lysed in eight 
pellet volumes 0.03% saponin in PBS on ice for 10 min. The washed parasite pellets were 
dissolved in 200 μl sample loading buffer supplemented with 1x Complete Protease Inhibitor (PIC; 
Roche) and DNase I (75ug/ml) (Sigma). Samples were sonicated for 5 min at 30 sec intervals at 
high intensity (Bioruptor, Diagenode) and stored at -20°C until further use. Sample preparation for 
solubility assays was done as described previously (35). 
Parasite lysates were thawed and boiled at 95°C for 5 min, pulse-vortexed and centrifuged at 
full speed for 1 min. 10 μl of supernatant were loaded onto a 4-12% or 12% NOVEX NuPAGE Bis-
Tris gel and run in MOPS or MES buffer (Life Technologies). Proteins were blotted using the iBlot 2 
(Life Technologies) at program P0 and subsequently membranes were blocked in 5% milk in TNT 
(100 mM Tris, 150 mM NaCl, 43 mM HCl, and 0.1% Tween 20). Antibodies were diluted in milk/
TNT. Mouse anti-MAHRP1 (1:500), mouse anti-GAPDH (1:10,000), rabbit anti-GEXP02 (1: 1000, 
(36)), and rat anti-HA 3F10 (1:500; Roche), were used as primary antibodies. Goat anti-mouse-HRP 
(1:10,000; Pierce), goat anti-rabbit-HRP (1:5000; Jackson Immunology), and goat anti-rat-HRP 
(1:10,000; Southern Biotech) were used as secondary antibodies. Silver staining of gels was done 
with the SilverQuest Staining Kit (Invitrogen).  
Trypsin Cleavage Assay 
Stage III gametocytes were purified using a Percoll density gradient (29) and washed in PBS. 
The pellet was split and one aliquot was treated with 100 µg/ml trypsin (Sigma)/PBS for 15 min at 
37°C and the control was incubated in PBS only (500 µl each). The reaction was stopped by 
adding 500 µl 2 mg/ml soybean trypsin inhibitor (Sigma) and samples were incubated for 15 min 
at room temperature. Subsequently, samples were washed once in 1 ml PBS and the pellets were 
lysed in 1 ml 1% Triton X-100/1 mM DTT/PBS for 5 min on ice. After two wash steps in lysis buffer 
the proteins were extracted in 200 µl 2% SDS/10 mM DTT/1xPIC/PBS for 30 min under vigorous 
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shaking at room temperature. Finally, samples were centrifuged at 16,000 g for 20 min and the 
supernatants were subjected to SDS-PAGE. Subsequently, proteins were blotted and the 
membrane was probed with rat anti-HA 3F10 (1:1000; Roche) and rat anti-Glycophorin A (1:1000 
Thermo Scientific). Goat anti-mouse-HRP (1:10,000; Pierce) and goat anti-rabbit-HRP (1:5000; 
Jackson Immunology) were used as secondary antibodies. 
Microsphiltration 
Microsphiltration was performed as described by Lavazec et al. (37). Cultures were adjusted 
to approximately 3-4% gametocytemia at 1.5% hematocrit and 600 μl samples were injected per 
column. Samples were washed through the column with 5 ml medium at a flow rate of 60 ml/h. 
For each experiment and cell line six columns were loaded and Giemsa smears were prepared 
from the flow through and input samples. To determine the parasitemias of the flow through and 
input samples at least 1,000 cells were counted per slide. Experiments were conducted in 
complete PCM supplemented with 10% heat-inactivated serum. For mature gametocytes, the 
collection tubes were placed in a water bath at 37°C to inhibit gametocyte activation and 
exflagellation. No activated or exflagellated gametocytes were detected. 
Exflagellation 
The exflagellation capacity of NF54 and NF54/GEXP02-KO was assessed as published by 
Delves et al. (38). In brief, 10 μl of mature gametocyte culture at 5% hematocrit were mixed with 
an equal volume of exflagellation medium (100 μM xanthurenic acid in complete serum-
complemented PCM) and loaded into a Neubauer improved chamber. The chamber was covered 
with a wet tissue and incubated for 15 minutes at room temperature. Subsequently, exflagellation 
centers were counted in the four outermost grids of a 5x5 16-field grid using 40x magnification on 
a Leica DM1000 LED microscope (Leica Microsystems, Wetzlar, Germany). RBC counts were 
obtained by counting the total number of RBCs in the same grids.  
The percentage of exflagellating cells was obtained by dividing the number of exflagellation 
centers/ml (mean number of four grids x 2 (dilution factor) x 104) by the number of RBCs/ml 
(mean number of four grids x 2 (dilution factor) x 25 x 104) multiplied by 100 (38). The large 
squares in which exflagellation centers were counted contain 100 nl each, whereas the small 
squares in which RBCs were counted contain 4 nl each, thus the latter value was multiplied by the 
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factor 25 to adjust for the volume. Gametocytemia was determined by counting at least 1,000 
RBCs on a Giemsa smear of the same culture.  
Standard Membrane-Feeding Assay 
Anopheles stephensi mosquitoes were reared with a 12 hour day/night cycle at 30°C and 
70-80% humidity. Female mosquitoes at ages 1-5 days were used in standard membrane-feeding 
assay (SMFA) (39, 40). P. falciparum NF54 gametocytes from both parental and NF54/GEXP02-KO 
lines were obtained from a starting culture of 0.5% parasitemia and cultured with continuous 
shaking for two weeks in an automated suspension culture system (41). On day 14 the number of 
mature gametocytes and the male:female ratio was estimated using Giemsa-stained thin smears 
and by counting exflagellation centers. The SMFA was prepared using 1 ml gametocyte culture 
that was added to 600 μl of washed packed RBCs. Cells were spun down for 20 sec at 10,000 rpm 
and resuspended in 600 μl of pre-warmed normal human sera (37°C). Samples were added to pre-
warmed glass feeding devices and 100-150 laboratory raised female mosquitoes were allowed to 
feed for 10 min. Subsequently, all non-fed mosquitoes were removed and the remaining blood 
fed mosquitoes were kept at 26°C and 70-80% humidity. On day 7 post feeding 10-20 
mosquitoes were collected and dissected. The midgut contents were stained with 1% 
mercurochrome for oocysts counts. On day 14 post feeding the salivary glands of a minimum of 
30 mosquitoes were collected and pooled into 1 ml PBS and sporozoites were counted in a 
Bürker Türk counting chamber for a total of four counts per parasite line. 
NF54wt and the NF54/GEXP02-KO parasites lines were allowed to passage through 
mosquitoes (as described above) with slavery gland sporozoites collected on day 15. Primary 
human hepatocytes were incubated with either 10,000 sporozoites for traversal (42) or 50,000 
sporozoites (43) per well as previously described from both the knockout and parental line. Briefly, 
sporozoites for the traversal assay were incubated in conjunction with fluorescein isothiocyanate 
(FITC)-dextran and positive (traversed) hepatocytes counted via flow cytometry (42). For the 
invasion assay infected hepatocytes were fixed in and permeabilised and detected with 3SP2-
FITC antibodies (43) and counted by flow cytometry. 
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Microscopy 
For live cell imaging, 0.5 ml culture was centrifuged at 1200 rpm for 2 min and the pellet was 
resuspended in 0.5 ml pre-warmed PCM. Two μl Hoechst stain (500 μg/ml) were added to the 
sample and incubated for 15 min at 37°C in the dark, after which the cells were pelleted, washed 
and resuspended in one pellet volume PCM. Three μl of Vectashield mounting solution was 
added to 3 μl cell suspension and covered with a coverslip. 
Immunofluorescence assays (IFA) were performed either on methanol-fixed thin blood smears 
(100% methanol, -20°C, 2 min) or, to retain the three dimensional structure of the GIEs, on cells 
cross-linked with 4% paraformaldehyde/0.01% glutaraldehyde as described by Tonkin et al. (44). 
Sheared GIEs as described by Dearnley et al. (24) were blocked with 3% BSA in PBS and 
subsequently incubated with antibodies. The shearing of infected erythrocytes was done as 
previously described (24, 45). Immediately after shearing the slides were blocked in 3%BSA/PBS 
and then probed with antibodies. In all microscopy assays rat anti-HA 3F10 (1:100; Roche), mouse 
anti-Pfs16 (1:500), rabbit anti-GFP (1:200; Abcam), rabbit anti-GEXP02 (1:1000 (36)), mouse anti-
PFI1780w (1:1000; (17)), and mouse anti-glycophorin A (1:200; Abcam) were used as primary 
antibodies, and the matching combination of goat anti-mouse, anti-rabbit, or anti-rat conjugated 
with Alexa Flourophores 405, 488, or 594 (all 1:200; Invitrogen) were used as secondary 
antibodies. Nuclei were stained with DAPI (Vector Laboratories, Inc.) and membranes with 
Cellmask deep red plasma membrane stain (Invitrogen). Images were acquired with a Leica DM 
5000 B in combination with the LAS 4.9.0 software or with a Zeiss LSM700 upright confocal 
microscope, using the ZEN 2010 software and processed with Omero 5.3.3, Imaris 8.4, and 
ImageJ 1.48v.  
Electron Microscopy  
For immuno-electron microscopy (iEM) stage III gametocytes were purified by Percoll density 
gradient, fixed in 2% PFA/0.2% glutaraldehyde in phosphate buffer pH7.4, and then embedded 
according to Tokuyasu et al. (46). Ultrathin sections (70 nm) were prepared on a FC7/UC7-
ultramicrotome (Leica) at -120°C. The sections were immuno-gold labeled with rabbit anti-HA 
(1:30; Invitrogen), mouse anti-Pfs16 (1:100) and rabbit anti-mouse antibodies (1:350; Rockland) as 
secondary antibody against anti-Pfs16 and finally decorated with 5 or 10 nm protein A-gold, 
respectively (1:70; UMC, Utrecht, The Netherlands). Sections were stained with 4% uranyl acetate/
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methylcellulose (1:9) and examined with a Tecnai G2 Spirit or CM100 Philips transmission electron 
microscope at 80 kV. 
Co-Immunoprecipitation 
The 3D7GDV1/GEXP02-HA parasite line was treated with Shield-1 to induce sexual 
conversion. 300 ml of parasite culture at 5% hematocrit and ~7-8% gametocytemia was harvested 
at stage III and GIEs were separated by Percoll density gradient. The pellet was resuspended in 20 
ml 1% paraformaldehyde/PBS. After 30 min at 37°C the reaction was stopped by adding 4.1 ml 
2.5 M glycine. Cells were pelleted, lysed in 150 μl 0.03% Saponin in PBS for 10 min at 4°C, 
washed, resuspended in 5.2 ml sonication buffer (50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 1% SDS, 
1xPIC), and sonicated in 30 s intervals for 15 min at setting ‘high’ (Bioruptor, Diagenode). After 
centrifugation (20,000 g, 4°C) 650 μl supernatant was added to 50 μl magnetic anti-HA beads 
(Pierce), which were washed three times in 1x binding buffer. Four identical technical replicates 
were set up for both the GEXP02-HA co-IP and the negative control co-IP. For the GEXP02-HA co-
IP, 650 μl 2x binding buffer (50 mM Tris (pH 7.4), 300 mM NaCl, 2% Nonidet P40, 1x PIC) were 
added to the supernatant/bead suspension. The negative control co-IP was supplemented with 
450 μl 2x binding buffer and 200 μl HA peptide in 1x binding buffer at 0.5 mg/ml. Samples were 
incubated over night at 4°C on a rotator, the beads were collected using a magnetic stand and 
the supernatant was removed. Beads were washed three times with 500 μl wash buffer (50 mM 
Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% Nonidet P40, 1x PIC) and then washed twice in 
ddH2O. Beads were resuspended in 1x LDS sample buffer (Pierce), boiled for 5 min, and 
processed for LC-MS/MS analysis. 
For the native co-IP, the 3D7GDV1/GEXP02-HA parasite line was treated with Shield-1 to 
induce sexual conversion. 300 ml of parasite culture at 5% hematocrit and ~7-8% gametocytemia 
was harvested at stage III and GIEs were separated by Percoll density gradient. The pellet was 
lysed in 1 ml 0.03% Saponin in PBS for 10 min at 4°C, washed, resuspended in 2 ml extraction 
buffer (0.2% Triton X-100 in PBS, 1 mM EDTA, 1x PIC), incubated on ice for 60 min and then 
pelleted (5 min, 4°C, 16,000 g). The supernatant was used to set up the co-IP using Pierce anti-HA 
magnetic beads that were washed three times in a 1:1 mixture of extraction and 2x binding buffer 
(2x binding buffer: 50 mM Tris-HCl (pH 7.4), 300 mM NaCl, 2% Nonidet P40, 1x PIC). For the 
GEXP02-HA co-IP, 250 μl supernatant were mixed with 250 μl 2x binding buffer and then applied 
to 50 μl washed beads. For the negative co-IP control, 250 μl supernatant, 170 μl 2x binding 
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buffer, and 80 μl HA-peptide (0.5 mg/ml in 1x binding buffer) were added to 50 μl beads. For the 
GEXP-02 co-IP and the negative control, four technical replicates were done each. Samples were 
incubated over night at 4°C on a rotator, the beads were collected using a magnetic stand and 
the supernatant was removed. Beads were washed three times with 500 μl wash buffer (50 mM 
Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% Nonidet P40, 1x PIC). Proteins were then eluted with 
30 μl HA-peptide and 10 μl 4x LDS sample buffer was added to the eluate which was then 
prepared for analysis by mass spectrometry. 
LC-MS/MS analysis 
Samples were loaded onto a 4%-12% gradient Bis-Tris gel (Thermo) and run in 1x MOPS 
buffer at 180 V for 10 min. Each lane was sliced, minced and transferred to a reaction tube, in-gel 
digest was then performed as previously described (47), and samples were stored on StageTips 
(48) until measurement. Digested peptides to be measured were separated on a 25 cm reverse-
phase capillary (75 µM inner diameter, New Objective) packed with Reprosil C18 material (Dr. 
Maisch GmbH) and eluted with a 2 h gradient from 2%-40% acetonitrile buffer followed by a 95% 
acetonitrile wash-out at 200 nl/min on the Easy nLC1000 HPLC system (Thermo). Mass 
spectrometry measurements were performed with a Q Exactive Plus mass spectrometer (Thermo) 
operated with a Top10 data-dependent MS/MS acquisition method per full scan. Spray voltage 
was set to 2.2-2.4 kV. 
Raw MS data was analyzed using MaxQuant v1.5.2.8 (49) with standard settings except match 
between runs and LFQ quantitation was activated. The search was performed against the human 
Uniprot database (81,194 entries) and the Plasmodium falciparum database (PlasmoDB 9.3, 5,538 
entries). The proteinGroups file was filtered for known contaminants and proteins identified from 
the reversed database were removed prior to statistical analysis. Non-measured data points were 
imputed by a beta distribution at the limit of quantitation. Data was plotted as a volcano plot 
using the R environment with in-house scripts: log2 fold enrichment was calculated as median 
from the four replicates and the p-value was determined by a two-sided unpaired t-test Welch. 
The threshold line for enriched proteins is defined with p = 0.05, enrichment = 2 and s0 = 1. 
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Results 
Expression and localization of GEXP02 
GEXP02 is one of few PHIST proteins expressed in early gametocytes and present throughout 
gametocyte development (26, 50). To study GEXP02 in gametocytes we used our recently 
established approach to obtain high gametocyte numbers through conditional over-expression of 
GDV1. This system employs parasites carrying an episomal GDV1-GFP-DD expression cassette 
(3D7GDV1) (30). Upon addition of Shield-1, GDV1-GFP-DD is stabilized, resulting in sexual 
conversion rates of 50-60% (30). Hence, to test for export and localization of GEXP02, we 
generated the 3D7GDV1/GEXP02-tdTomato cell line, which expresses GEXP02-tdTomato under 
control of the endogenous promoter and contains the pHcam-GDV1-GFP-DD episomal plasmid 
(30). Correct tagging of the gexp02 gene was confirmed by PCR on genomic DNA (gDNA) (Figure 
1A). Live fluorescence microscopy revealed that GEXP02-tdTomato localizes to the periphery of 
the GIE in all five gametocyte stages (Figure 1B). 
We also generated a similar cell line (3D7GDV1/GEXP02-HA) where GEXP02 is tagged with a 
triple HA-tag because of its smaller size. Correct integration was confirmed by PCR (Figure 1A). 
Similar to GEXP02-tdTomato, GEXP02-HA localizes to the GIE periphery in all stages as shown by 
immunofluorescence assays (IFA) with a signal also observed within the parasite. We used 
antibodies against Pfs16, a gametocyte-specific protein localizing to the parasitophorous vacuolar 
membrane (PVM) (51), to confirm that GEXP02-HA was exported into the RBC in sexual stages 
(Figure S1A).  
To compare protein abundance of GEXP02-HA in different intra-erythrocytic stages, cell 
lysates were prepared from each stage and run on a SDS-PAGE followed by immunoblotting. 
Almost no signal was detected in asexual stages, while all gametocyte stages showed strong 
signals. The strongest signal was detected in stage I gametocytes and signal strength declined 
continuously throughout the following stages (Figure 1C). To compare the total protein amount 
loaded for each stage, the nitrocellulose membrane was stained with Ponceau S prior to being 
probed with anti-HA antibodies.  
We confirmed the peripheral localization of GEXP02-HA in negatively stained ultrathin 
sections of stage III gametocytes by immunoelectron microscopy. GEXP02-HA was decorated with 
5 nm gold particles and found to be evenly distributed underneath the entire GIE membrane, 
while Pfs16 was decorated with 10 nm gold particles at the PVM (Figure 1D). Using differential 
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protein extraction from Percoll-purified 3D7/GEXP02-HA gametocytes, GEXP02-HA was extracted 
in carbonate buffer suggesting GEXP02 to be a membrane-associated protein (Figure 1E). 
Considering that both our localization and solubility data indicated that GEXP02 localizes to the 
GIE membrane, we wanted to determine if it associates with the cytoskeleton or whether it is 
exposed on the surface of the GIE. After trypsin digestion of intact, Percoll-purified stage III 3D7/
GEXP02-HA GIEs, Western blot analysis showed no cleavage of GEXP02-HA in stage III GIEs 
confirming that GEXP02 is not surface exposed. In contrast, the abundant erythrocyte surface 
protein glycophorin A (52) was found cleaved in the trypsin fraction as its surface exposed C-
terminus could not be detected with an anti-glycophorin A antibody that recognizes the C-
terminus (Figure 1F).  
All localization data suggested close proximity of GEXP02 to the cytoskeleton. To test 
whether there are physical interactions of GEXP02 with the cytoskeleton, we applied controlled 
shear forces to eliminate most of the cell structure and leave behind the cell membrane, 
cytoskeleton, and other structures firmly attached to it (24, 45). After probing with anti-HA 
antibodies and an antibody targeting the extracellular domain of glycophorin A, a substantial 
number of retained structures were filled with red dots (GEXP02-HA) whilst nearly all stained 
positive for glycophorin A, suggesting that GEXP02 binds to the cytoskeleton strongly enough to 
remain attached even under shearing conditions (Figure 1G). Due to the lack of a gametocyte 
marker that associates with the GIE cytoskeleton, we were not able to confirm that all structures 
derived from GIEs were GEXP02-HA-positive.  
Co-immunoprecipitation of GEXP02 
Purified stage III 3D7GDV1/GEXP02-HA GIEs were treated with paraformaldehyde to 
crosslink protein-protein interactions and processed for co-IP to identify potential interaction 
partners of GEXP02. After preparation of the lysate, anti-HA beads were added and half of the 
suspension was saturated with a molar excess of soluble HA-peptides to be used as negative 
control. Four technical replicates of the GEXP02-HA co-IP sample and negative control co-IP were 
simultaneously prepared. After washing and elution of bound proteins, samples were analyzed on 
a silver-stained SDS-PAGE gel. More protein bands were detected in the elution fraction of the 
probe than in the elution fraction of the negative control (Figure 2A). After LC/MS-MS analysis of 
the elution fractions a total of 570 proteins were detected among all eight samples. Of these, 66 
were significantly enriched in the GEXP02-HA co-IP eluates, while only seven proteins were 
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enriched in the negative control co-IP (Figure 2B, Table S2). The ten erythrocyte or parasite 
proteins with the lowest p-value are shown in Figure 2C. In parallel, we performed another co-IP 
experiment under native conditions without crosslinking and only four proteins were found to be 
enriched, namely ankyrin, band 3, and both subunits of spectrin, all of which are part of the 
human band 3 complex that anchors the erythrocyte cytoskeleton to the membrane (Figure 2D) 
(53). The dual identification of these four cytoskeleton proteins in both immunoprecipitations 
(Table S2) provides strong evidence for true interactions between GEXP02 and these RBC 
cytoskeleton proteins. 
Co-labeling of potential interaction partners 
As GEXP02 is a PHIST protein, we wanted to colocalize it with other PHIST proteins that were 
detected in the cross-linked co-IP samples. PF3D7_0800600 and PF3D7_0115100 have the lowest 
p-value but also nearly identical sequences. We therefore selected PF3D7_0424600 and 
PF3D7_0936800 (PFI1780w), two other PHIST proteins that were also among our top ten putative 
GEXP02-interacting candidates (Figure 2C). We transfected 3D7/GEXP02-HA with an episomal 
plasmid encoding PF3D7_0424600-GFP under the regulation of the pfcrt promoter (Figure 3A) 
and gametocytes were obtained by overgrowing highly synchronized cultures. Stage III 
gametocytes were prepared for confocal microscopy and probed with anti-HA (GEXP02) and anti-
GFP (PF3D7_0424600). Both localized to the GIE periphery with the latter also showing a signal 
within the parasite. Anti-Pfs16 was used for two reasons, first to show that the cells positive for 
GEXP02 are indeed gametocytes, and second to label the PVM and thus show that the GEXP02 
and PF3D7_0424600 proteins localise outside the PVM. By staining membranes with CellMask we 
could further confirm the peripheral localization of GEXP02 and a fraction of PF3D7_0424600 
(Figure 3B and Suppl. Figure 1B). Next, we labeled these double-transfected stage III GIEs with 
antibodies against the HA and GFP tags as well as antibodies against PFI1780w, a PHISTc protein 
that is exported to the iRBC membrane in asexual parasites (17). PFI1780w showed a distribution 
highly similar to that of GEXP02-HA, also localizing close to the GIE membrane (Figure 3C and 
Suppl. Figure 1C). A three-dimensional rendering was obtained from z-stacks of stage III 
gametocytes labeled with antibodies against GEXP02-HA, PF3D7_0424600-GFP, and PFI1780w. A 
surface reconstruction of signals of these three proteins showed that all three proteins localize to 
the same space (Figure 3D and Supplementary Video). To further confirm the colocalization of 
GEXP02-HA and PFI1780w at the GIE cytoskeleton, erythrocyte shearing experiments were 
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performed with 3D7GDV1/GEXP02-HA and co-labeled with antibodies against HA and PFI1780w, 
showing a nearly complete overlap of those two signals (Figure 3E) and suggesting that they act 
in concert on the GIE cytoskeleton.  
GEXP02 is not essential for gametocyte maturation in vitro 
To study the role of GEXP02 during gametocyte development and cytoskeleton remodeling, 
we generated two knock-out lines using CRISPR-Cas9-based gene editing: 3D7GDV1/GEXP02-
KO and NF54/GEXP02-KO. Successful deletion of the gexp02 gene was confirmed by PCR 
(Figure 4A) and absence of GEXP02 expression from 3D7GDV1/GEXP02-KO and NF54/GEXP02-
KO was confirmed by Western blotting using GEXP02-specific antibodies (36) (Figure 4B). 
Subsequently, the anti-GEXP02 antibody was used for fluorescence microscopy and wild-type 3D7 
parasites showed strong signals for GEXP02 while only weak background signals were detected in 
3D7GDV1/GEXP02-KO (Figure 4C). Compared to wild-type parasites, both knock-out parasite 
lines showed no obvious morphological aberrations or developmental delays over the course of 
all five gametocyte stages when stained with Giemsa (Figure 4D). 
Gametocyte deformability, exflagellation, and mosquito and liver cell infectiousness of 
GEXP02-KO parasites 
Next we assessed the effect of GEXP02 depletion on GIE rigidity throughout sexual stage 
development. Gametocyte conversion was induced in synchronized NF54wt and NF54/GEXP02-
KO cultures and asexual parasites were removed by a five day treatment with GlcNAc (41). To 
determine the deformability of GIEs, microsphiltration experiments were performed. The 
retention rate in the column is positively correlated to GIE deformability (37). Microsphiltration 
was done with stage III and stage V gametocytes since GIE stiffness reaches the maximum during 
stage III and is lost in stage V gametocytes (19, 54). NF54/GEXP02-KO parasites showed no 
significant differences in retention rates when compared to NF54wt (Figure 4E), indicating that 
depletion of GEXP02 does not affect cytoskeleton rigidity and deformability in stage III or stage V 
gametocytes. 
To test if exflagellation is impaired in absence of GEXP02, we activated stage V gametocytes 
of NF54/GEXP02-KO and NF54wt with xanthurenic acid and quantified exflagellation rates in 
biological triplicates. In all three exflagellation experiments, there was no pronounced difference 
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in the number of exflagellation centers in NF54/GEXP02-KO parasites compared to NF54wt, 
suggesting that the knock-out parasites are equally capable of exflagellating as the wild-type 
parasites (Figure 4F).  
To further explore if the absence of GEXP02 impairs sexual stage development in the 
mosquito vector, we performed standard membrane feeding assays (SMFA). Stage V gametocytes 
of NF54/GEXP02-KO and NF54wt were fed to mosquitoes and oocysts were counted. There was 
no difference in oocyst numbers or numbers of sporozoites produced per oocyst, indicating that 
both parasite lines can be transmitted to and develop in the mosquito with similar efficiency 
(Figure 4G). Furthermore, sporozoites from both parasite lines were able to traverse and invade 
hepatocytes (Figure 4H). Combined, these data show that GEXP02 is not required for maturation 
of gametocytes in vitro, transmission to mosquitoes, sporozoite production, and hepatocyte 
infection.  
Discussion 
There is only a small number of PHIST proteins that have been shown to be expressed in 
gametocytes and very little is known about their function, localization, or interaction partners. 
Therefore, the expression of the exported PHISTb protein GEXP02 throughout all stages of 
gametocyte development and its localization at the host cell cytoskeleton make it an interesting 
candidate to study host-parasite protein interactions in gametocytes. We also detected weak 
signals for GEXP02 in asexual parasites by Western blot but the most likely source of GEXP02 in 
these samples are the small numbers of gametocytes that are always present in in vitro cultures. 
Lasonder et al. found a significant increase of GEXP02 protein levels in male compared to female 
gametocytes (55); however, we did not detect substantial differences in the abundance of GEXP02 
by IFA analysis among individual gametocytes in GDV1-induced cultures where all gametocytes 
stained positive for GEXP02 with similar fluorescence intensities. While our IFA results suggest 
that both male and female gametocytes express GEXP02, we have not quantified GEXP02 protein 
abundance and cannot therefore rule out a slight difference between the sexes. 
Maier and colleagues could generate gexp02 knock-out parasites in the CS2 strain 
background and PfEMP1 presentation and iRBC rigidity was not affected (36). Similarly, we readily 
obtained gexp02 knock-out parasites in 3D7 and NF54 parasites and did not observe any growth-
related phenotypes in both mutants. This is not surprising given that GEXP02 is not expressed to 
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appreciable levels in asexual blood stage parasites. Similar to the observation in asexual parasites, 
depletion of GEXP02 also does not seem to affect gametocytogenesis in vitro. GEXP02 knock-out 
and wild-type gametocytes showed similar deformability properties, were able to exflagellate, 
infected mosquitoes with similar rates of oocyst and sporozoite production, and also showed 
comparable levels of hepatocyte traversal and invasion. Although there is no discernable 
phenotype in the GEXP02 knock-out parasite, we provide some evidence that GEXP02 might play 
a role in host-cell remodeling. Its localization in close proximity to the GIE membrane as shown by 
IFAs and immunoelectron microscopy, its solubility attributes, and the potential RBC cytoskeletal 
interaction partners identified by co-IP followed by LC-MS/MS analysis all suggest that GEXP02 
interacts with the GIE cytoskeleton. This is strongly supported our co-purification of four host cell 
cytoskeleton and membrane proteins (spectrin alpha, spectrin beta, ankyrin, and band 3) with 
GEXP02 in both cross-linked and native co-IP experiments. The lack of an obvious loss-of-function 
phenotype after GEXP02 depletion might be explained by functional redundancy of proteins of 
the PHIST family. In P. falciparum 89 PHIST proteins have been identified (14, 15) and it is 
conceivable that other proteins containing PHIST domains could compensate for the loss of 
GEXP02 in vitro. In fact, we identified two PHIST proteins that co-localized with GEXP02 and 
might fulfill identical or similar roles as GEXP02. It is noteworthy that all hitherto examined PHISTb 
proteins target the host cytoskeleton as has been shown with several episomally over-expressed 
PHISTb-GFP fusion proteins (including GEXP02) (18). It is also important to realize that all 
gametocyte experiments reported here were performed in vitro, and it is conceivable that 
GEXP02 may play an important role in the biology of gametocytes in vivo, which is currently 
extremely difficult if not impossible to be measured for reasons of technical limitations.  
This is one of the first studies to describe and characterize an exported P. falciparum protein 
in gametocytes that is involved in host cell remodeling during gametocytogenesis. It also proves 
the excellent value provided by a novel tool to produce large numbers of synchronous 
gametocytes via conditional expression of GDV1 as described by Filarsky and colleagues (30) for 
the detailed molecular analysis of gametocyte proteins and better understanding of gametocyte 
biology. 
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Figure Legends 
Figure 1.  
Expression, export, and localization of GEXP02: (A) Schematic representation of the 
endogenous and transgenic gexp02 loci indicating location of the homology region (HR) and the 
tdTomato- or HA-tag. Arrows indicate primer sites used to confirm integration of the plasmids into 
the gexp02 locus (the plasmid backbone is indicated as a dotted line). Right panel shows PCR 
products confirming plasmid integration. PCR primers A-C are indicated in the left panel. HA, 
3D7GDV1/GEXP02-HA; tdT, 3D7GDV1/GEXP02-tdTomato; 3D7, 3D7 wild-type. (B) Live 
fluorescence microscopy of all gametocyte stages of the 3D7GDV1/GEXP02-tdTomato parasite 
line. First column shows differential interference contrast (DIC); second column shows tdTomato 
fluorescence; third column shows nuclei stained with Hoechst; fourth column shows an overlay of 
all fluorescence channels; fifth column shows a merge with all images (scale bar = 5 μm). (C) 
Western blot analyses of 3D7GDV1/GEXP02-HA parasite lysates probed with anti-HA antibodies. 
The Ponceau S-stained membrane shows comparable amounts of total protein loaded in each 
lane. (D) Immunoelectron micrograph of negatively stained ultrathin sections of 3D7GDV1/
GEXP02-HA. GEXP02 was probed with anti-HA (5 nm gold, indicated by arrows) and Pfs16 with 
anti-Pfs16 (10 nm gold). PVM: parasitophorous vacuole membrane, GIE: gametocyte-infected 
erythrocyte (white scale bar = 1 μm, black scale bar = 200 nm). (E) Western blot analysis of protein 
extracts obtained from the serial solubility assay probed with antibodies as indicated. Anti-
MAHRP1 (35) and anti-GAPDH served as controls for the respective fractions. (F) Western blot 
analysis of lysed cell pellets of trypsin-treated (right lane) and untreated (left lane) 3D7/GEXP02-
HA stage III gametocytes probed with antibodies against the HA-tag and against glycophorin A. 
(G) IFA using sheared GIEs probed with antibodies against the HA-tag and glycophorin A (GYPA) 
(scale bar = 10 μm). 
  
Figure 2. 
Co-immunoprecipitation (co-IP) and LC-MS/MS: (A) Silver-stained SDS gel of the input, flow 
through (FT), wash, and elution fractions of the co-IP experiment. +, GEXP02 co-IP; -, negative 
control co-IP. (B) Volcano plot showing proteins enriched in the GEXP02-HA and negative control 
Co-IPs using cross-linked samples. Proteins significantly enriched (p < 0.05, enrichment > 2, s0 = 
1) are marked in blue, GEXP02 is highlighted in red. (C) Table showing the ten most significantly 
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enriched exported partners identified by Co-IP using crosslinked samples. The complete list of 
identified proteins can be found in the Supplementary Table 2. (D) Table showing the four proteins 
identified in the native GEXP02-HA co-IP. 
Figure 3.  
Colocalization of GEXP02 with potential interaction partners. (A) Vector map of the plasmid 
used for episomal over-expression of PF3D7_0424600-GFP. Crt: crt promoter; GFP: green 
fluorescent protein. The arrow indicates the start of the coding sequence and the circle the end. 
(B) and (C) Confocal microscopy images of 3D7/GEXP02-HA stage III gametocytes expressing 
PF3D7_0424600-GFP. Antibodies against the epitope tags or native proteins are indicated (scale 
bar = 5 μm). (D) Three dimensional rendering of a stage III gametocyte of the same parasite line 
probed with anti-HA (red), anti-GFP (blue), and anti-PFI1780w (green). The signal of each channel 
is shown as a surface reconstruction (scale bar = 5 μm). An animated 3D image can be found in 
the Supplementary Video. (E) IFAs of sheared stage III gametocytes of 3D7GDV1/GEXP02-HA 
parasites probed with antibodies as indicated (scale bar = 10 μm).  
Figure 4.  
Characterization of GEXP02 knock-out parasites: (A) Schematic representation of the 
endogenous loci of 3D7GDV1, NF54wt, 3D7GDV1/GEXP02-KO, and NF54/GEXP02-KO parasite 
lines. Primer positions used for PCR confirmation of integration are indicated by arrows. Right 
panel: PCR products for 3D7GDV1 (3D7) and NF54 and the corresponding knock-out lines (KO) to 
confirm successful deletion of GEXP02. PCR primers A-F are indicated in the left panel. (B) 
Western blot of 3D7GDV1, 3D7GDV1/GEXP02-HA, and 3D7GDV1/GEXP02–KO as well as 
NF54wt and NF54/GEXP02-KO lysates probed with anti-GEXP02 antibodies to confirm absence 
of GEXP02 in the KO lines. Anti-GAPDH was used as loading control. (C) IFAs of 3D7GDV1 and 
3D7GDV1/GEXP02-KO using an antibody against GEXP02 to confirm the absence of GEXP02 in 
the knock-out cell line. DAPI was used to stain nuclei (scale bar = 5 μm). (D) Giemsa-stained blood 
smears of all five gametocyte stages from NF54 and NF54/GEXP02-KO as well as 3D7GDV1 and 
3D7GDV1/GEXP02-KO parasites. (E) Retention rates of stage III and stage V NF54 and NF54/
GEXP02-KO gametocytes as measured by microsphiltration. (F) Bar chart showing data from three 
biological replicates of exflagellation assays. All measurements were normalized to the 
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exflagellation rates determined for NF54. (G) Summary of the results obtained from mosquito 
feeding experiments. (H) Summary of results from liver infectivity experiments, which measured 
traversal and hepatocyte invasion. The values are in percent. 
Figure S1.  
Co-labeling in immunofluorescence assays: (A) IFAs of all five gametocyte stages of 
3D7GDV1/GEXP02-HA parasites. The first column represents the differential interference contrast 
(DIC) image, the second column shows anti-HA signal labeling GEXP02-HA, the third column 
shows anti-Pfs16 staining, the fourth column depicts a fluorescence overlay and the fifth column is 
a merge of all images. All stages were imaged with the same microscope setting, but because the 
anti-HA signal in gametocyte stages IV and V was weaker the signal was digitally increased post-
acquisition to improve its visibility (scale bar = 5 μm). (B) Confocal microscopy IFAs of 3D7/
GEXP02-HA gametocytes also expressing PF3D7_0424600-GFP. First column shows DIC; second 
column shows anti-GEXP02; third column shows anti-GFP; fourth column shows anti-Pfs16; fifth 
column shows the membrane stain CellMask; sixth column shows an overlay of anti-GEXP02, anti-
GFP, and anti-Pfs16. The seventh column shows an overlay of all fluorescence images and the final 
column shows a merge of all images. (C) Confocal microscopy IFAs of 3D7/GEXP02-HA 
gametocytes also expressing PF3D7_0424600-GFP. First column shows DIC; second column 
shows anti-HA; third column shows anti-GFP; fourth column shows anti-PFI1780w; fifth column 
shows an overlay of the fluorescent images and the sixth column shows a merge of all images 
(scale bars = 5 μm). 
Document S1 
Nucleotide Sequences and alignment of the wild-type and the P. falciparum codon-optimized 
sequences encoding the tdTomato tag.  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Figure 3 
!173
A
D E
DIC a-HA
(GEXP02)
a-GFP
(0424600)
Overlay Mergea-PFI1780w
DIC a-HA
(GEXP02)
a-GFP
(0424600)
Cellmask Mergea-Pfs16 Overlay 1 Overlay 2
a-HA
(GEXP02)
Overlaya-PFI1780w
C
B
PF3D7_0424600-GFP - episome
PF3D7_0424600pfcrt 5’ PbDT 3’GFP
hrp2 hdhfr cam
Chapter 6: Gametocyte PHIST Protein GEXP02   
Figure 4 
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Figure S1 
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Table S1 
Primer Name Sequence (5’ -> 3’)
GsePb1 forward aaaAGATCTGTTAACACTAGAGAACATGG
GsePb1 reverse aaaGCTAGCACCTATATAAGGAGCTTCTG
GsePb1 tomato fw aaaCTGCAGGTTAACACTAGAGAACATGG
GsePb1 tomato rv aaaGTCGACACCTATATAAGGAGCTTCTG
GsePb1 HR1 fwd TCAGGGTAGCTGATATCGGATCCGTATATGGAAATAAGAACGAGC
GsePb1 HR1 rev TTCTATAAATTGATGTGGAATAACATAATACATGTATG
GsePb1 RES fwd TTATGTTATTCCAC ATCAATTTATAGAAACAAAATATATAC
GsePb1 RES rev ATCATTTAGAGTTTGTCTAGATTTAATAAATATGTTCTTATA
GsePb1 HR2 fwd TTATTAAATCTAGACAAACTCTAAATGATTATCCAAAG
GsePb1 HR2 rev GCGAGGAAGCGGAAGCTTTAAGTATATACATCTGTTGATGATAA
GsePb1 gRNA + TATTGGGAAATTAGGAGTAAGAAG
GsePb1 gRNA - AAACCTTCTTACTCCTAATTTCCC
GsePb1 forward aaaAGATCTGTTAACACTAGAGAACATGG
GsePb1 reverse aaaGCTAGCACCTATATAAGGAGCTTCTG
HA integr GACATAAAGTTGTTAGAGCTC
tdTomato integr TACCTTACTTATATAATTCATCC
GsePb1 KO rev ttactttatattccatgtgtag
camR_KO ttatacaagtatatattttgtttctataaattg
GsePb1 KO fwd gtatcttatgttctataattgttc
hrp2F_KO catgttttgtaatttatgggatagcg
PF3D7_0424600 fw ataactcgagcttaagATGAAGTTTTTTAACGGATCAAGCTTT
PF3D7_0424600 rv cctttactcatatcgatTATATCAATAAAATTTTTACTACGCATGA
TdT_F_SalI aaagtcgacATGGTTAGTAAAGGAGAAGAAG
TdT_R_KpnI aaaggtaccttaCTTATATAATTCATCCATACC
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Table S2 
Table with LC/MSMS data from cross-linked and native co-immunoprecipitations available 
under the following DOI: 10.5281/zenodo.2582927. 
Supplementary Video 
Transgenic Plasmodium falciparum stage III gametocyte expressing GEXP02-HA and 
PF3D7_0424600-GFP treated with paraformaldehyde and glutaraldehyde and then labeled with 
antibodies against PF3D7_0936800 (green), HA-tag (red), and GFP-tag (blue). Sections obtained 
with a confocal microscope were visualized in Imaris and a surface resconstruction of all three 
channels was obtained.  
This video can be accessed under the following DOI: 0.5281/zenodo.2579764. 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Document S1 
Wild-type TdTomato: 
atggtgagcaagggcgaggaggtcatcaaagagttcatgcgcttcaaggtgcgcatggagggctccatgaacggccacgagttcg
agatcgagggcgagggcgagggccgcccctacgagggcacccagaccgccaagctgaaggtgaccaagggcggccccctgcc
cttcgcctgggacatcctgtccccccagttcatgtacggctccaaggcgtacgtgaagcaccccgccgacatccccgattacaagaagc
tgtccttccccgagggcttcaagtgggagcgcgtgatgaacttcgaggacggcggtctggtgaccgtgacccaggactcctccctgc
aggacggcacgctgatctacaaggtgaagatgcgcggcaccaacttcccccccgacggccccgtaatgcagaagaagaccatggg
ctgggaggcctccaccgagcgcctgtacccccgcgacggcgtgctgaagggcgagatccaccaggccctgaagctgaaggacgg
cggccactacctggtggagttcaagaccatctacatggccaagaagcccgtgcaactgcccggctactactacgtggacaccaagct
ggacatcacctcccacaacgaggactacaccatcgtggaacagtacgagcgctccgagggccgccaccacctgttcctggggcatg
gcaccggcagcaccggcagcggcagctccggcaccgcctcctccgaggacaacaacatggccgtcatcaaagagttcatgcgcttc
aaggtgcgcatggagggctccatgaacggccacgagttcgagatcgagggcgagggcgagggccgcccctacgagggcaccca
gaccgccaagctgaaggtgaccaagggcggccccctgcccttcgcctgggacatcctgtccccccagttcatgtacggctccaaggc
gtacgtgaagcaccccgccgacatccccgattacaagaagctgtccttccccgagggcttcaagtgggagcgcgtgatgaacttcga
ggacggcggtctggtgaccgtgacccaggactcctccctgcaggacggcacgctgatctacaaggtgaagatgcgcggcaccaact
tcccccccgacggccccgtaatgcagaagaagaccatgggctgggaggcctccaccgagcgcctgtacccccgcgacggcgtgct
gaagggcgagatccaccaggccctgaagctgaaggacggcggccactacctggtggagttcaagaccatctacatggccaagaag
cccgtgcaactgcccggctactactacgtggacaccaagctggacatcacctcccacaacgaggactacaccatcgtggaacagtacg
agcgctccgagggccgccaccacctgttcctgtacggcatggacgagctgtacaagtaa 
P. falciparum Codon optimized tdTomato: 
atggttagtaaaggagaagaagtaataaaagaatttatgagatttaaggtacgaatggaaggatcaatgaatggacatgagtttgaaa
ttgaaggagaaggagaaggtagaccttatgaaggtacgcaaacggctaaattgaaagtaacaaaaggaggtccattaccctttgcat
gggatatattaagtccacaatttatgtatggaagtaaagcatatgtaaaacatccagctgatatacctgattacaagaagttgagttttcca
gagggttttaaatgggaacgtgttatgaattttgaggatggaggtttagtaacagttacacaagattctagtttacaagacgggactctta
tatataaagtgaaaatgagaggaactaattttcctcctgatggaccagtaatgcaaaagaaaacaatgggatgggaggcaagtaccg
aaagattatatcctagagatggagtgttgaaaggagaaatacatcaagcacttaaattaaaagacggtggacactatttggtagaattta
aaactatatatatggccaagaaaccagtacagttacctggatattattatgtagacacgaagttagatattacatcacataatgaagattat
actatagttgaacaatatgaaagaagtgaaggaaggcatcatttattcttaggtcatgggacgggtagtactggtagtggaagttctgg
tactgcttcaagtgaagataacaatatggctgttattaaagaattcatgagatttaaagttagaatggaaggaagtatgaatggtcatga
atttgaaatagagggagaaggtgaaggtcgtccatatgaaggaacacaaaccgcaaaattaaaggtaacaaagggtggaccattac
catttgcttgggatattttatctcctcaatttatgtacggatcaaaagcttatgtaaagcatcccgcagatataccagattataagaaattatc
atttccagaaggtttcaaatgggagagagtaatgaattttgaagatggtggattagttaccgtaactcaagattcttctttacaagatggg
acattaatttataaggttaaaatgcgagggacaaattttccacccgatggtcctgttatgcagaagaaaactatgggttgggaggcatct
acagaaaggttatatcctagggatggtgtgttaaaaggtgaaattcatcaagctttgaaattaaaagatggaggtcactatttagtagaa
ttcaaaacaatatacatggcaaagaaaccagttcaattaccaggttattattatgttgatacaaaattagatataacaagtcataatgagga
ttatacaattgtggaacaatatgagagatctgaagggcgtcatcatttgtttctttatggtatggatgaattatataagta 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Multiple sequence allignment 
TdTomato          MVSKGEEVIKEFMRFKVRMEGSMNGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLPFAWD 60 
TdTomato_opt      MVSKGEEVIKEFMRFKVRMEGSMNGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLPFAWD 60 
                  ************************************************************ 
TdTomato          ILSPQFMYGSKAYVKHPADIPDYKKLSFPEGFKWERVMNFEDGGLVTVTQDSSLQDGTLI 120 
TdTomato_opt      ILSPQFMYGSKAYVKHPADIPDYKKLSFPEGFKWERVMNFEDGGLVTVTQDSSLQDGTLI 120 
                  ************************************************************ 
TdTomato          YKVKMRGTNFPPDGPVMQKKTMGWEASTERLYPRDGVLKGEIHQALKLKDGGHYLVEFKT 180 
TdTomato_opt      YKVKMRGTNFPPDGPVMQKKTMGWEASTERLYPRDGVLKGEIHQALKLKDGGHYLVEFKT 180 
                  ************************************************************ 
TdTomato          IYMAKKPVQLPGYYYVDTKLDITSHNEDYTIVEQYERSEGRHHLFLGHGTGSTGSGSSGT 240 
TdTomato_opt      IYMAKKPVQLPGYYYVDTKLDITSHNEDYTIVEQYERSEGRHHLFLGHGTGSTGSGSSGT 240 
                  ************************************************************ 
TdTomato          ASSEDNNMAVIKEFMRFKVRMEGSMNGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLPFA 300 
TdTomato_opt      ASSEDNNMAVIKEFMRFKVRMEGSMNGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLPFA 300 
                  ************************************************************ 
TdTomato          WDILSPQFMYGSKAYVKHPADIPDYKKLSFPEGFKWERVMNFEDGGLVTVTQDSSLQDGT 360 
TdTomato_opt      WDILSPQFMYGSKAYVKHPADIPDYKKLSFPEGFKWERVMNFEDGGLVTVTQDSSLQDGT 360 
                  ************************************************************ 
TdTomato          LIYKVKMRGTNFPPDGPVMQKKTMGWEASTERLYPRDGVLKGEIHQALKLKDGGHYLVEF 420 
TdTomato_opt      LIYKVKMRGTNFPPDGPVMQKKTMGWEASTERLYPRDGVLKGEIHQALKLKDGGHYLVEF 420 
                  ************************************************************ 
TdTomato          KTIYMAKKPVQLPGYYYVDTKLDITSHNEDYTIVEQYERSEGRHHLFLYGMDELYK 476 
TdTomato_opt      KTIYMAKKPVQLPGYYYVDTKLDITSHNEDYTIVEQYERSEGRHHLFLYGMDELYK 476 
                  ******************************************************** 
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Malaria remains one of the deadliest infectious diseases worldwide (1) with Plasmodium 
falciparum being accountable for most deaths (2). About halfway into the 48 hour intraerythrocytic 
asexual developmental cycle, the major parasite derived virulence factor PfEMP1 is inserted into 
the infected red blood cell (iRBC) membrane (3). PfEMP1-mediated cytoadhesion to endothelial 
cells allows parasites to sequester in the vasculature and thus escape splenic clearance (4, 5), a 
mechanisms that is linked to severe malaria (6, 7). On the cytosolic side of the iRBC membrane, 
PfEMP1 is anchored to the cytoskeleton in electron-dense protrusions called knobs (8, 9). This 
anchoring requires major refurbishment of the erythrocyte which is devoid of any protein 
translation or trafficking machinery. It requires cellular reorganization and a general modulation of 
the cytoskeleton that results in altered iRBC deformability and rigidity. Hence, the parasite has to 
establish a protein trafficking machinery to export parasite proteins into the iRBC where they carry 
out their function (10). Several exported proteins have been shown to target the iRBC 
cytoskeleton during asexual intraerythrocytic stages. Amongst these are MESA (11, 12), Pf332 (13, 
14), PfEMP3 (15, 16), as well as members of the Plasmodium helical interspersed subtelomeric 
(PHIST) family, namely RESA (17, 18), PF3D7_0402000 (19, 20), PF3D7_0532400 (LyMP or 
PFE1605w) and PF3D7_0936800 (PFI1780w) (21-23). Less is known about protein export and the 
extent of cytoskeleton remodeling in gametocytes. One example of an exported protein targeting 
the gametocyte-infected erythrocyte (GIE) cytoskeleton is STEVOR, which has been shown to 
modulate the deformability of the GIE, a process that is linked to gametocyte sequestration (24). 
Hence, the cytoskeleton is the target of many exported proteins and therefore represents an 
interface of host-parasite interactions during all intraerythrocytic stages. Identifying and 
understanding the key players and process involved in cytoskeleton remodeling will contribute to 
a more detailed understanding of the intracellular survival mechanisms of the malaria parasite. 
In this study, we therefore set out to understand the function of the PHIST protein family and 
establish an interaction network of exported proteins. The first project presents findings from a 
study on selected members of the large family of exported proteins, the PHIST protein family (25, 
26). A new approach to express and export recombinant human proteins in P. falciparum to be 
used in interaction studies between host and parasite proteins is presented in the second project. 
In the third project, we investigated the exported PHIST protein GEXP02 (PF3D7_1102500) and its 
potential role in host cell remodeling during gametocyte development. In addition, I conducted 
two extensive literature reviews on the PHIST protein family and iRBC cytoskeleton remodeling to 
combine and analyze existing knowledge with the aim of drawing new conclusions and gaining an 
even deeper understanding of host cell remodeling during P. falciparum infection. 
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With 89 members, the PHIST family comprises ~14% of the PEXEL proteins (25, 26). It is 
therefore to be expected that its members play an important role in host cell remodeling. 
Previous immunoprecipitations with the Maurer’s cleft protein MAHRP1 identified a number of 
PHIST proteins (unpublished and (27)) and started the interest of our lab in the PHIST family. While 
it was not feasible to investigate all of them at once, a selection has been made that was based 
on the presence of the MESA-erythrocyte cytoskeleton binding motif (28) or previous reports of 
peripheral localization in the iRBC (29). I could show that most of the selected PHIST proteins 
localize to the iRBC cytoskeleton which is in agreement with previous studies on PHIST proteins 
(21, 23, 29) and supported our hypothesis that this protein family might play a central role in host 
cell remodeling. 
To study the interactions of the selected proteins, BioID was used because it does not require 
protein-protein interactions to remain intact, a feature needed to sufficiently solubilize cytoskeletal 
proteins for immunoprecipitations. The biotin ligase BirA* is fused to the bait protein and 
covalently biotinylates proximal protein (30). While BioID proved to be a fairly simple way to 
screen for potential interaction partners, its limitations also became obvious. The low activity of 
the BirA* ligase required 20 hours incubation (31) and resulted in the labeling and identification of 
many proteins involved in translation and trafficking, proteins that are only temporary interaction 
partners, but not the final target of the bait. Further improvements to BioID such as a drastic 
reduction of the incubation time are required to make this an even more powerful tool. 
Nevertheless, I used the data obtained with BioID in combination with data from previous 
immunoprecipitation studies to generate a network of interactions between erythrocyte 
cytoskeleton and exported P. falciparum parasite proteins. The presence of cytoskeletal proteins in 
each BioID or immunoprecipitation again confirmed our hypothesis that the investigated PHIST 
proteins target the cytoskeleton. At the same time, a number of other exported parasite proteins 
were identified. Their recurrence in multiple experiments and their resulting interconnected status 
in the protein interaction network suggest that they interact in concert with the investigated 
proteins. This network forms the basis for further research on iRBC cytoskeleton remodeling. Since 
proximity does not necessarily result in a physical interaction, each of the proposed interactions 
from the network must be confirmed in the future on an individual basis using techniques such as 
reverse immunoprecipitations, colocalization analyses, or biochemical interaction studies.  
Having identified potential protein-protein interactions, their verification would be the next 
step. Adding molecular tags to potential interaction partners and performing co-localization 
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analyses or reverse immunoprecipitations would be two frequently employed approaches. An 
interesting facet of iRBC cytoskeleton remodeling is the interaction between proteins from two 
different species and types of cells. In this context, the human erythrocyte presents additional 
challenges as it is terminally differentiated and lacks a nucleus, making the genetic manipulation 
of erythrocytes and thus the generation of fusion proteins difficult. One workaround would be to 
manipulate erythrocyte precursor cells (32-34), which is cost-intensive and yields only small 
amounts of cells preventing large-scale cultures required for immunoprecipitations. As alternative, 
I have successfully designed and established a method which allows the expression of 
recombinant erythrocyte proteins in the parasite and targets these proteins for export into the 
host cell via its own established protein trafficking machinery. This humanized parasite approach 
was designed in a way that these recombinant human proteins should be soluble in the 
erythrocyte cytosol. This would eliminate the problem of releasing cytoskeleton proteins in 
immunoprecipitations from the skeleton. While in the iRBC cytosol, the fusion proteins are 
expected to bind their putative parasite interaction partners on their way to their final destination 
within the host cell. Thus, they can be used to screen for new or confirm potential interaction 
partners.  
We showed that different N-termini from exported proteins including the signal peptide and 
PEXEL motif target recombinant erythrocyte cytoskeleton proteins for export into the host cell. 
For some of our fusion proteins, namely band3_1-379 and band4.1_FL, any combination of export 
sequence and tag resulted in efficient protein export. However, other proteins were hardly 
exported at all, regardless of which export sequence of tag was added. PEXEL proteins are 
translocated through the PTEX (35, 36) and protein unfolding is necessary in this process (37). It is 
therefore conceivable that sequence and structure of the selected human proteins might influence 
their ability to be unfolded prior to translocation though the PTEX. The ankyrin repeat is a very 
stably folded structural motif (38) and is present 23 times in the Ankyrin_1-827 construct and over 
10 times in each of both truncated Ankyrin_1-400 and Ankyrin_401-827 constructs (InterPro search 
using ankyrin accession number P16157). Inefficient or unsuccessful unfolding could explain the 
observed partial export while most of the protein seems to be retained in the parasite or 
parasitophorous vacuole. While band7_55-288 was not exported, the stomatin domain alone 
(band7_85-218) was well exported into the host cell indicating that some features of 
band7_55-288 might interfere with export. In general, the humanized parasite approach offers 
new ways to express and export recombinant erythrocyte proteins in the malaria parasite P. 
falciparum to study host-parasite protein interactions or other features requiring heterologous 
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genes being expressed as recently has been shown with human redox reporter (39). While most 
research on exported P. falciparum proteins has focused on asexual stages, less is known about 
the extent of protein export and especially the role and function of exported proteins during 
gametocyte development. Understanding the mechanisms that play a role in rigidity and 
deformability changes during gametocyte development (40) that lead to sequestration in 
extravascular spaces of the bone marrow (41) would therefore be important for the identification 
of new targets in the effort to stop gametocyte development and thus transmission to the 
mosquito vector. 
Taking advantage of recent advances in achieving high sexual conversion rates in vitro (42), I 
set out to investigate the role of GEXP02, a PHIST protein that has been reported to be expressed 
early in gametocytes (43). Here I have shown that GEXP02, along with two other PHIST proteins 
that were identified as potential interaction partners, targets the GIE cytoskeleton. While no 
function could be attributed to GEXP02 yet, our work shows that exported proteins target the GIE 
cytoskeleton and thus play a potential role in host cell remodeling at this stage as well. Despite 
initially finding fewer exflagellation centers in vitro, we could not observe an effect in biological 
replicates. Although it is tantalizing to consider a more male centered function of GEXP02 
because of the previously observed increased expression in male gametocytes (44) we need to 
assume that even if a small effect would be due to the lack of GEXP02, it has no significance for 
natural infections. 
Major differences in cytoskeleton remodeling between asexual stages and gametocytes have 
been observed, e.g. gametocytes lack knobs (45), which eliminates the need to locally restructure 
the cytoskeleton for their anchoring. In contrast, gametocytes present STEVOR on their surface, 
which has been implicated in the continuous increase of GIE rigidity up to stage IV. When 
transitioning from stage IV to stage V, STEVOR is lost from the surface and rigidity decreases (40, 
46). Interestingly, immunofluorescence analyses suggest that GEXP02 it partially internalized 
during stages IV and V, which coincides with the loss of STEVOR from the surface and the 
decreased rigidity. Although the mechanisms of this switch in GIE rigidity has not yet been solved, 
it shows that cytoskeleton remodeling does occur in gametocytes. The peripheral localization of 
exported proteins in gametocytes as shown by our study adds further evidence to their 
involvement in host cytoskeleton remodeling also during these stages. 
Erythrocyte cytoskeleton remodeling seems to occur in both asexual and sexual stages. The 
PHIST protein PFI1780w for example was previously found at the cytoskeleton of asexual stages 
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(21) and could now also be detected in this study. It is conceivable that protein such as PFI1780w 
might fulfil a general role in all intraerythrocytic stages, such as a general modulation or regulation 
of cytoskeletal integrity and stability. The presence of knobs in asexual stages (45) implies that 
some remodeling is specific to asexual stages whilst sexual stage-specific expression and 
presence of GEXP02 at the GIE cytoskeleton in turn suggests that some exported proteins might 
remodel the cytoskeleton only in gametocytes.  
In addition to the experimental data generated in this study, I performed two extensive 
literature reviews. One review focused on the molecular mechanisms of erythrocyte cytoskeleton 
remodeling during P. falciparum infection. Combining findings from nearly 200 publications, a 
more detailed picture of the remodeling process was gained. It became apparent that remodeling 
is highly stage-specific to meet the requirements of the growing parasite at specific times within 
its life cycle. Understanding these requirements will help to formulate and test new hypotheses for 
future research.  
In my second review I focused on the PHIST protein family, which has been central to the 
experimental studies on iRBC cytoskeleton remodeling conducted in this thesis work. Although 
PHIST proteins have been described as protein family over a decade ago, there has not been a 
global study on the entire PHIST family. Many research articles on exported proteins and host 
remodeling mention one or more members of the PHIST family. Collecting individual references to 
PHIST proteins form primary literature and accompanying supplementary data and using various 
protein identifications, I was able to collect comprehensive information on this large protein 
family. Although it is yet impossible to clearly attribute specific functions or roles to most PHIST 
proteins or to the different subgroups, the combined data strongly supports the notion that PHIST 
proteins play an important role in iRBC cytoskeleton remodeling. 
In conclusion, the present thesis underlines the relevance of investigating exported P. 
falciparum proteins in the context of host cell remodeling. I could show that several PHIST 
proteins target the iRBC or GIE cytoskeleton. Furthermore, with the humanized parasite approach, 
I have designed and developed a system to express erythrocyte cytoskeleton proteins in P. 
falciparum and to export them into the host cell cytosol. With the exported gametocyte protein 
GEXP02, I present a detailed analysis of a previously uncharacterized PHIST protein. 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2015   European Congress on Tropical Medicine and International    
   Health, Basel, Switzerland 
Teaching and Training Experiences 
2018    Supervision of Master Students, Swiss TPH, Basel, Switzerland 
   Training and supervision of two master students during the 12 months 
   long lab and thesis work with the title „Using humanized malaria   
   parasites to study protein interactions at the erythrocyte    
   cytoskeleton“ 
2017   Supervision of Master Student, Swiss TPH, Basel, Switzerland 
   Training and supervision of one master student during the 12 months  
   long lab and thesis work with the title „PHISTb proteins and their   
   interactions with the human cytoskeleton“    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   Block Course for Bachelor Students, Swiss TPH, Basel, Switzerland 
   Training and supervision of 4 bachelor students during a two   
   week course in a molecular biology lab, working on     
   Plasmodium falciparum 
2016   Supervision of Master Student, Swiss TPH, Basel, Switzerland 
   Training and supervision of one master student during the 12 months  
   long lab and thesis work with the title „Studies on interaction of   
   PHIST proteins with the host cytoskeleton and the VAR2CSA-encoded 
   PfEMP1“ 
   Block Course for Bachelor Students, Swiss TPH, Basel, Switzerland 
   Training and supervision of 3 bachelor students during a two   
   week course in a molecular biology lab, working on     
   Plasmodium falciparum 
2015   Block Course for Bachelor Students, Swiss TPH, Basel, Switzerland 
   Training and supervision of 4 bachelor students during a two   
   week course in a molecular biology lab, working on     
   Plasmodium falciparum 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